# EDGAR Filing Document

**Accession Number:** 0001786286
**File Stem:** 0001493152-25-021962
**Filing Date:** 2025-11
**Character Count:** 255794
**Document Hash:** 87477edbf1327b354faa21daf413d5c3
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-25-021962.hdr.sgml**: 20251112

**ACCESSION NUMBER**: 0001493152-25-021962

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 103

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251112

**DATE AS OF CHANGE**: 20251112

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Draganfly Inc.
- **CENTRAL INDEX KEY:** 0001786286
- **STANDARD INDUSTRIAL CLASSIFICATION:** AIRCRAFT [3721]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 000000000
- **STATE OF INCORPORATION:** A1
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40688
- **FILM NUMBER:** 251473552

**BUSINESS ADDRESS:**
- **STREET 1:** 2108 ST. GEORGE AVENUE
- **CITY:** SASKATOON
- **STATE:** A9
- **ZIP:** S7M 0K7
- **BUSINESS PHONE:** 403-781-6671

**MAIL ADDRESS:**
- **STREET 1:** 235 103RD ST. E.
- **CITY:** SASKATOON
- **STATE:** A9
- **ZIP:** S7N 1Y8

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16**

**UNDER THE SECURITIES EXCHANGE ACT OF 1934**

For the month of **November 2025**

Commission File Number: **001-40688**

**DRAGANFLY INC.**

(*Name of registrant*)

**235 103<sup>rd</sup> St. E.**

**Saskatoon, Saskatchewan S7N 1Y8**

**Canada**

*(Address of principal executive office)*

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

☒ Form 20-F ☐ Form 40-F

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  |  | **Draganfly Inc.** |
|  |  | (Registrant) |
| Date: November 12, 2025 |  | */s/ Paul Sun* |
|  | Name: | Paul Sun |
|  | Title: | Chief Financial Officer |

---

**Form 6-K Exhibit Index**

---

| | |
|:---|:---|
| **Exhibit Number** | **Document Description** |
| 99.1 | [Unaudited Condensed Consolidated Interim Financial Statements for the Three and Nine Months Ended September 30, 2025.](ex99-1.htm) |
| 99.2 | [Management's Discussion and Analysis for the Three and Nine Months Ended September 30, 2025.](ex99-2.htm) |
| 99.3 | [Certification of the CEO Pursuant to NI 52-109.](ex99-3.htm) |
| 99.4 | [Certification of the CFO Pursuant to NI 52-109.](ex99-4.htm) |

---

## Exhibit 99.1

?xml version='1.0' encoding='ASCII'?

**Exhibit 99.1**

![](ex99-1_001.jpg)

**Draganfly Inc.**

**Condensed Consolidated Interim Financial Statements - Unaudited**

**For the Three and Nine Months Ended September 30, 2025**

**(Expressed in Canadian Dollars)**

**Draganfly Inc.**

**Condensed Consolidated Interim Statements of Financial Position - Unaudited**

**Expressed in Canadian Dollars**

---

| | | | |
|:---|:---|:---|:---|
|  |  | **September 30,** | December 31, |
| **As at** | Notes | **2025** | 2024 |
| **ASSETS** |  |  |  |
| Current Assets |  |  |  |
| &nbsp;&nbsp;&nbsp;Cash |  | $**69881348** | $6252409 |
| &nbsp;&nbsp;&nbsp;Receivables | 4 | **1249555** | 573390 |
| &nbsp;&nbsp;&nbsp;Inventory | 5 | **2930594** | 1532263 |
| &nbsp;&nbsp;&nbsp;Prepaids and deposits | 6 | **1913632** | 724513 |
| Total current assets |  | **75975129** | 9082575 |
| &nbsp;&nbsp;&nbsp;Equipment | 7 | **780836** | 529542 |
| &nbsp;&nbsp;&nbsp;Intangible assets |  | **38370** | 45141 |
| &nbsp;&nbsp;&nbsp;Investments |  | **21428** | 14286 |
| &nbsp;&nbsp;&nbsp;Receivable | 4 | **-** | 156200 |
| &nbsp;&nbsp;&nbsp;Right of use assets | 8 | **265298** | 372344 |
| **TOTAL ASSETS** |  | $**77081061** | $10200088 |
| **LIABILITIES AND SHAREHOLDERS' EQUITY** |  |  |  |
| Current Liabilities |  |  |  |
| &nbsp;&nbsp;&nbsp;Trade payables and accrued liabilities | 1016 | $**2997745** | $2399187 |
| &nbsp;&nbsp;&nbsp;Customer deposits |  | **81415** | 466295 |
| &nbsp;&nbsp;&nbsp;Deferred income | 11 | **168637** | 18542 |
| &nbsp;&nbsp;&nbsp;Derivative liability | 12 | **3037087** | 2198121 |
| &nbsp;&nbsp;&nbsp;Lease liabilities | 9 | **151033** | 154147 |
| Total current liabilities |  | **6435917** | 5236292 |
| Non-current Liabilities |  |  |  |
| &nbsp;&nbsp;&nbsp;Deferred Income | 11 | **49908** | 68139 |
| &nbsp;&nbsp;&nbsp;Lease liabilities | 9 | **162815** | 273874 |
| **TOTAL LIABILITIES** |  | **6648640** | 5578305 |
| **SHAREHOLDERS' EQUITY** |  |  |  |
| &nbsp;&nbsp;&nbsp;Share capital | 12 | **188400703** | 110742984 |
| &nbsp;&nbsp;&nbsp;Reserves – share-based payments | 12 | **8898765** | 7698304 |
| &nbsp;&nbsp;&nbsp;Reserves - warrants |  | **4337236** | 3776428 |
| &nbsp;&nbsp;&nbsp;Accumulated deficit |  | **(130822612)** | (117465829) |
| &nbsp;&nbsp;&nbsp;Accumulated other comprehensive income |  | **(381671)** | (130104) |
| **TOTAL SHAREHOLDERS' EQUITY** |  | **70432421** | 4621783 |
| **TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY** |  | $**77081061** | $10200088 |

---

**Nature and Continuance of Operations** (Note 1)

**Subsequent events (**Note 18**)**

Approved and authorized for issuance by the Board of Directors on November 12, 2025.

---

| | |
|:---|:---|
| ***"Scott Larson"*** | ***"Cameron Chell"*** |
| *Director* | *Director* |

---

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

**Draganfly Inc.**

**Condensed Consolidated Interim Statements of Comprehensive loss - Unaudited**

**Expressed in Canadian Dollars**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  |  | **For the three months ended** | **For the three months ended** | **For the nine months ended** | **For the nine months ended** |
|  |  | **September 30, 2025** | September 30, 2024 | **September 30, 2025** | September 30, 2024 |
| Sales of goods | 13.0 | $**1622286** | $1328675 | $**5065682** | $3953974 |
| Provision of services | 13.0 | **533707** | 556647 | **753281** | 993920 |
| **TOTAL REVENUE** |  | **2155993** | 1885322 | **5818963** | 4947894 |
| **COST OF SALES** | 5.0 | **(1735046)** | (1444542) | **(4583337)** | (3765429) |
| **GROSS PROFIT** |  | **420947** | 440780 | **1235626** | 1182465 |
| **OPERATING EXPENSES** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Amortization |  | $**2257** | $2821 | $**6771** | $8464 |
| &nbsp;&nbsp;&nbsp;Depreciation | 78.0 | **85939** | 139358 | **234403** | 424039 |
| &nbsp;&nbsp;&nbsp;Director fees | 16.0 | **122965** | 131469 | **394803** | 375369 |
| &nbsp;&nbsp;&nbsp;Insurance |  | **157314** | 234279 | **468315** | 954259 |
| &nbsp;&nbsp;&nbsp;Office and miscellaneous | 14.0 | **1330796** | 620696 | **3209956** | 1699555 |
| &nbsp;&nbsp;&nbsp;Professional fees |  | **85395** | 424717 | **691458** | 1229244 |
| &nbsp;&nbsp;&nbsp;Research and development |  | **321331** | 347373 | **609029** | 659832 |
| &nbsp;&nbsp;&nbsp;Share-based payments | 1216.0 | **474729** | 400575 | **1139063** | 904629 |
| &nbsp;&nbsp;&nbsp;Travel |  | **302573** | 57436 | **607615** | 174367 |
| &nbsp;&nbsp;&nbsp;Employee and management expenses | 16.0 | **2463477** | 1766354 | **6870712** | 5622176 |
| Total operating expenses |  | **(5346776)** | (4125078) | **(14232125)** | (12051934) |
| **OTHER INCOME (EXPENSE)** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Change in fair value of derivative liability | 12.0 | **(1837618)** | 3575559 | **(1860107)** | 2788734 |
| &nbsp;&nbsp;&nbsp;Finance and other gain |  | **366000** | 38632 | **410494** | 85436 |
| &nbsp;&nbsp;&nbsp;Foreign exchange gain (loss) |  | **1127680** | (48216) | **1023272** | 26344 |
| &nbsp;&nbsp;&nbsp;Gain (loss) on disposal of assets |  | **16545** | 7846 | **16242** | 32148 |
| &nbsp;&nbsp;&nbsp;Gain (loss) on recovery (impairment) of notes receivable |  | **35461** | 7564 | **69646** | 18425 |
| &nbsp;&nbsp;&nbsp;Other income (expense) | 15.0 | **47964** | (97281) | **(19831)** | (1237169) |
| Total Other operating income |  | $**(243968)** | $3484104 | $**(360284)** | $1713918 |
| **NET LOSS** |  | $**(5169797)** | $(200194) | $**(13356783)** | $(9155551) |
| **OTHER COMPREHENSIVE INCOME (LOSS)** |  |  |  |  |  |
| **Items that may be reclassified to profit or loss** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Foreign exchange translation |  | **(248065)** | 1086 | **(258710)** | (15935) |
| **Items that will not be reclassified to profit or loss** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Change in fair value of equity investments at FVOCI |  | **(7142)** | (165441) | **7143** | (175117) |
| &nbsp;&nbsp;&nbsp;**COMPREHENSIVE LOSS** |  | **(5425004)** | (364549) | **(13608350)** | (9346603) |
| **Net Loss per share – Basic & diluted** |  | $**(0.25)** | $(0.06) | $**(1.17)** | $(3.28) |
| **Weighted average number of common shares outstanding – Basic & diluted** |  | **20555945** | 3351778 | **11379877** | 2794072 |

---

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

**Draganfly Inc.**

**Condensed Consolidated Interim Statements of Changes in Shareholders' Equity - Unaudited**

**Expressed in Canadian Dollars**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | | | | | | **Accumulated Other Comprehensive Income (Loss)** | **Accumulated Other Comprehensive Income (Loss)** | **Accumulated Other Comprehensive Income (Loss)** |
|  |<br>**Number of Shares** |<br>**Share Capital** |<br>**Reserve – Share-Based Payments** |<br>**Reserves – Warrants** |<br>**Accumulated Deficit** | **Change in Fair Value of Investments at FVTOCI** | **Exchange Differences on Translation of Foreign Operations** | **Total Shareholders' Equity** |
| **Balance at December 31, 2023** | **1969566** | $**97070976** | $**6870139** | $**-** | $**(103588356)** | $**(434303)** | $**489260** | $**407716** |
| Shares issued for financing | 1077208 | 5111911 |  |  |  |  |  | 5111911 |
| &nbsp;&nbsp;&nbsp;Share issue costs |  | (877474) | 327696 |  |  |  |  | (549778) |
| Shares issued for the exercise of warrants | 791668 | 4056657 |  |  |  |  |  | 4056657 |
| Shares issued for the exercise of RSUs | 22766 | 829361 | (829361) |  |  |  |  |  |
| Warrants – equity treatment |  |  |  | 3776428 |  |  |  | 3776428 |
| Share-based payments |  |  | 904628 |  |  |  |  | 904628 |
| Shares returned to treasury | (36000) |  |  |  |  |  |  |  |
| Net loss |  |  |  |  | (9155551) |  |  | (9155551) |
| Change in fair value of equity investments at FVOCI |  |  |  |  |  | (175117) |  | (175117) |
| Translation of foreign operations | - | - | - | - | - | - | (15935) | (15935) |
| **Balance at September 30, 2024** | **3825208** | $**106191431** | $**7273102** | $**3776428** | $**(112743907)** | $**(609420)** | $**473325** | $**4360959** |
| Shares issued for financing | 400000 | 5272234 |  |  |  |  |  | 5272234 |
| &nbsp;&nbsp;&nbsp;Share issue costs |  | (755397) | 181758 |  |  |  |  | (573639) |
| Shares issued for the exercise of warrant | 1200000 | 171 |  |  |  |  |  | 171 |
| Shares issued for the exercise of RSUs | 2587 | 34545 | (34545) |  |  |  |  |  |
| Share-based payments |  |  | 277989 |  |  |  |  | 277989 |
| Net loss |  |  |  |  | (4721922) |  |  | (4721922) |
| Translation of foreign operations | - | - | - | - | - | - | 5991 | 5991 |
| **Balance at December 31, 2024** | **5427795** | $**110742984** | $**7698304** | $**3776428** | $**(117465829)** | $**(609420)** | $**479316** | $**4621783** |
| Unites issued for financing | 11887895 | 56907745 |  | 1103825 |  |  |  | 58011570 |
| Share issue costs |  | (7203673) | 2225727 |  |  |  |  | (4977946) |
| Shares issued for exercise of overallotment | 100000 | 294000 |  |  |  |  |  | 294000 |
| Share issue costs – overallotment |  | (28030) |  |  |  |  |  | (28030) |
| Shares issued for the exercise of warrants | 5711131 | 26438554 | (915207) | (543017) |  |  |  | 24980330 |
| Shares issued for the exercise of RSUs | 134191 | 1249123 | (1249123) |  |  |  |  |  |
| Share-based payments |  |  | 1139063 |  |  |  |  | 1139063 |
| Net loss |  |  |  |  | (13356783) |  |  | (13356783) |
| Change in fair value of equity investments at FVOCI |  |  |  |  |  | 7143 |  | 7143 |
| Translation of foreign operations | - | - | - | - | - | - | (258710) | (258710) |
| **Balance at September 30, 2025** | **23261012** | $**188400703** | $**8898765** | $**4337236** | $**(130822612)** | $**(602277)** | $**220606** | $**70432421** |

---

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

**Draganfly Inc.**

**Condensed Consolidated Interim Statements of Cash Flows - Unaudited**

**Expressed in Canadian Dollars**

---

| | | |
|:---|:---|:---|
|  | **For the nine months ended September 30,** | **For the nine months ended September 30,** |
|  | **2025** | 2024 |
| **OPERATING ACTIVITIES** |  |  |
| &nbsp;&nbsp;&nbsp;Net loss | $**(13356783)** | $(9155551) |
| &nbsp;&nbsp;&nbsp;Adjustments for: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization | **6771** | 8464 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation | **234403** | 424039 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Impairment of accounts receivable | **(11882)** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change in fair value of derivative liability | **1860107** | (2788734) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Impairment of inventory | **15091** | 148760 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on recovery of notes receivable | **(69646)** | (18425) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Finance and other costs | **45812** | 1204434 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on disposal of assets | **11469** | (22553) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Share-based payments | **1139063** | 904629 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjustments for profit loss | **(10125595)** | (9294937) |
| Net changes in non-cash working capital items: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receivables | **(508083)** | (360757) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventory | **(1376773)** | (62595) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaids | **(1189119)** | 369747 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade payables and accrued liabilities | **(683423)** | (220627) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Customer deposits | **(384880)** | (9363) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income | **131864** | (24574) |
| **Cash used in operating activities** | **(14136009)** | (9603106) |
| **INVESTING ACTIVITIES** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchase of equipment | **(426770)** | (73027) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Disposal of equipment | **-** | 103923 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repayment of notes receivable | **69646** | 18425 |
| **Cash provided by (used in) investing activities** | **(357124)** | 49321 |
| **FINANCING ACTIVITIES** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of common shares for financing | **58277541** | 12479693 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Share issue costs | **(5005668)** | (2036067) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of common shares for warrants exercised | **23941100** | 373244 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repayment of loans | **-** | (85058) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repayment of lease liabilities | **(114173)** | (258127) |
| **Cash provided by financing activities** | **77098800** | 10473685 |
| Effects of exchange rate changes on cash | **1023272** | (15935) |
| Change in cash | **62605667** | 919900 |
| Cash and cash equivalents, beginning of period | **6252409** | 3093612 |
| **Cash and cash equivalents, end of period** | $**69881348** | $3997577 |
| **SUPPLEMENTARY CASH FLOW DISCLOSURE** |  |  |
| Interest paid | $**9820** | $15428 |
| Share issue costs in accounts payable | **-** | 71912 |

---

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

**Draganfly Inc.**

**Notes to the Condensed Consolidated Interim Financial Statements**

**For the Three and Nine Months Ended September 30, 2025**

**Expressed in Canadian Dollars (unaudited)** 

**1.** **NATURE AND CONTINUANCE OF OPERATIONS**

Draganfly Inc. (the "Company") was incorporated on June 1, 2018 under the Business Corporations Act (British Columbia). The Company creates quality, cutting-edge unmanned and remote data collection and analysis platforms and systems that are designed to revolutionize the way companies do business. The Company's shares trade on the Canadian Securities Exchange (the "CSE"), on the Nasdaq Capital Market (the "Nasdaq") under the symbol "DPRO" and on the Frankfurt Stock Exchange under the symbol "3U8A". The Company's head office is located at 235 103<sup>rd</sup> St. E, Saskatoon, SK, S7N 1Y8 and its registered office is located at 2800 – 666 Burrard Street, Vancouver, BC, V6C 2Z7.

These condensed consolidated interim financial statements have been prepared on the assumption that the Company will continue as a going concern, meaning it will continue in operation for the foreseeable future and will be able to realize assets and discharge liabilities in the ordinary course of operations. To date, the Company has not been profitable and has an accumulated deficit of $130,822,612. The Company's ability to continue as a going concern is dependent upon its ability to obtain additional financing and or achieve profitable operations in the future. These factors raise substantial doubt over the Company's ability to continue as a going concern. These condensed consolidated interim financial statements do not reflect adjustments that would be necessary if the going concern assumption were not appropriate. These adjustments could be material.

**2.** **BASIS OF PREPARATION**

***Statement of Compliance***

These condensed consolidated interim financial statements have been prepared in accordance with International Accounting Standard ("IAS") 34, "Interim Financial Reporting". These condensed consolidated interim financial statements include all necessary disclosures required for interim financial statements but do not include all disclosures required for annual financial statements. These condensed consolidated interim financial statements should be read in conjunction with the Company's annual financial statements for the year ended December 31, 2024.

These condensed consolidated interim financial statements were authorized for issue by the Board of Directors on November 12, 2025.

***Basis of consolidation***

 ****

Each subsidiary is fully consolidated from the date of acquisition, being the date on which the Company obtains control, and continues to be consolidated until the date when such control ceases.

The condensed consolidated interim financial statements include the accounts and results of operations of the Company and its wholly owned subsidiaries listed in the following table:

---

| | | |
|:---|:---|:---|
| **Name of Subsidiary** | **Place of Incorporation** | **Ownership Interest** |
| Draganfly Innovations Inc. ("DII") | Canada | 100% |
| Draganfly Innovations USA, Inc. ("DI USA") | US | 100% |
| Dronelogics Systems Inc. ("Dronelogics") | Canada | 100% |

---

All intercompany balances and transactions were eliminated on consolidation.

**Draganfly Inc.**

**Notes to the Condensed Consolidated Interim Financial Statements**

**For the Three and Nine Months Ended September 30, 2025**

**Expressed in Canadian Dollars (unaudited)**

**2.** **BASIS OF PRESENTATION (CONT'D)**

***Reclassification***

 **

Certain prior year amounts have been reclassified to conform to the fiscal 2025 presentation. Overall results were not impacted by the reclassification of items within the Operating Expenses of the Condensed Consolidated Statements of Comprehensive Loss. For the three and nine months ended September 30, 2024 $349,352 and $1,013,563 was moved out of professional fees with $237,210 and $689,993 going to employee and management costs and $112,142 and $323,570 going to office and miscellaneous.

**3.** **MATERIAL ACCOUNTING POLICY INFORMATION, ESTIMATES, AND JUDGEMENTS**

These condensed consolidated interim financial statements have been prepared following the same accounting principles and methods of computation as outlined in the Company's consolidated financial statements for the year ended December 31, 2024. A description of the accounting standards and interpretations that have been adopted by the Company can be found in the notes of the annual financial statements for the year ended December 31, 2024.

The preparation of the condensed consolidated interim financial statements requires management to make assumptions and estimates that affect the reported amounts of assets and liabilities at the date of the financial statements and reported amounts of income and expenses during the reporting period. These condensed consolidated interim financial statements include estimates, which by their nature, are uncertain. These assumptions and associated estimates are based on historical experience and other factors that are considered to be relevant. As such, actual results may differ from estimates and the effect of such differences may be material. Significant estimates and judgements used in the preparation of these condensed consolidated interim financial statements remained unchanged from those disclosed in the Company's annual consolidated financial statements for the year ended December 31, 2024.

**4.** **RECEIVABLES**

---

| | | |
|:---|:---|:---|
| **As at** | **September 30,<br> 2025** | December 31,<br> 2024 |
| Trade accounts receivable | $**1135754** | $674998 |
| Sales tax receivable | **113801** | 54592 |
|  | $**1249555** | $729590 |
| Current portion | $**1249555** | $573390 |
| Long term portion | **-** | 156200 |
|  | $**1249555** | $729590 |

---

**Expected credit loss**

---

| | |
|:---|:---|
| Balance at December 31, 2023 | 289495 |
| &nbsp;&nbsp;&nbsp;Increase during the year | 140011 |
| Balance at December 31, 2024 | **429506** |
| &nbsp;&nbsp;&nbsp;Decrease during the period | (11882) |
| **Balance at September 30, 2025** | $**417624** |

---

During the nine months ended September 30, 2025, the Company recorded a reduction in the allowance for doubtful accounts of $11,882 (2024 – $40,409).

**Draganfly Inc.**

**Notes to the Condensed Consolidated Interim Financial Statements**

**For the Three and Nine Months Ended September 30, 2025**

**Expressed in Canadian Dollars (unaudited)**

**4.** **RECEIVABLES (CONT'D)** 

The Company assumes that the credit risk on a financial asset has increased if it is outstanding beyond the agreed payment terms. The Company considers a receivable to be default when the customer is unlikely to pay its obligations to the Company in full. The carrying amount of a receivable is written off (either partially or in full) to the extent that there is no realistic prospect of recovery.

Indicators that there is no reasonable expectation of recovery include, amongst others, business failure, the failure of a debtor to engage in a repayment plan, and a failure to make contractual payments over the negotiated contract period.

**5.** **INVENTORY**

---

| | | |
|:---|:---|:---|
| **As at** | **September 30,<br> 2025** | December 31,<br> 2024 |
| Finished goods | $**1591500** | $954453 |
| Parts | **1339094** | 577810 |
|  | $**2930594** | $1532263 |

---

During the three and nine months ended September 30, 2025, $1,363,053 (2024 - $1,152,068) and $3,844,309 (2024 – $3,296,218) of inventory was recognized in cost of sales respectively including an allowance to value its inventory for obsolete and slow-moving inventory of $43,337 (2024-$176,422) and $15,091 (2024-$459,591) respectively.

Cost of sales consist of the following:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the three months ended** | **For the three months ended** | **For the nine months ended** | **For the nine months ended** |
|  | **September 30, 2025** | September 30, 2024 | **September 30, 2025** | September 30, 2024 |
| Inventory | $**1363053** | $1152068 | $**3844309** | $3296218 |
| Consulting and services | **259676** | 279598 | **464612** | 418035 |
| Other | **112317** | 12876 | **274416** | 51176 |
|  | $**1735046** | $1444542 | $**4583337** | $3765429 |

---

**6.** **PREPAIDS AND DEPOSITS**

---

| | | |
|:---|:---|:---|
| **As at** | **September 30, 2025** | December 31, 2024 |
| Insurance | $**540183** | $370609 |
| Prepaid other | **282529** | 112439 |
| Deposits | **1090920** | 241465 |
|  | $**1913632** | $724513 |

---

Deposits consist of amounts required to be pre-paid in order for vendors to manufacture or supply goods.

**Draganfly Inc.**

**Notes to the Condensed Consolidated Interim**

**Financial Statements For the Three and Nine Months Ended September 30, 2025**

**Expressed in Canadian Dollars (unaudited)**

**7.** **EQUIPMENT**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Computer Equipment** | **Furniture and Equipment** | **Leasehold Improvements** | **Vehicles** | **Total** |
| **Cost** |  |  |  |  |  |
| Balance at December 31, 2023 | $133273 | $1040192 | $86530 | $60343 | $1320338 |
| &nbsp;&nbsp;&nbsp;Additions | 6876 | 137562 | 2359 |  | 146797 |
| &nbsp;&nbsp;&nbsp;Disposals | (9821) | (180338) | - | - | (190159) |
| Balance at December 31, 2024 | 130328 | 997416 | 88889 | 60343 | 1276976 |
| &nbsp;&nbsp;&nbsp;Additions | **31607** | **432130** | **1300** | **-** | **465037** |
| &nbsp;&nbsp;&nbsp;Disposals | **(17668)** | **(119379)** | **(38266)** | **-** | **(175313)** |
| **Balance at September 30, 2025** | $**144267** | $**1310167** | $**51923** | $**60343** | $**1566700** |
| **Accumulated depreciation** |  |  |  |  |  |
| Balance at December 31, 2023 | $58178 | $545403 | $6790 | $29166 | $639537 |
| &nbsp;&nbsp;&nbsp;Charge for the year | 37881 | 143885 | 17845 | 9354 | 208965 |
| &nbsp;&nbsp;&nbsp;Disposals | (3383) | (97685) | - | - | (101068) |
| Balance at December 31, 2024 | 92676 | 591603 | 24635 | 38520 | 747434 |
| &nbsp;&nbsp;&nbsp;Charge for the period | **23869** | **138536** | **9797** | **4911** | **177113** |
| &nbsp;&nbsp;&nbsp;Disposals | **(14395)** | **(111582)** | **(12706)** | **-** | **(138683)** |
| **Balance at September 30, 2025** | $**102150** | $**618557** | $**21726** | $**43431** | $**785864** |
| **Net book value:** |  |  |  |  |  |
| December 31, 2024 | $37652 | $405813 | $64254 | $21823 | $529542 |
| **September 30, 2025** | $**42117** | $**691610** | $**30197** | $**16912** | $**780836** |

---

**8. RIGHT OF USE ASSETS**

---

| | | | |
|:---|:---|:---|:---|
|  | **Buildings** | **Land** | **Total** |
| Balance at December 31, 2023 | $515071 | $206616 | $721687 |
| Depreciation | (142727) | (214114) | (356841) |
| Foreign exchange translation | - | 7498 | 7498 |
| Balance at December 31, 2024 | $372344 | $- | $372344 |
| Depreciation | **(107046)** | **-** | **(107046)** |
| **Balance at September 30, 2025** | $**265298** | $**-** | $**265298** |

---

There were no additions to the right of use assets during the three and nine months ended September 30, 2025 nor the year ended December 31, 2024.

**Draganfly Inc.**

**Notes to the Condensed Consolidated Interim**

**Financial Statements For the Three and Nine Months Ended September 30, 2025**

**Expressed in Canadian Dollars (unaudited)**

**9.** **LEASE LIABILITIES**

The Company leases certain assets under lease agreements. The lease liabilities consist of leases of facilities and vehicles with terms ranging from one to five years. The leases are calculated using incremental borrowing rates ranging from 11.7% to 13.3%.

---

| | |
|:---|:---|
|  | **Total** |
| Balance at December 31, 2023 | $790023 |
| &nbsp;&nbsp;&nbsp;Interest expense | 65378 |
| &nbsp;&nbsp;&nbsp;Lease payments | (423157) |
| &nbsp;&nbsp;&nbsp;Foreign exchange translation | (4223) |
| Balance at December 31, 2024 | 428021 |
| &nbsp;&nbsp;&nbsp;**Interest expense** | **28969** |
| &nbsp;&nbsp;&nbsp;**Lease payments** | **(143142)** |
| **Balance at September 30, 2025** | $**313848** |

---

Which consists of:

---

| | | |
|:---|:---|:---|
|  | **September 30,<br> 2025** | December 31,<br> 2024 |
| Current lease liability | $**151033** | $154147 |
| Non-current lease liability | **162815** | 273874 |
| **Ending balance** | $**313848** | $428021 |

---

---

| | | |
|:---|:---|:---|
| **Maturity analysis** | **September 30,<br> 2025** | December 31,<br> 2024 |
| Less than one year | $**176094** | $190856 |
| One to three years | **178161** | 282419 |
| Four to five years | **-** | 71836 |
| Total undiscounted lease liabilities | **354255** | 545111 |
| Amount representing interest | **(40407)** | (117090) |
|  | $**313848** | $428021 |

---

**10.** **TRADE PAYABLES AND ACCRUED LIABILITIES**

---

| | | |
|:---|:---|:---|
| **As at** | **September 30,<br> 2025** | December 31,<br> 2024 |
| Trade accounts payable (note 16) | $**801602** | $609869 |
| Accrued liabilities | **2196143** | 1789318 |
|  | $**2997745** | $2399187 |

---

**Draganfly Inc.**

**Notes to the Condensed Consolidated Interim Financial Statements**

**For the Three and Nine Months Ended September 30, 2025**

**Expressed in Canadian Dollars (unaudited)**

**11.** **DEFERRED INCOME**

At times, the Company may take payment in advance for services to be rendered. These amounts are held and recognized as services are rendered.

---

| | | |
|:---|:---|:---|
|  | **September 30,<br> 2025** | December 31,<br> 2024 |
| Deferred, revenue beginning | $**86681** | $107674 |
| Revenue recognized | **(31871)** | (21852) |
| Unearned revenues received | **169329** | 1744 |
| Foreign exchange | **(5594)** | (885) |
|  | $**218545** | $86681 |
| Current portion | $**168637** | $18542 |
| Long term portion | **49908** | 68139 |
|  | $**218545** | $86681 |

---

Deferred revenue of $168,637 as of September 30, 2025 is expected to be recognized as revenue within one year. The remaining is related to a long-term support and maintenance arrangements and will be recognized according to the terms of these arrangements over the next 2.33 years.

**12.** **SHARE CAPITAL**

***Authorized share capital***

 ****

Unlimited number of common shares without par value.

 **

***Issued share capital***

 **

During the nine months ended September 30, 2025,

● The Company issued 134,191 common shares for the vesting of restricted share units.

● On May 5, 2025, the Company issued 1,715,000 units consisting of one common share and one warrant and in a financing for $4,973,404 with share issue costs of $665,659 for net proceeds of $4,307,745 . The value of the issuance was allocated $4,545,997 to the shares and $427,407 to the warrants. This issuance included an overallotment of 100,000 warrants convertible to 100,000 shares. Warrants were valued using the residual method.

● The Company issued 100,000 shares related to the overallotment of the May 5, 2025 share issuance for gross proceeds of $290,000 with share issue costs of $28,030 for net proceeds of $265,970 .

● On June 12, 2025 the Company issued 5,500,000 units consisting of one common share and one warrant in a financing for $18,758,889 with share issue costs of $1,625,345 for net proceeds of $17,113,545 . The value of the issuance was allocated $18,082,472 to the shares and $676,418 to the warrants. Warrants were valued using the residual method.

● On July 21, 2025 the Company issued 4,672,895 units consisting of one common share and one warrant in a financing for $34,279,276 with share issue costs of $2,686,635 for net proceeds of $31,592,641 .

● 5,711,131 shares were issued for the exercise of warrants

During the year ended December 31, 2024,

● The Company issued 25,353 common shares for the vesting of restricted share units.

● The Company issued 1,991,668 common shares for the exercise of warrants

**Draganfly Inc.**

**Notes to the Condensed Consolidated Interim Financial Statements**

**For the Three and Nine Months Ended September 30, 2025**

**Expressed in Canadian Dollars (unaudited)**

**12.** **SHARE CAPITAL (CONT'D)** 

● On February 26, 2024, the Company issued 448,000 units consisting of one common share and one warrant and 88,000 units consisting of one prefunded warrant and one warrant in a financing for $4,877,475 with share issuance costs of $752,498 for net proceeds of $4,124,977 . Of the total share issuance costs $441,166 was expensed in other income (expense). The value of the issuance was allocated $2,017,966 to the shares, and $2,859,509 to the warrants, including $431,084 allocated to prefunded warrants. The prefunded warrants were exercised on the date of issue. On March 27, 2024, the exercise price of the warrants was amended to US$0.1761 from the original exercise price of USD $0.36 due to a one time exercise price reset Post share consolidation, the new exercise price is US$4.4025 . 36,000 shares were returned to treasury that were held in escrow related to the Vital Intelligence Inc. acquisition for failure to meet required milestones. The shares had a carrying value of $nil on cancellation.

● On April 29, 2024, the Company issued 282,541 units consisting of one common share and one warrant and 258,000 units consisting of one prefunded warrant and one warrant in a financing for $4,882,168 with share issuance costs of $779,615 for net proceeds of $4,102,553 . Of the total share issuance costs $671,747 was expensed in other income (expense). The value of the issuance was allocated $396,137 to the shares, and $4,422,815 to the warrants, including $1,248,343 allocated to prefunded warrants.

● On August 21, 2024, the Company issued 346,667 units consisting of one common share and one warrant, and 320,000 units consisting of one prefunded warrant and one warrant in a financing for $2,720,050 with share issue costs of $343,676 for net proceeds of $2,376,374 . The value of the issuance was allocated $160,076 to the shares, and $2,559,974 to the warrants including $591,265 allocated to prefunded warrants.

● On November 19, 2024 the Company issued 400,000 units consisting of one common share and one warrant and 1,200,000 units consisting of one prefunded warrant and one warrant in a financing for $5,272,234 with share issue costs of $755,397 for net proceeds of $4,516,837 . The value of the issuance was allocated $329,515 to the shares and $4,942,719 to the warrants including $1,977,088 allocated to the prefunded warrants.

***Stock Options***

 ****

The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the CSE requirements, grant to directors, officers, employees, and technical consultants to the Company, non-transferable stock options to purchase common shares. The total number of common shares reserved and available for grant and issuance pursuant to this plan shall not exceed 15% (in the aggregate) of the issued and outstanding common shares from time to time. The number of options awarded and underlying vesting conditions are determined by the Board of Directors in its discretion.

As at September 30, 2025, the Company had the following options outstanding and exercisable:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Grant Date** | **Expiry Date** | **Exercise Price** | **Remaining Contractual Life (years)** | **Number of Options Outstanding** | **Number of Options Exercisable** |
| October 30, 2019 | October 30, 2029 | $62.50 | 4.08 | 10464 | 10464 |
| April 30, 2020 | April 30, 2030 | $62.50 | 4.58 | 240 | 240 |
| April 30, 2020 | April 30, 2030 | $96.25 | 4.58 | 4400 | 4400 |
| November 24, 2020 | November 24, 2030 | $62.50 | 5.15 | 1280 | 1280 |
| February 2, 2021 | February 2, 2031 | $330.00 | 5.35 | 1200 | 1200 |
| March 8, 2021 | March 8, 2026 | $347.50 | 0.44 | 400 | 400 |
| April 27, 2021 | April 27, 2031 | $253.75 | 5.58 | 3640 | 3640 |
| September 9, 2021 | September 9, 2026 | $121.00 | 0.94 | 1034 | 1034 |
| November 9, 2023 | November 9, 2033 | $15.75 | 8.12 | 1200 | 800 |
|  |  |  |  | **23858** | **23458** |

---

**Draganfly Inc.**

**Notes to the Condensed Consolidated Interim Financial Statements**

**For the Three and Nine Months Ended September 30, 2025**

**Expressed in Canadian Dollars (unaudited)**

**12.** **SHARE CAPITAL (CONT'D)** 

---

| | | |
|:---|:---|:---|
|  | **Number of Options** | **Weighted Average Exercise Price** |
| Outstanding, December 31, 2023 | 35954 | $112.00 |
| Forfeited | (4350) | 106.83 |
| Outstanding, December 31, 2024 | 31604 | $112.05 |
| Expired | **(4000)** | **80.00** |
| Forfeited | **(3746)** | **113.55** |
| **Outstanding, September 30, 2025** | **23858** | $**116.34** |

---

No options were granted by the Company during the nine months ended September 30, 2025.

During the three and nine months ended September 30, 2025, the Company recorded $1,013 (2024 – $5,600) and $3,040 (2024 - $58,978) respectively in stock-based compensation in relation to the vesting of stock options. The fair values of stock options granted were estimated using the Black-Scholes Option Pricing Model.

***Restricted Share Units***

 ****

During the three and nine months ended September 30, 2025, the Company recorded share-based payment expense of $473,716 (2024 - $394,975) and $1,136,023 (2024 - $845,650) for RSUs, based on the fair values of RSUs granted which were calculated using the closing price of the Company's stock on the day prior to grant.

 ****

The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the Exchange requirements, grant to directors, officers, employees and technical consultants to the Company, restricted stock units (RSUs). The number of RSUs awarded and underlying vesting conditions are determined by the Board of Directors in its discretion. RSUs will have a 3-year vesting period following the award date. The total number of common shares reserved and available for grant and issuance pursuant to this plan, and the total number of Restricted Share Units that may be awarded pursuant to this plan, shall not exceed 15% (in the aggregate) of the issued and outstanding common shares from time to time.

As at September 30, 2025, the Company had the following RSUs outstanding:

---

| | | |
|:---|:---|:---|
|  | **Number of RSUs** | **Average Price** |
| Outstanding, December 31, 2023 | 44545 | $32.45 |
| Vested | (25353) | 35.63 |
| Issued | 185240 | 8.99 |
| Forfeited | (16332) | 13.41 |
| Outstanding, December 31, 2024 | 188100 | 10.74 |
| **Vested** | **(134191)** | **13.10** |
| **Issued** | **450964** | **2.55** |
| **Forfeited** | **(9175)** | **10.78** |
| **Outstanding, September 30, 2025** | **495698** | $**3.86** |

---

**Draganfly Inc.**

**Notes to the Condensed Consolidated Interim Financial Statements**

**For the Three and Nine Months Ended September 30, 2025**

**Expressed in Canadian Dollars (unaudited)**

**12.** **SHARE CAPITAL (CONT'D)** 

***Warrants***

 ****

During the year ended December 31, 2024 and the year ended December 31, 2023, the Company issued pre-funded warrants ("USD pre-funded Warrants") where a portion of the funds related to the eventual exercise have already been received with the remaining exercise price in USD. As part of these same issuances, shares with warrants attached were issued. Being in a foreign currency that is not the Company's functional currency and these pre-funded warrants were not issued in exchange for services, the value related to the future exercise price of the USD pre-funded Warrants are required to be recorded as a financial liability and not as equity. As a financial liability, the portion of the USD pre-funded Warrants related to the future exercise price will be revalued on a quarterly basis to fair market value with the change in fair value being recorded in profit or loss. The warrants issued with the shares are also in USD and are also accounted for as a liability. In addition, the Company issued pre-funded warrants with an exercise price in Canadian dollars ("Pre-funded Warrants"). These are treated as a liability as the agreement contains clauses that do not meet the fixed for fixed test. As a financial liability, the portion of the Pre-funded Warrants related to the future exercise price will be revalued on a quarterly basis to fair market value with the change in fair value being recorded in profit or loss. The warrants issued with the shares are accounted for as a liability as these contain clauses that do not meet the fixed for fixed test.

On August 7, 2024, the exercise price of the April 29, 2024 warrants were amended to $5.625. The exercise price of the October Warrants was reduced twice and converted to Canadian dollars for a new exercise price of $5.6925. For the October 2023 issuance and the April 2024 issuance, the warrant agreements were further amended as of August 7, 2024 to remove the cashless exercise feature and any anti-dilution clauses that would lead to variability in settlement so they now meet the requirement for equity classification. The warrants were fair valued on August 7, 2024 and transferred to equity.

To determine the fair value of the warrants, a Black Scholes calculation is used, calculated in USD for those with a USD exercise price and in CAD for those with a Canadian exercise price. The Black Scholes value per warrant is then multiplied by the number of outstanding warrants and then multiplied by the foreign exchange rate at the end of the period for those denominated in USD.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| 2024 Issuances | February Issuance | February Issuance | April Issuance | April Issuance | August Issuance | November Issuance |
|  | Warrants | Broker | Warrants | Broker | Broker | Broker |
| Volatility | 119.23% | 107.8% | 119.80% | 108.67% | 118.87% | 115.27% |
| Risk free rate | 4.33% | 4.48% | 4.65% | 4.62% | 3.74% | 4.24% |
| Expected life | 5 years | 3 years | 5 years | 3 years | 3 years | 3 years |
| Expected dividend yield | 0% | 0% | 0% | 0% | 0% | 0% |

---

Warrant Derivative Liability

---

| | |
|:---|:---|
| Balance at December 31, 2023 | $4196125 |
| Warrants issued | 7282325 |
| Exercised | (3661283) |
| Change in fair value of warrants outstanding | (1842618) |
| Reclassify to equity | (3776428) |
| **Balance at December 31, 2024** | $**2198121** |
| **Exercised** | **(1021141)** |
| **Change in fair value of warrants outstanding** | **1860107** |
| **Balance at September 30, 2025** | $**3037087** |

---

**Draganfly Inc.**

**Notes to the Condensed Consolidated Interim Financial Statements**

**For the Three and Nine Months Ended September 30, 2025**

**Expressed in Canadian Dollars (unaudited)**

**12.** **SHARE CAPITAL (CONT'D)** 

Details of these warrants and their fair values are as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Issue Date** | **Exercise<br> Price** | **Exercise<br> Price** | **Number of Warrants<br> Outstanding at** <br> **September 30, 2025** | **Fair Value at<br> September 30, 2025** | **Number of Warrants<br> Outstanding at<br> December 31, 2024** | **Fair Value at<br> December 31, 2024** |
| **Derivative Liability** | | | | | | |
| February 26, 2024 (1) | US$ | 4.4025 | 318035 | $3037087 | 474332 | $2198121 |
|  |  |  | **318035** | $**3037087** | 474332 | $2198121 |

---

1) The warrants expire February 26, 2029.

The fair values of these warrants were estimated using the Black-Scholes Option Pricing Model with the following weighted average assumptions:

---

| | | |
|:---|:---|:---|
|  | **September 30, 2025** | December 31, 2024 |
| Risk free interest rate | **3.76%** | 4.38% |
| Expected volatility | **128.72%** | 124.06% |
| Expected life | **3.41 years** | 4.16 years |
| Expected dividend yield | **0%** | 0% |

---

As at September 30, 2025, the Company had the following warrants outstanding:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Date issued** | **Expiry date** | **Exercise price** | **Exercise price** | **Number of warrants outstanding September 30, 2025** | **Number of warrants outstanding December**<br> **31, 2024** |
| October 30, 2023 | October 30, 2026 | CAD$ | 23.20 | 12800 | 12800 |
| October 30, 2023 | October 30, 2028 | CAD$ | 3.3086 | 256000 | 256000 |
| February 26, 2024 | February 26, 2027 | US$ | 8.44 | 26800 | 26800 |
| February 26, 2024 | February 26, 2029 | US$ | 4.4025 | 318035 | 474332 |
| April 29, 2024 | April 29, 2029 | CAD$ | 3.3086 | 540541 | 540541 |
| April 29, 2024 | April 29, 2027 | CAD$ | 11.06 | 27028 | 27028 |
| August 21, 2024 | August 21, 2029 | CAD$ | 3.3086 |  | 666667 |
| August 21, 2024 | August 21, 2027 | CAD$ | 5.12 |  | 33334 |
| November 19, 2024 | November 19, 2029 | CAD$ | 3.3086 | 266667 |  |
| May 5, 2025 | May 5, 2030 | CAD$ | 3.9779 | 485000 |  |
| May 5, 2025 | May 5, 2028 | CAD$ | 3.632 | 90750 |  |
| June 12, 2025 | June 12, 2030 | CAD$ | 5.0768 | 3763500 |  |
| July 21, 2025 | July 21, 2030 | CAD$ | 7.3579 | 4572895 |  |
| July 21, 2025 | July 21, 2028 | CAD$ | 9.1973 | 233644 | - |
|  |  |  |  | **10593660** | **2037502** |

---

The weighted average remaining contractual life of warrants outstanding as of September 30, 2025, was 4.59 years (December 31, 2024 – 4.6 years).

**Draganfly Inc.**

**Notes to the Condensed Consolidated Interim Financial Statements**

**For the Three and Nine Months Ended September 30, 2025**

**Expressed in Canadian Dollars (unaudited)**

**12.** **SHARE CAPITAL (CONT'D)** 

---

| | | |
|:---|:---|:---|
|  | **Number of Warrants** | **Weighted Average Exercise Price** |
| Outstanding, December 31, 2023 | 342992 | $15.75 |
| Issued | 5376370 | 3.35 |
| Exercised | (1991668) | 0.96 |
| Expired | (10192) | 125.00 |
| Outstanding, December 31, 2024 | 3717502 | $5.16 |
| **Issued** | **12587289** | **5.81** |
| **Exercised** | **(5711131)** | **(4.24)** |
| **Outstanding September 30, 2025** | **10593660** | $**6.01** |

---

**13.** **SEGMENTED INFORMATION**

The Company operates in 2 reportable segments. The Company organizes its two segments based on its product line as well as a corporate segment. The two segments are Drones and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV) while the Corporate segment includes all costs not directly associated with the Drone segment. The Company aggregates the information for the segments by analyzing the revenue stream and allocating direct costs to that respective segment. The Corporate segment is aggregated by relying on the entity that includes corporate costs (Draganfly Inc.).

Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision maker.

**Draganfly Inc.**

**Notes to the Condensed Consolidated Interim Financial Statements**

**For the Three and Nine Months Ended September 30, 2025**

**Expressed in Canadian Dollars (unaudited)**

**13.** **SEGMENTED INFORMATION (CONT'D)** 

The board of the Company relies on executive management which assesses the financial performance and position of the group and makes strategic decisions. Executive management, which has been identified as being the chief operating decision maker, consists of the chief executive officer, chief operating officer and chief financial officer.

---

| | | | |
|:---|:---|:---|:---|
| **September 30, 2025** | **Drones** | **Corporate** | **Total** |
| Sales of goods | $5065682 | $- | $5065682 |
| Provision of services | 753281 | - | 753281 |
| **Total revenue** | **5818963** | **-** | **5818963** |
| Segment loss (income) | 4873571 | 9606914 | 14480485 |
| Finance and other costs | 403392 | 7102 | 410494 |
| Depreciation | 226771 | 7632 | 234403 |
| Amortization | 6771 |  | 6771 |
| Change in fair value of derivative liability |  | (1860107) | (1860107) |
| Loss on write-off of notes receivable |  | 69646 | 69646 |
| Loss on write down of inventory | 15091 | - | 15091 |
| **Net loss for the period** | $**5525596** | $**7831187** | $**13356783** |

---

---

| | | | |
|:---|:---|:---|:---|
| **September 30, 2024** | **Drones** | **Corporate** | **Total** |
| Sales of goods | $3953974 | $- | $3953974 |
| Provision of services | 993920 | - | 993920 |
| **Total revenue** | **4947894** | **-** | **4947894** |
| Segment loss (income) | 4488920 | $1165111 | 5654031 |
| Finance and other costs | 85436 |  | 85436 |
| Depreciation | 412544 | 11495 | 424039 |
| Amortization | 8464 |  | 8464 |
| Change in fair value of derivative liability |  | 2788734 | 2788734 |
| Loss on write-off of notes receivable |  | 18425 | 18425 |
| Loss on write down of inventory | 176422 | - | 176422 |
| **Net loss for the period** | $**5171786** | $**3983765** | $**9155551** |

---

Geographic revenue is measured by aggregating sales based on the country and the entity where the sale was made.

---

| | | |
|:---|:---|:---|
|  | **September 30, 2025** | December 31, 2024 |
| **Non-current assets** |  |  |
| Canada | $**904828** | $1117513 |
| United States | $**201104** | - |
|  | $**1105932** | $1117513 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the three months ended September 30,** | **For the three months ended September 30,** | **For the nine months ended September 30,** | **For the nine months ended September 30,** |
|  | 2025 | 2024 | **2025** | 2024 |
| **Revenue** |  |  |  |  |
| Canada | $2149141 | $1860227 | $**5804975** | $4913720 |
| United States | 6852 | 25095 | **13988** | 34174 |
|  | $2155993 | $1885322 | $**5818963** | $4947894 |

---

**Draganfly Inc.**

**Notes to the Condensed Consolidated Interim Financial Statements**

**For the Three and Nine Months Ended September 30, 2025**

**Expressed in Canadian Dollars (unaudited)**

**14.** **OFFICE AND MISCELLANEOUS**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the three months ended September 30,** | **For the three months ended September 30,** | **For the nine months ended September 30,** | **For the nine months ended September 30,** |
|  | **2025** | 2024 | **2025** | 2024 |
| Advertising, Marketing, and Investor Relations | $**550263** | $240942 | $**1096629** | $649700 |
| Compliance fees | **137649** | 63988 | **436602** | 205753 |
| Business development | **163230** | 61249 | **508255** | 193842 |
| General freight | **77446** | 39316 | **276308** | 84908 |
| General office | **402208** | 215201 | **892162** | 565352 |
| Office and Miscellaneous Expenses | $**1330796** | $620696 | $**3209956** | $1699555 |

---

**15.** **OTHER EXPENSE**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the three months ended September 30,** | **For the three months ended September 30,** | **For the nine months ended September 30,** | **For the nine months ended September 30,** |
|  | **2025** | 2024 | **2025** | 2024 |
| Share issue costs | $**-** | $60179 | $**-** | $1254629 |
| Write off of accounts (payable) receivable | **(48128)** | 40409 | **(23486)** | (8424) |
| Other | **164** | (3307) | **3655** | (9036) |
| Total other expenses | $**(47964)** | $97281 | $**(19831)** | $1237169 |

---

**16.** **RELATED PARTY TRANSACTIONS**

On August 1, 2019, the Company entered in a business services agreement (the "Agreement") with Business Instincts Group ("BIG"), a company that Cameron Chell, CEO and director has a material interest in that he previously controlled, to provide: corporate development and governance, strategic facilitation and management, general business services, office space, corporate business development video content, website redesign and management, and online visibility management. The services are provided by a team of consultants and the costs of all charges are based on the fees set in the Agreement. For the three and nine months ended September 30, 2025, the Company incurred fees of $124,208 (2024 - $64,463) and $302,886 (2024 - $190,164) respectively. As at September 30, 2025, the Company was indebted to this company in the amount of $nil (2024 - $1,874).

On October 1, 2019, the Company entered into an independent consultant agreement ("Consultant Agreement") with 1502372 Alberta Ltd, a company controlled by Cameron Chell, CEO and director, to provide executive consulting services to the Company. The costs of all charges are based on the fees set in the Consultant Agreement. For the three and nine months ended September 30, 2025, the Company incurred fees of $109,438 (2024 - $109,438) and $520,089 (2024 - $325,125) respectively. As at September 30, 2025, the Company was indebted to this company in the amount of $nil (2024 - $nil).

On May 2, 2022, the Company and entered into an agreement with Scott Larson, a director, to provide executive consulting services to the Company and all fees are set in the consulting agreement. For the three and nine months ended September 30, 2025, the Company incurred fees of $30,744 (2024 - $41,911) and $70,203 (2024 - $119,335). As at September 30, 2025, the Company was indebted to this company in the amount of $nil (2024 - $9,000).

**Draganfly Inc.**

**Notes to the Condensed Consolidated Interim Financial Statements**

**For the Three and Nine Months Ended September 30, 2025**

**Expressed in Canadian Dollars (unaudited)**

**16.** **RELATED PARTY TRANSACTIONS (CONT'D)** 

**Trade receivables/payables and accrued receivables/payables:**

As at September 30, 2025, the Company had $122,965 (2024 - $10,874) payable to other related parties that was included in accounts payable. The balances outstanding are unsecured, non-interest bearing and due on demand.

**Key management compensation**

Key management personnel include those persons having authority and responsibility for planning, directing and controlling the activities of the Company as a whole. Compensation awarded to key management for the three and nine months ended September 30, 2025 and 2024 included:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the three months ended September 30,** | **For the three months ended September 30,** | **For the nine months ended September 30,** | **For the nine months ended September 30,** |
|  | **2025** | 2024 | **2025** | 2024 |
| Director fees | $**122965** | $131469 | $**394803** | $375368 |
| Salaries | **632338** | 127329 | **1087594** | 396916 |
| Share-based payments | **297738** | 223364 | **697301** | 527224 |
|  | $**1053041** | $482162 | $**2179698** | $1299508 |

---

**Other related party transactions**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the three months ended September 30,** | **For the three months ended September 30,** | **For the nine months ended September 30,** | **For the nine months ended September 30,** |
|  | **2025** | 2024 | **2025** | 2024 |
| Management fees paid to a company controlled by CEO and director | $**109438** | $109437 | $**520089** | $325125 |
| Management fees paid to a company that the CEO holds an economic interest in | **124208** | 64463 | **302886** | 190164 |
| Management fees paid to a company controlled by a director | **30744** | 41910 | **70203** | 119335 |
|  | $**264390** | $215810 | $**893178** | $634624 |

---

**17.** **FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT**

The Company is exposed in varying degrees to a variety of financial instrument related risks. The Board of Directors approves and monitors the risk management processes, inclusive of documented investment policies, counterparty limits, and controlling and reporting structures. The type of risk exposure and the way in which such exposure is managed is provided as follows:

 **

***Credit risk***

 **

Credit risk is the risk that of an unexpected loss if a customer or third party fails to meet its contractual obligations.

The Company is subject to credit risk on its cash and receivables. The majority of cash is deposited in bank accounts held with a major bank in Canada and the United States. As most of the Company's cash is held by one bank there is a concentration of credit risk. This risk is managed by using major banks that are high credit quality financial institutions as determined by rating agencies.

**Draganfly Inc.**

**Notes to the Condensed Consolidated Interim Financial Statements**

**For the Three and Nine Months Ended September 30, 2025**

**Expressed in Canadian Dollars (unaudited)**

**17.** **FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (CONT'D)** 

***Receivables***

 ****

Receivables primarily consist of trade receivables and taxes receivable. The Company provides credit in the normal course of business in the form of payment terms and has an established process for determining terms to offer customers to mitigate credit risk. Receivables are shown net of any provision made for impairment of the receivables. Due to this factor, the Company believes that no additional credit risk, beyond amounts provided for collection loss, is inherent in receivables.

Expected credit loss ("ECL") analysis is performed at each reporting date using an objective approach to measure expected credit losses. The provision amounts are based on direct management interface with the customer. The calculations reflect the probability-weighted outcome, the time value of money and reasonable supportable information that is available at the reporting date about past events, current conditions and forecasts of future economic conditions. Receivables are written off where there is no reasonable expectation of recovery. Indicators that there is no reasonable expectation of recovery include, amongst others, business failure, the failure of a debtor to engage in a repayment plan, and a failure to make contractual payments over the negotiated contract period.

***Fair value***

A number of the Company's accounting policies and disclosures require the measurement of fair values for financial assets and liabilities. The Company has established a control framework with respect to the measurement of fair values. Fair values are categorized into different levels of a fair value hierarchy based on the inputs used in the valuation techniques as follows:

Level 1: quoted (unadjusted) prices in active markets for identical assets or liabilities.

Level 2: other techniques for which all inputs which have a significant effect on the recorded fair value are observable, either directly or indirectly.

Level 3: techniques which use inputs which have a significant effect on the recorded fair value that are not based on observable market data.

Equity securities in investee companies and warrants are measured at fair value. The financial assets and liabilities measured at fair value by hierarchy are shown in the table below. The amounts shown are based on the amounts recognized in the condensed consolidated interim statements of financial position. These financial assets are measured at fair value through profit and loss.

---

| | | | |
|:---|:---|:---|:---|
| **September 30, 2025** | Level 1 | Level 3 | Total |
| Equity securities in investee companies | $21428 | $- | $21428 |
| Derivative liability | **-** | (3037087) | (3037087) |
| **Total** | $**21428** | $**(3037087)** | $**(3015659)** |

---

---

| | | | |
|:---|:---|:---|:---|
| **December 31, 2024** | **Level 1** | **Level 3** | **Total** |
| Equity securities in investee companies | $14286 | $- | $14286 |
| Derivative liability | - | (2198121) | (2198121) |
| **Total** | $**14286** | $**(2198121)** | $**(2183835)** |

---

**Draganfly Inc.**

**Notes to the Condensed Consolidated Interim Financial Statements**

**For the Three and Nine Months Ended September 30, 2025**

**Expressed in Canadian Dollars (unaudited)**

**17.** **FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (CONT'D)** 

The following table shows the valuation techniques used in measuring Level 3 fair values for the derivative liability as well as the significant unobservable inputs used.

---

| | | | |
|:---|:---|:---|:---|
| **Type** | **Valuation technique** | **Key inputs** | **Inter-relationship between significant inputs and fair value measurement** |
| Warrant derivative liability | The fair value of the warrants derivative liability at initial recognition and at year end has been calculated using the Black Scholes Option Pricing Model | Key observable inputs<br> ● Share price<br> ● Risk free interest rate<br> ● Dividend yield<br> Key unobservable inputs<br> ● Expected volatility | The estimated fair value would increase (decrease) if:<br> ● The price was higher (lower)<br> ● The risk-free rate was higher (lower)<br> ● The dividend yield was lower (higher)<br> ● The expected volatility was higher (lower) |

---

For the fair value of the derivative liability, reasonable possible changes to the expected volatility, the most significant unobservable input would have the following effects:

---

| | | | |
|:---|:---|:---|:---|
|  | | Impact on comprehensive loss | Impact on comprehensive loss |
| Unobservable Inputs | Change | Nine months ended<br> September 30, 2025 | Year ended<br> December 31, 2024 |
| Volatility | 20% | $154683 | $201109 |

---

**18.** **SUBSEQUENT EVENTS**

Subsequent to September 30, 2025, there have been a total of 5,622,994 warrants exercised for total proceeds of CAD$28,949,428 and a total of 378,222 broker warrants exercised for total proceeds of $3,128,947. Warrant and broker warrants exercises were from the following issuances:

---

| | | |
|:---|:---|:---|
| **Warrants**<br>**Issuance** |<br>**Number exercised** |<br>**Proceeds** |
| October 30, 2023 | 256000 | $847429 |
| February 26, 2024 | 256124 | 1580782 |
| April 29, 2024 | 540540 | 1789333 |
| November 19, 2024 | 266667 | 882204 |
| May 5, 2025 | 464000 | 1845752 |
| June 12, 2025 | 2762500 | 14050264 |
| July 21, 2025 | 1077163 | 7953664 |
|  | 5622994 | $28949428 |

---

---

| | | |
|:---|:---|:---|
| **Broker Warrants**<br>**Issuance** |<br>**Number exercised** |<br>**Proceeds** |
| February 26, 2024 | 26800 | $315267 |
| April 29, 2024 | 27028 | 304854 |
| May 5, 2025 | 90750 | 333812 |
| July 21, 2025 | 233644 | 2175014 |
|  | 378222 | $3128947 |
| **Total exercises** | 6001216 | $32078375 |

---

## Exhibit 99.2

**Exhibit 99.2**

![](ex99-2_001.jpg)

**Management Discussion and Analysis**

**For the Three and Nine Months ended September 30, 2025**

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

This Management's Discussion and Analysis ("MD&A") of Draganfly Inc. ("Draganfly" or the "Company") is presented and dated as of November 12, 2025, and should be read in conjunction with the unaudited consolidated interim financial statements and related notes for the three and nine months ended September 30, 2025 and the annual consolidated financial statements and related notes for the year ended December 31, 2024. The Company's audited consolidated financial statements have been prepared on a "going concern" basis, which presumes that the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future.

The operations of the Company have been primarily funded through its Regulation A+ Offering of units, its Nasdaq prospectus financing, internally generated cashflow and private placements of equity and convertible debentures. The continued operations of the Company are dependent on the Company's ability to generate profitable operations in the future, develop and execute a sufficient financing plan for future operations and receive continued financial support from shareholders and other providers of finance.

The consolidated financial statements do not reflect the adjustments, if any, or changes in presentation that may be necessary should the Company not be able to continue on a going concern basis.

All currency amounts in the accompanying financial statements and this management discussion and analysis are in Canadian dollars unless otherwise noted.

**Special Note Regarding Forward Looking Information**

This Management Discussion & Analysis is intended to provide readers with the information that management believes is required to gain an understanding of the current results of the Company and to assess the Company's future prospects. Accordingly, certain sections of this report, other than statements of historical fact, may contain forward-looking statements that are based on current plans and expectations and are subject to certain risks and uncertainties. These forward-looking statements include information about possible or assumed future results of our business, financial condition, results of operations, liquidity, plans and objectives. In some cases, you can identify forward-looking statements by terminology such as "believe," "may," "estimate," "continue," "anticipate," "intend," "should," "plan," "expect," "predict," "potential," or the negative of these terms or other similar expressions.

The statements we make regarding the following matters are forward-looking by their nature and are based on certain of the assumptions noted below:

● the intentions, plans and future actions of the Company;

● statements relating to the business and future activities of the ‎Company;

● anticipated developments in operations of the Company;

● market position, ability to compete and future ‎financial or operating performance of the Company;

● the timing and amount of funding required to execute the ‎Company's business plans;

● capital expenditures;

● the effect on the Company of any changes to existing or new ‎legislation or policy or government regulation;

● ‎the availability of labor;

● requirements for additional capital;

● goals, strategies and future ‎growth;

● the adequacy of financial resources;

● expectations regarding revenues, ‎expenses and anticipated cash needs‎;

● general market conditions and macroeconomic trends driven by geopolitical conflicts, including supply chain disruptions, market volatility, inflation, and labor challenges, among other factors.

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

The preceding list is not intended to be an exhaustive list of all of our forward-looking statements. The forward-looking statements are based on our beliefs, assumptions, and expectations of future performance, taking into account the information currently available to us. Furthermore, unless otherwise stated, the forward-looking statements contained in these statements are made as of the date hereof, and we have no intention and undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, changes or otherwise, except as required by law.

These statements are only predictions based upon our current expectations and projections about future events. There are important factors that could cause our actual results, levels of activity, performance or achievements to differ materially from the results, levels of activity, performance or achievements expressed or implied by the forward-looking statements. These include, without limitation, the Company's current and planned operations and the expected results of new operations and new clients. These risks and uncertainties include, but are not restricted to:

● The Company's history of losses;

● The dilution of holdings in the Company's securities;

● Research and development costs;

● The failure of new business models to produce financial returns;

● Operational risks for which the Company may not be adequately insured;

● The Company operates in an evolving market that makes it difficult to evaluate business and future prospects;

● Competitive market conditions and challenges from competitors;

● The pace of technological change and the Company's ability to stay on top of market and technology changes;

● The failure to obtain necessary regulatory approvals and permits or limitations placed on the development, operation, and sale of unmanned aerial vehicles ("UAVs") by governments;

● Risks associated with any particular future acquisitions that would allow the company to provide additional product or service offerings;

● The Company's ability to retain key employees and personnel and the Company's ability to manage growth;

● Adverse economic changes;

● Negative macroeconomic and geopolitical trends that could restrict the Company's ability to access capital;

● Uncertainties associated with operations in foreign countries;

● Adverse tax policies;

● An inability to access critical components or raw materials used to manufacture the Company's products and supply chain disruptions;

● Weather and other natural outdoor conditions that can imperil the use of UAVs;

● The Company's products may be subject to recalls or returns or defective products or services that could negatively affect the Company's operating results;

● An inability to secure adequate funding for research and development;

● Export controls or restrictions on the Company's ability to deliver its product outside of Canada;

● Consumer perception regarding the use and safety of UAVs;

● A failure to successfully market the Company's products;

● Security risks associated with electronic communications and IT infrastructure;

● Inadequate consumer protection and data privacy practices;

● An inability of our business partners to fulfill their obligations to us or to secure company information;

● A failure to protect the Company's intellectual property, proprietary rights, and trade secrets, including through a failure to adequately apply for or seek such protections;

● Failure to adhere to financial reporting obligations and mandates associated with being a public company;

● The Company's limited experience operating as publicly traded corporation;

● Changes in accounting standards and subjective assumptions, estimates and judgments by management related to ‎complex accounting matters;

● Write-downs of goodwill or other intangible assets;

● Legal proceedings in which the Company may become involved;

● Conflicts of interests among our directors and officers;

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

● Volatility related to our share price;

● A failure to maintain an active trading market for our common shares;

● The Company may never pay dividends, and a return on an investment in the Company will depend upon an appreciation in the price of our shares after purchase;

● The Company may be classified as a "passive foreign investment company" for U.S. federal income tax purposes;

● United States investors may not be able to obtain an enforcement of civil liabilities against the Company

● The Company's status as an "emerging growth company";

● Increased costs and compliance matters related to our status as a public company in the United States; and

● The Company's status as a "foreign private issuer."

Readers are cautioned to read more about the potential risks the Company faces under the heading "Business Risks" at the end of this MD&A.

**Non-GAAP Measures and Additional GAAP Measures**

In this MD&A we describe certain income and expense items that are unusual or non-recurring. There are terms not defined by International Financial Reporting Standards ("IFRS"). Our usage of these terms may vary from the usage adopted by other companies. Specifically, *Gross profit, Gross margin* and *Cash flow from operations* are undefined terms by IFRS that may be referenced herein. We provide this detail so that readers have a better understanding of the significant events and transactions that have had an impact on our results.

Throughout this document, reference is made to "gross profit," "gross margin," and "working capital", which are non-IFRS measures. Management believes that gross profit, defined as revenue less cost of sales, is a useful supplemental measure of operations. Gross profit helps provide an understanding of the level of costs needed to create revenue. Gross margin illustrates the gross profit as a percentage of revenue. Management believes that working capital, defined as current assets less current liabilities, is an indicator of the Company's liquidity and its ability to meet its current obligations. Readers are cautioned that these non-IFRS measures may not be comparable to similar measures used by other companies. Readers are also cautioned not to view these non-IFRS financial measures as an alternative to financial measures calculated in accordance with IFRS.

**Core Business and Strategy**

Draganfly creates quality, cutting-edge unmanned and remote data collection and analysis platforms and systems that are designed to revolutionize the way companies do business. The Company is incorporated under the British Columbia Business Corporations Act and has its registered office located at 2800 – 666 Burrard Street, Vancouver, BC, V6C 2Z7 with a head office at 235 103<sup>rd</sup> St. E, Saskatoon, SK, S7N 1Y8.

Recognized as being at the forefront of UAV (unmanned aerial vehicles) technology for over two decades, Draganfly is an award-winning, industry-leading manufacturer, contract engineering, and product development company within the commercial UAV space serving the public safety, civil, military, agriculture, industrial inspections, and mapping and surveying markets. Draganfly is a company driven by passion, ingenuity, and the need to provide efficient solutions and first-class services to its customers around the world with the goal of saving time, money, and lives.

Founded in 1998, Draganfly is recognized as one of the first commercial multi-rotor manufacturers and has a legacy for its innovation and superior customer service. The company has sold products and services to over 50 countries.

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

Draganfly can provide its customers with an entire suite of products and services that include quad-copters, fixed-wing aircrafts, handheld controllers, flight training, and software used for tracking, live streaming, data collection, and health monitoring. The integrated UAV system is equipped for automated take-offs and landings with altitude and return to home functions as well as in-house created survey software. Draganfly's standard features combined with custom fit camera payloads ranging from multi-spectral, hyper-spectral, LIDAR, thermal, and infrared allows Draganfly to offer a truly unique solution to clients.

With 23 issued and one pending fundamental UAV patents in the portfolio, Draganfly will continue to expand and grow its intellectual property portfolio.

Historically, the main business of the Company was as a manufacturing company offering commercial UAVs directly to its customer base across various industry verticals. The Company has evolved to offer drone solutions, including continuing to sell and develop its own OEM products, providing engineering procurement, drone services, and reselling third party products.

Draganfly works with its customers to customize a product or platform from idea to research and development (R&D) to completion and testing. A work plan is created with timelines and budgets which includes materials, travel, testing, and engineering time. The work plan is approved by the customer before work begins. To date, the majority of this work is considered proprietary in nature and is protected by trade secrets and other intellectual property protections.

The Company's scope includes providing custom built parts, accessories, drone services, and the ability to sell third-party manufactured UAVs along with support services.

On July 21, 2025, The Company completed a public offering of 4,672,895 units consisting of one common share and one warrant. Each unit was sold at a price of USD $5.35 for gross proceeds of $24,999,988 (CAD $34,279,276). Net proceeds of CAD $31,592,641 was received after share issue costs of $CAD $2,686,635. The warrants have an exercise price of CAD $7.3579 and are exercisable immediately with a term of 5 years. As part of the transaction 233,644 warrants were issued to the underwriter with an exercise price of CAD $9.1973 and will have a term of 3 years.

On June 12, 2025, the Company completed a public offering of 5,500,000 units consisting of one common share and one warrant. Each unit was sold at a price of USD $2.50 for gross proceeds of $13,750,000 (CAD $18,758,889). Net proceeds of CAD $17,113,545 was received after share issue costs of $1,625,345. The warrants have an exercise price of CAD $5.0768 and are exercisable immediately with a term of 5 years. As part of the transaction 275,000 warrants were issued to the underwriter with an exercise price of $4.276 and will have a term of 3 years.

On May 5, 2025, the Company completed a public offering of 1,715,000 units consisting of one common share sold at US $2.10 per unit and one warrant and 100,000 warrants under an over-allotment sold at US $0.01 per warrant. Gross proceeds from the issuance was $3,206,500 (CAD $4,973,404). Net proceeds of CAD $4,307,745 was received after share issue costs of $665,659. The warrants and over allotment have an exercise price of CAD $3.9779 and are exercisable immediately with a term of 5 years. As part of the transaction 90,750 warrants were issued to the underwriter with an exercise price of $3.632 and will have a term of 3 years.

On November 19, 2024, the Company completed a public offering for 400,000 units consisting of one common share and one warrant and 1,200,000 units consisting of one prefunded warrant and one warrant. Each unit was sold at a price of USD $2.35 for gross proceeds of $3,759,880 million (CAD $5,272,234). Net proceeds of CAD $4,672,298 was received after share issue costs of $599,936. The prefunded warrants have an exercise price of CAD $0.00014 which are exercisable immediately with a term of 5 years. The remaining warrants have an exercise price of CAD $3.3086 and are exercisable immediately with a term of 5 years. As part of the transaction 80,000 warrants were issued to the underwriter with an exercise price of CAD $4.1357 and will have a term of 3 years.

On September 5, 2024 the Company effected a 25:1 share consolidation. All share, warrant, option and RSU numbers in these statements are shown post consolidation, including exercise prices, unless otherwise noted.

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

On August 21, 2024, the Company completed a public offering for 346,667 units consisting of one common share and one warrant and 320,000 units consisting of one prefunded warrant and one warrant. Each unit was sold at a price of USD $3.75 for gross proceeds of USD $1,999,199 million (CAD $2,720,050 million). Net proceeds of CAD $2,376,374 million was received after share issue costs of CAD $343,676. The prefunded warrants have an exercise price of CAD $0.035 which are exercisable immediately with a term of 5 years. The remaining warrants have an exercise price of CAD $5.12 and are exercisable immediately with a term of 5 years. On November 19, 2024 the warrant exercise price was amended to CAD $3.3086. As part of the transaction 33,334 warrants were issued to the underwriter with an exercise price of CAD $5.12 and will have a term of 3 years.

On April 29, 2024, the Company completed a public offering for 282,541 units consisting of one common share and one warrant and 258,000 units consisting of one pre-funded warrant and one warrant. Each unit was sold at a price of USD$6.47 for gross proceeds of USD $3,500,000 million (CAD $4,882,168 million). Net proceeds of CAD $4,102,553 million was received after share issue costs of CAD $779,615. The prefunded warrants had an exercise price of CAD $0.00014 pre-consolidation which are exercisable immediately with a term of 5 years. All prefunded warrants were exercised prior to the share consolidation. On August 7, 2024, the warrants were amended to allow for them to be treated as equity versus debt on the Company's balance sheet and the exercise price of the warrants were amended to CAD $5.6250. On November 19, 2024 the warrant exercise price was further amended to CAD $3.3086. The warrants are exercisable immediately with a term of 5 years. As part of the transaction 27,028 warrants were issued to the underwriter with an exercise price of CAD $11.0625 and will have a term of 3 years.

Pursuant to a prior underwritten public offering, the Company issued 256,000 common share warrants (the "October Warrants") with each warrant entitling the holder thereof to purchase one common share of the Company at an exercise price of USD $15.31, until October 28, 2028. In connection with the closing of the offering above, the Company and the holder of the October Warrants have entered into amendment agreements whereby the exercise price of the October Warrants was reduced twice and converted to Canadian dollars for a new exercise price of CAD $5.6925 and the warrants were amended to allow for them to be treated as equity versus debt on the Company's balance sheet. As of November 19, 2024, the exercise price on these warrants was further amended to CAD $3.3086.

On February 26, 2024, the Company completed an underwritten share placement of 448 000 units with each unit consisting of one common share and one warrant to purchase one common share and 88,000 units consisting of one pre-funded warrant to purchase one common share and one warrant to purchase one common share. Each unit was sold at a price of USD $6.75 for gross proceeds of USD $3,617,780 million (CAD $4,877,475 million). Net proceeds of USD $3,055,765 million (CAD $4,124,977 million) was received after share issue costs of USD $326,814 (CAD $441,166). The pre-funded warrants had an exercise price of USD $0.0001 pre-consolidation and were exercised on the date of issue prior to the share consolidation. The remaining warrants have an exercise price of USD $9.00, subject to adjustment, and are exercisable immediately with a term of 5 years. On March 27, 2024 the exercise price on these warrants was updated to USD $4.4025 per the terms of the agreement allowing for a one-time adjustment to the exercise price. As part of this transaction 26,800 warrants were issued to the underwriter with an exercise price of USD $8.44 and will have a term of 3 years.

In order to become compliant with Nasdaq regulations, the company also underwent a stock consolidation. Effective July 29, 2021, the Company consolidated its issued and outstanding common shares on a 5 to 1 basis, which resulted in 27,045,909 common shares outstanding post-consolidation.

Subsequent to the period ending June 30, 2024, on July 23, 2024, the remaining 3,099,000 of the pre-funded warrants from the May 1, 2024 issuance were exercised.

Additional information relating to the Company may be found at the Company's website, <u>www.draganfly.com</u>.

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

**2025 Q3 Highlights**

● **2025 Q3 Total Revenues of $2,155,993 with Product Sales of $1,622,286** 

2025 Q3 revenues increased by $270,671 from $1,885,322 in Q3 2024 to $2,155,993 with the bulk of this revenue coming from product revenue. Service revenue decreased by $22,940 from $556,647 in Q3 2024 to $533,707 in Q3 2025.

● **Gross Profit was $420,947 with a Gross Margin decrease of 3.9% in Q3 2025 compared to Q3 2024.** 

In Q3 2025, the Company's total gross margin was 19.5% compared to 23.4% in Q3 2024.

● **Continued Diversification of its Product and Services Offering** 

Given the Company's deep engineering talent, the Company continues to expand its product and services available to its customers. Doing this leverages the Company's core skill set of innovation that tends to lead to future projects, bringing in more consistent revenue. The Company continues to increase its scope of products and services to include the sale of third-party manufactured UAVs and drone-as-a-service type work. Having a larger breadth of products and services, in part mitigates some risk for the Company given its offering covers a broader market.

● **Risks Related to Operations** 

The Company's UAVs are sold in rapidly evolving markets. The commercial UAV market is in early stages of customer adoption. Accordingly, the Company's business and future prospects may be difficult to evaluate. The Company cannot accurately predict the extent to which demand for its products and services will increase, if at all. The challenges, risks and uncertainties frequently encountered by companies in rapidly evolving markets could impact the Company's ability to do the following:

● generate sufficient revenue to maintain profitability;

● acquire and maintain market share;

● achieve or manage growth in operations;

● develop and renew contracts;

● attract and retain additional engineers and other highly qualified personnel;

● successfully develop and commercially market new products;

● adapt to new or changing policies and spending priorities of governments and government agencies; and

● access additional capital when required and on reasonable terms.

For further and more detailed risk disclosure, please reference "Business Risks" at the end of this MD&A.

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

**Outlook and Guidance**

**General**

The Company believes that drone regulations are gradually evolving in favor of additional use cases, which could lead to more revenue opportunities from a greater pool of customers. The Company is positioned properly to take advantage of this dynamic given its legacy and ongoing innovative product development coupled with being publicly traded providing greater market awareness than its private competitors. The Company will increasingly focus on some of its growth initiatives beyond Canada and into the United States and abroad. All else being equal, accessing more capital will help the Company expand and diversify its engineering and drone services businesses. The Company has already built the infrastructure including human resources from an oversight, sales, and engineering perspective. Further, the Company will continue to focus on innovation, product development, and expanding its hardware offerings opportunistically into niche segments of the UAV and related sectors. Finally, the Company has considered providing various other non-engineering services and it may make more sense to buy an existing industry player than to build out this offering. The Company expects to be active in this regard reviewing partnerships and acquisitions in the current fiscal year and the near future.

**Selected Financial Information**

The following selected financial data has been extracted from the unaudited condensed consolidated interim financial statements, prepared in accordance with International Financial Reporting Standards, for the fiscal years indicated and should be read in conjunction with the unaudited condensed consolidated interim financial statements. All earnings per share calculations are shown post-consolidation.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months ended September 30,** | **Three months ended September 30,** | **Nine months ended September 30,** | **Nine months ended September 30,** |
|  | **2025** | 2024 | **2025** | 2024 |
| Total revenues | $**2155993** | $1885322 | $**5818963** | $4947894 |
| Gross Margin (as a % of revenues) <sup>(1)</sup> | **19.5%** | 23.4% | **21.2%** | 23.9% |
| Net income (loss) | **(5169797)** | (200194) | **(13356783)** | (9155551) |
| Net income (loss) per share ($) |  |  |  |  |
| &nbsp;&nbsp;&nbsp;- Basic | **(0.25)** | (0.06) | **(1.17)** | (3.28) |
| &nbsp;&nbsp;&nbsp;- Diluted | **(0.25)** | (0.06) | **(1.17)** | (3.28) |
| Comprehensive income (loss) | **(5425004)** | (364549) | **(13608350)** | (9346603) |
| Comprehensive income (loss) per share ($) |  |  |  |  |
| &nbsp;&nbsp;&nbsp;- Basic | **(0.26)** | (0.11) | **(1.20)** | (3.35) |
| &nbsp;&nbsp;&nbsp;- Diluted | **(0.26)** | (0.11) | **(1.20)** | (3.35) |
| Change in cash and cash equivalents | $**47310289** | (1292970) | $**63628939** | $903965 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) Gross
 Profit (as a % of revenues) would have been 21.5% and 32.7% not including a non-cash write
 down of inventory for $43,337 and $176,422 respectively for the three-month period ending
 September 30, 2025 and 2024. Gross Profit (as a % of revenues) would have been 21.5% and
 33.2% not including a non-cash write down of inventory for $15,091 and of $459,591 respectively
 for the nine month period ending September 30, 2025 and 2024.

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

The net income (loss) and comprehensive income (loss) for the three and nine months ended September 30, 2025, includes non-cash changes comprised of a change in fair value of derivative liability of $1,837,618 and $1,860,107, a write down of inventory of $43,337 and $15,091, and an impairment gain on notes receivable of $35,461 and $69,646. The net loss and comprehensive loss for the three and nine month period ended September 30, 2025 would otherwise have been a loss of $3,324,303 and $11,551,231 for the net loss, and a loss of $3,579,510 and $11,802,798 for the comprehensive loss.

The net income (loss) and comprehensive income (loss) for the three and nine months ended September 30, 2024, includes non-cash changes comprised of a change in fair value of derivative liability of $(3,575,559) and $(2,788,734) and a write down of inventory of $176,422 and $459,591 and an impairment gain on notes receivable of $7,564 and $18,425. The net loss and comprehensive loss for the three and nine month period ended September 30, 2024 would otherwise have been losses of $3,606,895 and $11,503,119 for the net loss, and a comprehensive loss of $3,771,250 and $11,694,171.

---

| | | |
|:---|:---|:---|
| **As at** | **September 30, 2025** | December 31, 2024 |
| Total assets | $**77081061** | $10200088 |
| Working capital | **69539212** | 3846283 |
| Total non-current liabilities | **212723** | 342013 |
| Shareholders' equity | $**70432421** | $4621783 |
| Number of shares outstanding | **23261012** | 5427795 |

---

Shareholders' equity and working capital as at September 30, 2025, includes a fair value of derivative liability of $3,037,087 (2024 - $2,198,121) and would otherwise be $73,469,508 (2024 - $6,819,904) and $72,576,299 (2024 - $6,044,404), respectively.

**Results of Operations**

**Revenue**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months ended September 30,** | **Three months ended September 30,** | **Nine months ended September 30,** | **Nine months ended September 30,** |
|  | **2025** | 2024 | **2025** | 2024 |
| Sales of goods | $**1622286** | $1328675 | $**5065682** | $3953974 |
| Provision of services | **533707** | 556647 | **753281** | 993920 |
| **Total revenue** | $**2155993** | $1885322 | $**5818963** | $4947894 |

---

Total revenue for the three months ended September 30, 2025, increased by $270,671 or 14.4% as compared to Q3 2024. The increase in revenue is largely due to increased revenue from the sales of goods from Draganfly Innovations Inc. ("Innovations") and Dronelogics Systems Inc. ("Dronelogics").

Services revenue decreased by $22,940 or 4.1% in Q3 2025 as compared to Q3 2024. The decrease in revenue is largely due to decreased service revenue from Dronelogics.

Total revenue for the nine months ended September 30, 2025, increased by $871,069 or 17.6% as compared to the nine months ended September 30, 2024. The increase in revenue is largely due to increased revenue from the sales of goods from Innovations and Dronelogics.

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

**Cost of sales / Gross Margin**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months ended September 30,** | **Three months ended September 30,** | **Nine months ended September 30,** | **Nine months ended September 30,** |
|  | **2025** | 2024 | **2025** | 2024 |
| Cost of sales <sup>(1)</sup> | $**(1735046)** | $(1444542) | $**(4583337)** | $(3765429) |
| Gross profit | **420947** | 440780 | $**1235626** | $1182465 |
| Gross margin (%) | **19.5%** | 23.4% | **21.2%** | 23.9% |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) Cost
 of sales would have been $1,691,709 and $1,268,120 not including a non-cash recovery of inventory
 for $43,337 and $176,422, respectively for the three-month periods ending September 30, 2025
 and 2024. Cost of sales would have been $4,568,246 and $3,305,838 not including a non-cash
 write down of inventory for $15,091 $459,591, respectively for the nine month periods ending
 September 30, 2025 and 2024.

Gross profit is the difference between the revenue received and the direct cost of that revenue. Gross margin is gross profit divided by revenue and is often presented as a percent.

For the three months ended September 30, 2025, the Company's Gross Profit decreased by $19,833 or 4.5% compared to Q3 2024. As a percentage of sales, gross margin decreased from 23.4% in Q3 2024 to 19.5% in Q3 2025. Not including the non-cash write down of inventory of $43,337 (2024 - $176,422), the Company's Gross Profit decreased by $152,918 or 24.8% compared to Q3 2024. The decrease in gross margin percentage was due to a larger increase in cost of sales than in sales.

For the nine months ended September 30, 2025, the Company's Gross Profit increased by $53,161 or 4.5% compared to the nine months ended September 30, 2024. As a percentage of sales, gross margin decreased from 23.9% in 2024 to 21.2% in 2025. Not including the non-cash recovery of inventory of 15,091 (2024 – write down of $459,591), the Company's Gross Profit decreased by $391,699 or 23.8%% compared to the nine months ending September 30, 2024.

**Selling, General, and Administrative (SG&A)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months ended September 30** | **Three months ended September 30** | **Nine months ended September 30,** | **Nine months ended September 30,** |
|  | **2025** | 2024 | **2025** | 2024 |
| Insurance | $**157314** | $234279 | $**468315** | $954259 |
| Office and Miscellaneous | **1330796** | 620696 | **3209956** | 1699555 |
| Professional Fees | **85395** | 424717 | **691458** | 1229244 |
| Research and development | **321331** | 347373 | **609029** | 659832 |
| Share-based payments | **474729** | 400575 | **1139063** | 904629 |
| Travel | **302573** | 57436 | **607615** | 174367 |
| Employee and management | **2463477** | 1766354 | **6870712** | 5622176 |
| **Total** | $**5135615** | $3851430 | $**13596148** | $11244062 |

---

For the three months ended September 30, 2025, SG&A expenses increased by 33.3% from $3,851,430 in Q3 2024 to $5,135,615 in Q3 2025. The largest contributors to the increase are office and miscellaneous, travel and employee and management costs.

For the nine months ended September 30, 2025, SG&A expenses increased by 20.9%, from $11,244,062 for the nine months ended September 30, 2024 to $13,596,148 for the nine months ended September 30, 2025. The largest contributors to the increase are office and miscellaneous, travel and employee and management costs.

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

**Net and Comprehensive Income (Loss)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months ended September 30,** | **Three months ended September 30,** | **Nine months ended September 30,** | **Nine months ended September 30,** |
|  | **2025** | 2024 | **2025** | 2024 |
| Loss from operations | $**(4925829)** | $(3684298) | $**(12996499)** | $(10869469) |
| Change in fair value of derivative liability | **(1837618)** | 3575559 | **(1860107)** | 2788734 |
| Finance and other costs | **366000** | 38632 | **410494** | 85436 |
| Foreign exchange gain (loss) | **1127680** | (48216) | **1023272** | 26344 |
| Gain (loss) on disposal of assets | **16545** | 7846 | **16242** | 32148 |
| Recovery of notes receivable | **35461** | 7564 | **69646** | 18425 |
| Other income (loss) | **47964** | (97281) | **(19831)** | (1237169) |
| **Net income (loss)** | **(5169797)** | (200194) | **(13356783)** | (9155551) |
| Cumulative translation differences | **(248065)** | 1086 | **(258710)** | (15935) |
| Change in fair value of equity investments at FVOCI | **(7142)** | (165441) | **7143** | (175117) |
| **Comprehensive income (loss)** | $**(5425004)** | $(364549) | $**(13608350)** | $(9346603) |

---

For the three months ended September 30, 2025, the Company recorded a comprehensive loss of $5,425,004 compared to comprehensive loss of $364,549 in Q3 2024.

The net and comprehensive loss for the three months ended September 30, 2025, includes non-cash changes comprised of a change in fair value of derivative liability of $1,837,618, a write down of inventory of $43,337, and a recovery of notes receivable of $35,461 and would otherwise be a loss of $3,324,303 and comprehensive loss of $3,579,510. The net and comprehensive loss for the same period last year, included a change in fair value of derivative liability of $(3,575,559), an inventory write down of $176,422 and a recovery of notes receivable of $7,564 and would otherwise be a loss of $3,606,895 and a comprehensive loss of $3,771,250.

For the nine months ended September 30, 2025, the Company recorded a comprehensive loss of $13,608,350 compared to a loss of $9,346,603 in 2024.

The net and comprehensive loss for the nine months ended September 30, 2025, includes non-cash changes compromised of change in fair value of derivative liability of $1,860,107, a write down of inventory of $15,091, and a recovery of notes receivable of $69,646, and would otherwise be losses of $11,551,231 and $11,802,798 respectively. The net and comprehensive income for the same period last year, included a change in fair value of derivative liability of $(2,788,734), a write down of inventory of $459,591 and a recovery of notes receivable of $18,425, and would otherwise be losses of $11,503,119 and $11,694,171, respectively.

**Authorized share capital**

Unlimited number of common shares without par value.

 ****

**Issued share capital**

During the nine months ended September 30, 2025,

● The Company issued 134,191 common shares for the vesting of restricted share units.

● On May 5, 2025, the Company issued 1,715,000 units consisting of one common share and one warrant and in a financing for $4,973,404 with share issue costs of $665,659 for net proceeds of $4,307,745. The value of the issuance was allocated $4,545,997 to the shares and $427,407 to the warrants. This issuance included an overallotment of 100,000 warrants convertible to 100,000 shares. Warrants were valued using the residual method.

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

● The Company issued 100,000 shares related to the overallotment of the May 5, 2025 share issuance for gross proceeds of $265,971 with share issue costs of $28,030 for net proceeds of $237,941.

● On June 12, 2025 the Company issued 5,500,000 units consisting of one common share and one warrant in a financing for $18,758,889 with share issue costs of $1,625,345 for net proceeds of $17,113,545. The value of the issuance was allocated $18,082,472 to the shares and $676,418 to the warrants. Warrants were valued using the residual method.

● On July 21, 2025 the Company issued 4,672,895 units consisting of one common share and one warrant in a financing for $34,279,276 with share issue costs of $2,686,634 for net proceeds of $31,592,641.

● 5,711,131 shares were issued for the exercise of warrants

During the year ended December 31, 2024,

● The Company issued 25,353 common shares for the vesting of restricted share units.

● The Company issued 1,991,668 common shares for the exercise of warrants

● On February 26, 2024, the Company issued 448,000 units consisting of one common share and one warrant and 88,000 units consisting of one prefunded warrant and one warrant in a financing for $4,877,475 with share issuance costs of $752,498 for net proceeds of $4,124,977. Of the total share issuance costs $441,166 was expensed in other income (expense). The value of the issuance was allocated $2,017,966 to the shares, and $2,859,509 to the warrants, including $431,084 allocated to prefunded warrants. The prefunded warrants were exercised on the date of issue. On March 27, 2024, the exercise price of the warrants was amended to US$0.1761 from the original exercise price of USD $0.36 due to a one time exercise price reset Post share consolidation, the new exercise price is US$4.4025.

● 36,000 shares were returned to treasury that were held in escrow related to the Vital Intelligence Inc. acquisition for failure to meet required milestones. The shares had a carrying value of $nil on cancellation.

● On April 29, 2024, the Company issued 282,541 units consisting of one common share and one warrant and 258,000 units consisting of one prefunded warrant and one warrant in a financing for $4,882,168 with share issuance costs of $779,615 for net proceeds of $4,102,553. Of the total share issuance costs $671,747 was expensed in other income (expense). The value of the issuance was allocated $396,137 to the shares, and $4,422,815 to the warrants, including $1,248,343 allocated to prefunded warrants.

● On August 21, 2024, the Company issued 346,667 units consisting of one common share and one warrant, and 320,000 units consisting of one prefunded warrant and one warrant in a financing for $2,720,050 with share issue costs of $343,676 for net proceeds of $2,376,374. The value of the issuance was allocated $160,076 to the shares, and $2,559,974 to the warrants including $591,265 allocated to prefunded warrants.

● On November 19, 2024 the Company issued 400,000 units consisting of one common share and one warrant and 1,200,000 units consisting of one prefunded warrant and one warrant in a financing for $5,272,234 with share issue costs of $755,387 for net proceeds of $4,516,837. The value of the issuance was allocated $329,515 to the shares and $4,942,719 to the warrants including $1,977,088 allocated to the prefunded warrants.

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

**Summary of Quarterly Results**

The following selected quarterly financial data has been extracted from the financial statements, prepared in accordance with International Financial Reporting Standards.

Total revenue for the three months ended September 30, 2025, increased by $270,671 or 14.4% as compared to the same period in 2024. The increase was mainly due to increased revenue from product sales.

SG&A expenses for the three months ended September 30, 2025 increased 33.3% compared to the same period in 2024 due to the increase in office and miscellaneous, employee and management costs and travel. The other income (expense) and comprehensive loss for the third quarter of 2025 includes non-cash changes of a change in fair value of derivative liability of $1,837,618, a recovery on notes receivable of $35,461 and would otherwise be an other expense of $1,558,189 and comprehensive loss for the third quarter of 2025 includes non-cash changes of a change in fair value of derivative liability of $1,837,618, a write down of inventory of $43,337, a recovery of notes receivable of $35,461 and would other wise have been a comprehensive loss of $3,579,510.

Total revenue for the three months ended September 30, 2025, increased by $40,738 or 2% as compared to the three months ended June 30, 2025. The primary increase in revenue is due to the increase in service revenue. Product sales decreased by $279,299 or 15% in the third quarter of 2025 as compared to the second quarter primarily due to decreased demand.

SG&A expenses increased by $375,791 or 7.9% compared to the second quarter of 2025 due to increased research and development, office and miscellaneous and travel.

The table below summarizes the quarterly results over the past eight fiscal quarters. All earnings per share calculations are shown post-consolidation.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **2025 Q3** | 2025 Q2 | 2025 Q1 | 2024 Q4 |
| Revenue | $**2155993** | $2115255 | $1547715 | $1613162 |
| Cost of sales<sup>(2)</sup> | $**(1735046)** | $(1610663) | $(1237627) | $(1397422) |
| Gross profit<sup>(3)</sup> | $**420947** | $504592 | $310088 | $215740 |
| Gross margin – percentage | **19.5%** | 23.9% | 20.0% | 13.4% |
| Operating expenses | $**(5346776)** | $(4974316) | $(3911035) | $(4085766) |
| Operating income (loss) | $**(4925829)** | $(4469724) | $(3600947) | $(3870026) |
| Operating loss per share - basic | $**(0.24)** | $(0.57) | $(0.67) | $(0.91) |
| Operating loss per share - diluted | $**(0.24)** | $(0.57) | $(0.67) | $(0.91) |
| Other income (expense) | $**1593650** | $(112119) | $18292 | $94220 |
| Change in fair value of derivative liability <sup>(1)</sup> | $**(1837618)** | $(180318) | $157830 | $(946116) |
| Other comprehensive income (loss) | $**(255207)** | $12527 | $(8887) | $5991 |
| Comprehensive income (loss) | $**(5425004)** | $(4749634) | $(3433712) | $(4715931) |
| Comprehensive income (loss) per share - basic | $**(0.26)** | $(0.60) | $(0.64) | $(1.11) |
| Comprehensive income (loss) per share - diluted | $**(0.26)** | $(0.60) | $(0.64) | $(1.11) |

---

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **2024 Q3** | 2024 Q2 | 2024 Q1 | 2023 Q4 |
| Revenue | $**1885322** | $1732990 | $1329581 | $916299 |
| Cost of sales<sup>(4)</sup> | $**(1444542)** | $(1271317) | $(1049570) | $(657420) |
| Gross profit<sup>(5)</sup> | $**440780** | $461673 | $280011 | $258879 |
| Gross margin – percentage | **23.4%** | 26.6% | 21.1% | 28.3% |
| Operating expenses | $**(4125078)** | $(4395923) | $(3530933) | $(3482141) |
| Operating loss | $**(3684298)** | $(3934250) | $(3250922) | $(3223262) |
| Operating loss per share - basic | $**(1.10)** | $(1.39) | $(1.48) | $(1.95) |
| Operating loss per share - diluted | $**(1.10)** | $(1.39) | $(1.48) | $(1.95) |
| Other income (expense) | $**(91455)** | $(552905) | $(430455) | $(1118870) |
| Change in fair value of derivative liability <sup>(1)</sup> | $**3575559** | $(2604394) | $1817569 | $153798 |
| Other comprehensive income (loss) | **(164355)** | $(6089) | $(20608) | $(3461) |
| Comprehensive income (loss) | $**(364549)** | $(7097638) | $(1884416) | $(4191796) |
| Comprehensive income (loss) per share - basic | $(0.11) | $(2.51) | $(0.86) | $(2.53) |
| Comprehensive income (loss) per share - diluted | $(0.11) | $(2.51) | $(0.86) | $(2.53) |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) Included
 in other income (expense).

&nbsp;&nbsp;&nbsp;&nbsp;(2) Cost
 of goods sold includes non-cash inventory write downs of $167,515 in Q4 2024, a recovery
 of a write down of $38,666 in Q1 2025, a write down of $10,421 in Q2 2025 and a write down
 of $43,337 in Q3 2025 and would have been $1,229,907 in Q4 2024, $1,276,293 in Q1 2025, $1,600,242
 in Q2 2025 and $1,691,709 in Q3 2025 before these recoveries.

&nbsp;&nbsp;&nbsp;&nbsp;(3) Gross
 profit would have been $383,255 in Q4 2024, $271,422 in Q1 2025, $515,013 in Q2 2025 and
 $464,284 in Q3 2025 without the write downs in number 2 above.

&nbsp;&nbsp;&nbsp;&nbsp;(4) Cost
 of goods sold includes non-cash inventory write downs of $123,424 in Q4 2023 and $148,760
 in Q1 2024, $134,410 in Q2 2024 and $176,422 in Q3 2024 and would have been $533,996 in Q4
 2023, $900,810 in Q1 2024 $1,136,907 in Q2 2024 and $1,268,120 in Q3 2024 before these write
 downs.

&nbsp;&nbsp;&nbsp;&nbsp;(5) Gross
 profit would have been $382,303 in Q4 2023, $428,771 in Q1 2024, $596,083 in Q2 2024 and
 $617,202 in Q3 2024, without the write downs in number 4 above.

**Liquidity and Capital Resources**

The Company's liquidity risk is derived from its loans, accounts payable, and accrued liabilities, as it may encounter difficulty discharging those obligations, but the Company endeavors to mitigate that risk through the careful management of its debt holders and the assertive pursuit of capital inflow for its operations. The Company's working capital of $69,539,212 as at September 30, 2025 would be increased to working capital of $72,576,299 if the non-cash derivative liability was excluded. The Company's working capital at December 31, 2024 was $2,198,121 and would be increased to $6,044,404 if the non-cash derivative liability was excluded.

The Company considers the items included in capital to include shareholders' equity. The Company manages its capital structure and makes adjustments to it in light of changes in economic and business conditions, financing environment, and the risk characteristics of the underlying assets. The Company does not have any contracted or committed capital expenditures as of the date of this MD&A. The Company utilizes its credit card facilities from time to time to make various purchases for their operations.

On July 21, 2025, The Company completed a public offering of 4,672,895 units consisting of one common share and one warrant. Each unit was sold at a price of USD $5.35 for gross proceeds of $24,999,988 (CAD $34,279,276). Net proceeds of CAD $31,592,641 was received after share issue costs of $CAD $2,686,635. The warrants have an exercise price of CAD $7.3579 and are exercisable immediately with a term of 5 years. As part of the transaction 233,644 warrants were issued to the underwriter with an exercise price of CAD $9.1973 and will have a term of 3 years.

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

On June 12, 2025, the Company completed a public offering of 5,500,000 units consisting of one common share and one warrant. Each unit was sold at a price of USD $2.50 for gross proceeds of $13,750,000 (CAD $18,758,889). Net proceeds of CAD $17,113,545 was received after share issue costs of $1,625,345. The warrants have an exercise price of CAD $5.0768 and are exercisable immediately with a term of 5 years. As part of the transaction 275,000 warrants were issued to the underwriter with an exercise price of $4.276 and will have a term of 3 years.

On May 5, 2025, the Company completed a public offering of 1,715,000 units consisting of one common share sold at US $2.10 per unit and one warrant and 100,000 warrants under an over-allotment sold at US $0.01 per warrant. Gross proceeds from the issuance was $3,206,500 (CAD $4,973,404). Net proceeds of CAD $4,307,745 was received after share issue costs of $665,659. The warrants and over allotment have an exercise price of CAD $3.9779 and are exercisable immediately with a term of 5 years. As part of the transaction 90,750 warrants were issued to the underwriter with an exercise price of $3.632 and will have a term of 3 years.

On November 19, 2024, the Company completed a public offering for 400,000 units consisting of one common share and one warrant and 1,200,000 units consisting of one prefunded warrant and one warrant. Each unit was sold at a price of USD $2.35 for gross proceeds of $3,759,880 million (CAD $5,272,234). Net proceeds of CAD $4,672,298 was received after share issue costs of $599,936. The prefunded warrants have an exercise price of CAD $0.00014 which are exercisable immediately with a term of 5 years. The remaining warrants have an exercise price of CAD $3.3086 and are exercisable immediately with a term of 5 years. As part of the transaction 80,000 warrants were issued to the underwriter with an exercise price of CAD $4.1357 and will have a term of 3 years.

On September 5, 2024 the Company effected a 25:1 share consolidation. All share, warrant, option and RSU numbers in these statements are shown post consolidation, including exercise prices, unless otherwise noted.

On August 21, 2024, the Company completed a public offering for 346,667 units consisting of one common share and one warrant and 320,000 units consisting of one prefunded warrant and one warrant. Each unit was sold at a price of USD $3.75 for gross proceeds of USD $1,999,199 million (CAD $2,720,050 million). Net proceeds of CAD $2,376,374 million was received after share issue costs of CAD $343,676. The prefunded warrants have an exercise price of CAD $0.035 which are exercisable immediately with a term of 5 years. The remaining warrants have an exercise price of CAD $5.12 and are exercisable immediately with a term of 5 years. On November 19, 2024 the warrant exercise price was amended to CAD $3.3086. As part of the transaction 33,334 warrants were issued to the underwriter with an exercise price of CAD $5.12 and will have a term of 3 years.

On April 29, 2024, the Company completed a public offering for 282,541 units consisting of one common share and one warrant and 258,000 units consisting of one pre-funded warrant and one warrant. Each unit was sold at a price of USD$6.47 for gross proceeds of USD $3,500,000 million (CAD $4,882,168 million). Net proceeds of CAD $4,102,553 million was received after share issue costs of CAD $779,615. The prefunded warrants had an exercise price of CAD $0.00014 pre-consolidation which are exercisable immediately with a term of 5 years. All prefunded warrants were exercised prior to the share consolidation. On August 7, 2024, the warrants were amended to allow for them to be treated as equity versus debt on the Company's balance sheet and the exercise price of the warrants were amended to CAD $5.6250. On November 19, 2024 the warrant exercise price was further amended to CAD $3.3086. The warrants are exercisable immediately with a term of 5 years. As part of the transaction 27,028 warrants were issued to the underwriter with an exercise price of CAD $11.0625 and will have a term of 3 years.

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

On February 26, 2024, the Company completed an underwritten share placement of 448 000 units with each unit consisting of one common share and one warrant to purchase one common share and 88,000 units consisting of one pre-funded warrant to purchase one common share and one warrant to purchase one common share. Each unit was sold at a price of USD $6.75 for gross proceeds of USD $3,617,780 million (CAD $4,877,475 million). Net proceeds of USD $3,055,765 million (CAD $4,124,977 million) was received after share issue costs of USD $326,814 (CAD $441,166). The pre-funded warrants had an exercise price of USD $0.0001 pre-consolidation and were exercised on the date of issue prior to the share consolidation. The remaining warrants have an exercise price of USD $9.00, subject to adjustment, and are exercisable immediately with a term of 5 years. On March 27, 2024 the exercise price on these warrants was updated to USD $4.4025 per the terms of the agreement allowing for a one-time adjustment to the exercise price. As part of this transaction 26,800 warrants were issued to the underwriter with an exercise price of USD $8.44 and will have a term of 3 years.

Pursuant to a prior underwritten public offering, the Company issued 256,000 common share warrants (the "October Warrants") with each warrant entitling the holder thereof to purchase one common share of the Company at an exercise price of USD $15.31, until October 28, 2028. In connection with the closing of the offering above, the Company and the holder of the October Warrants have entered into amendment agreements whereby the exercise price of the October Warrants was reduced twice and converted to Canadian dollars for a new exercise price of CAD $5.6925 and the warrants were amended to allow for them to be treated as equity versus debt on the Company's balance sheet. As of November 19, 2024, the exercise price on these warrants was further amended to CAD $3.3086.

Further, in order to maintain or adjust its capital structure, the Company may issue new shares, new debt, or scale back the size and nature of its operations. The Company is not subject to externally imposed capital requirements.

The Company's ability to continue as a going concern is dependent upon its ability to obtain additional financing and or achieve profitable operations in the future. These factors indicate the existence of a material uncertainty that may cast significant doubt on the Company's ability to continue as a going concern.

We expect, from time to time, to evaluate the acquisition of businesses, intellectual property, products and technologies for which a portion of the net proceeds may be used. There is always the potential that any acquisition or investment in a company or product has a negative impact on future cash flows of the Company.

Our plan of operations for the next year includes the following: (i) ensure production capacity is adequate to meet demand for products; (ii) continuing to hone existing product offerings; (iii) streamline workflow efficiencies; (iv) diversifying and expanding business lines organically and by considering potential acquisitions; (v) continuing to patent innovative ideas for new products; and (vi) developing and increasing current product offering to various niche industries that are not currently being served.

As of the date of this MD&A, we cannot predict with certainty all of the particular uses for the net proceeds received from the closing of past financings. The amounts and timing of our actual expenditures may vary significantly depending on numerous factors.

**Off-Balance Sheet Arrangements**

The Company has no material undisclosed off-balance sheet arrangements that have or are reasonably likely to have, a current or future effect on our results of operations, financial condition, revenues or expenses, liquidity, capital expenditures or capital resources.

**Contractual Obligations**

As of September 30, 2025, and as of the date of this MD&A, and in the normal course of business, the following is a summary of the Company's material obligations to make future payments, representing contracts, and other commitments that are known and committed.

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

**Right of Use Assets**

---

| | | | |
|:---|:---|:---|:---|
|  | **Buildings** | **Land** | **Total** |
| Balance at December 31, 2023 | $515071 | $206616 | $721687 |
| Depreciation | (142727) | (214114) | (356841) |
| Foreign exchange translation | - | 7498 | 7498 |
| Balance at December 31, 2024 | $372344 | $- | $372344 |
| Depreciation | **(107046)** | **-** | **(107046)** |
| **Balance at September 30, 2025** | $**265298** | $**-** | $**265298** |

---

There were no additions to the right of use assets during the three and nine months ended September 30, 2025 nor the year ended December 31, 2024.

**Lease Liability**

---

| | |
|:---|:---|
|  | **Total** |
| Balance at December 31, 2023 | $790023 |
| &nbsp;&nbsp;&nbsp;Interest expense | 65378 |
| &nbsp;&nbsp;&nbsp;Lease payments | (423157) |
| Foreign exchange translation | (4223) |
| Balance at December 31, 2024 | 428021 |
| **Interest expense** | **28969** |
| **Lease payments** | **(143142)** |
| **Balance at September 30, 2025** | $**313848** |

---

Which consists of:

---

| | | |
|:---|:---|:---|
|  | **September 30, 2025** | December 31, 2024 |
| Current lease liability | $**151033** | $154147 |
| Non-current lease liability | **162815** | 273874 |
| **Ending balance** | $**313848** | $428021 |

---

---

| | | |
|:---|:---|:---|
| **Maturity analysis** | **September 30, 2025** | December 31, 2024 |
| Less than one year | $**176094** | $190856 |
| One to three years | **178161** | 282419 |
| Four to five years | **-** | 71836 |
| Total undiscounted lease liabilities | **354255** | 545111 |
| Amount representing interest | **(40407)** | (117090) |
|  | $**313848** | $428021 |

---

**Related Party Transactions**

On August 1, 2019, the Company entered in a business services agreement (the "Agreement") with Business Instincts Group ("BIG"), a company that Cameron Chell, CEO and director has a material interest in that he previously controlled, to provide: corporate development and governance, strategic facilitation and management, general business services, office space, corporate business development video content, website redesign and management, and online visibility management. The services are provided by a team of consultants and the costs of all charges are based on the fees set in the Agreement. For the three and nine months ended September 30, 2025, the Company incurred fees of $124,208 (2024 - $64,463) and $302,886 (2024 - $190,164) respectively. As at September 30, 2025, the Company was indebted to this company in the amount of $nil (2024 - $1,874).

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

On October 1, 2019, the Company entered into an independent consultant agreement ("Consultant Agreement") with 1502372 Alberta Ltd, a company controlled by Cameron Chell, CEO and director, to provide executive consulting services to the Company. The costs of all charges are based on the fees set in the Consultant Agreement. For the three and nine months ended September 30, 2025, the Company incurred fees of $109,438 (2024 - $109,437) and $520,089 (2024 - $325,125) respectively. As at September 30, 2025, the Company was indebted to this company in the amount of $nil (2024 - $nil).

On May 2, 2022, the Company and entered into an agreement with Scott Larson, a director, to provide executive consulting services to the Company and all fees are set in the consulting agreement. For the three and nine months ended September 30, 2025, the Company incurred fees of $30,744 (2024 - $41,910) and $70,203 (2024 - $119,335). As at September 30, 2025, the Company was indebted to this company in the amount of $nil (2024 - $9,000).

**Trade receivables/payables and accrued receivables/payables:**

As at September 30, 2025, the Company had $122,965 (2024 - $10,874) payable to related parties that was included in accounts payable. The balances outstanding are unsecured, non-interest bearing and due on demand.

**Key management compensation**

Key management personnel include those persons having authority and responsibility for planning, directing and controlling the activities of the Company as a whole. Compensation awarded to key management for the three and nine months ended September 30, 2025 and 2024 included:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the three months ended September 30,** | **For the three months ended September 30,** | **For the nine months ended September 30,** | **For the nine months ended September 30,** |
|  | **2025** | 2024 | **2025** | 2024 |
| Director fees | $**122965** | $131469 | $**394803** | $375368 |
| Salaries | **632338** | 127329 | **1087594** | 396916 |
| Share-based payments | **297738** | 223364 | **697301** | 527224 |
|  | $**1053041** | $482162 | $**2179698** | $1299508 |

---

**Other related parties**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the three months ended September 30,** | **For the three months ended September 30,** | **For the nine months ended September 30,** | **For the nine months ended September 30,** |
|  | **2025** | 2024 | **2025** | 2024 |
| Management fees paid to a company controlled by CEO and director | $**109438** | $109437 | $**520089** | $325125 |
| Management fees paid to a company that the CEO holds an economic interest in | **124208** | 64463 | **302886** | 190164 |
| Management fees paid to a company controlled by a director | **30744** | 41910 | **70203** | 119335 |
|  | $**264390** | $215810 | $**893178** | $634624 |

---

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

**Share Capital**

---

| | | |
|:---|:---|:---|
|  | **Number of Common Shares** | **Share Capital** |
| Balance, December 31, 2023 | 1969566 | $97070976 |
| Shares issued for financing | 1477208 | 10384145 |
| &nbsp;&nbsp;&nbsp;Share issue costs |  | (1632871) |
| Shares issued for the exercise of warrants | 1991668 | 4056827 |
| Shares returned to treasury | (36000) |  |
| Shares issued for the exercise of RSU's | 25353 | 863907 |
| **Balance, December 31, 2024** | **5427795** | **110742984** |
| Shares issued for financing | 11887895 | 56907745 |
| &nbsp;&nbsp;&nbsp;Share issue costs |  | (7203673) |
| Shares issued for exercise of overallotment | 100000 | 294000 |
| &nbsp;&nbsp;&nbsp;Share issue costs |  | (28030) |
| Shares issued for the exercise of warrants | 5711131 | 26438554 |
| Shares issued for the exercise of RSU's | 134191 | 1249123 |
| **Balance, September 30, 2025** | **23261012** | $**188400703** |

---

**Stock options**

The following is the summary of the Company's stock option activity. Number of options and weighted average exercise prices in the table below are shown as they were outstanding, forfeited, granted, and exercised:

---

| | | |
|:---|:---|:---|
|  | **Number of Options** | **Weighted Average<br> Exercise Price** |
| Outstanding, December 31, 2023 | 35954 | $112.00 |
| Forfeited | (4350) | 106.83 |
| Outstanding, December 31, 2024 | 31604 | $112.05 |
| Expired | **(4000)** | **80.00** |
| Forfeited | **(3746)** | **113.55** |
| **Outstanding, September 30, 2025** | **23858** | $**116.34** |

---

**Restricted Share Units (RSUs)**

The following is the summary of the Company's RSU activity. Number of RSUs in the table below are shown as they were outstanding, exercised, forfeited, and issued:

---

| | | |
|:---|:---|:---|
|  | **Number of RSUs** | **Average Price** |
| Outstanding, December 31, 2023 | 44545 | $32.45 |
| Vested | (25353) | 35.63 |
| Issued | 185240 | 8.99 |
| Forfeited | (16332) | 13.41 |
| Outstanding, December 31, 2024 | 188100 | 10.74 |
| **Vested** | **(134191)** | **13.10** |
| **Issued** | **450964** | **2.55** |
| **Forfeited** | **(9175)** | **10.78** |
| **Outstanding, September 30, 2025** | **495698** | $**3.86** |

---

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

**Warrants**

During the year ended December 31, 2024 and the year ended December 31, 2023, the Company issued pre-funded warrants ("USD pre-funded Warrants") where a portion of the funds related to the eventual exercise have already been received with the remaining exercise price in USD. Being in a foreign currency that is not the Company's functional currency and these pre-funded warrants were not issued in exchange for services, the value related to the future exercise price of the USD pre-funded Warrants are required to be recorded as a financial liability and not as equity. As a financial liability, the portion of the USD pre-funded Warrants related to the future exercise price will be revalued on a quarterly basis to fair market value with the change in fair value being recorded in profit or loss. The initial fair value of these USD pre-funded Warrants was parsed out from equity and recorded as a financial liability.

To determine the fair value of the warrants, a Black Scholes calculation is used, calculated in USD for those with a USD exercise price and in CAD for those with a Canadian exercise price. The Black Scholes value per warrant is then multiplied by the number of outstanding warrants and then multiplied by the foreign exchange rate at the end of the period for those denominated in USD.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| 2024 Issuances | February Issuance | February Issuance | April Issuance | April Issuance | August Issuance | November Issuance |
|  | Warrants | Broker | Warrants | Broker | Broker | Broker |
| Volatility | 119.23% | 107.8% | 119.80% | 108.67% | 118.87% | 115.27% |
| Risk free rate | 4.33% | 4.48% | 4.65% | 4.62% | 3.74% | 4.24% |
| Expected life | 5 years | 3 years | 5 years | 3 years | 3 years | 3 years |
| Expected dividend yield | 0% | 0% | 0% | 0% | 0% | 0% |

---

Warrant Derivative Liability

---

| | |
|:---|:---|
| Balance at December 31, 2023 | $4196125 |
| Warrants issued | 7282325 |
| Exercised | (3661283) |
| Change in fair value of warrants outstanding | (1842618) |
| Reclassify to equity | (3776428) |
| **Balance at December 31, 2024** | $**2198121** |
| **Exercised** | **(1021141)** |
| **Change in fair value of warrants outstanding** | **1860107** |
| **Balance at September 30, 2025** | $**3037087** |

---

Details of these warrants and their fair values are as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Issue Date** | **Exercise Price** | **Exercise Price** | **Number of Warrants Outstanding at**<br> **September 30, 2025** | **Fair Value at September 30, 2025** | **Number of Warrants Outstanding at December 31, 2024** | **Fair Value at December 31, 2024** |
| **Derivative Liability** |  |  |  |  |  |  |
| February 26, 2024 (1) | US$ | 4.4025 | 318035 | $3037087 | 474332 | $2198121 |
|  |  |  | **318035** | $**3037087** | 474332 | $2198121 |

---

1) The warrants expire February 26, 2029.

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

The fair values of these warrants were estimated using the Black-Scholes Option Pricing Model with the following weighted average assumptions:

---

| | | |
|:---|:---|:---|
|  | **September 30, 2025** | December 31, 2024 |
| Risk free interest rate | **3.76%** | 4.38% |
| Expected volatility | **128.72%** | 124.06% |
| Expected life | **3.41 years** | 4.16 years |
| Expected dividend yield | **0%** | 0% |

---

As at September 30, 2025, the Company had the following warrants outstanding:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Date issued** | **Expiry date** | **Exercise price** | **Exercise price** | **Number of warrants outstanding September 30, 2025** | **Number of warrants outstanding December 31, 2024** |
| October 30, 2023 | October 30, 2026 | CAD$ | 23.20 | 12800 | 12800 |
| October 30, 2023 | October 30, 2028 | CAD$ | 3.3086 | 256000 | 256000 |
| February 26, 2024 | February 26, 2027 | US$ | 8.44 | 26800 | 26800 |
| February 26, 2024 | February 26, 2029 | US$ | 4.4025 | 318035 | 474332 |
| April 29, 2024 | April 29, 2029 | CAD$ | 3.3086 | 540541 | 540541 |
| April 29, 2024 | April 29, 2027 | CAD$ | 11.06 | 27028 | 27028 |
| August 21, 2024 | August 21, 2029 | CAD$ | 3.3086 |  | 666667 |
| August 21, 2024 | August 21, 2027 | CAD$ | 5.12 |  | 33334 |
| November 19, 2024 | November 19, 2029 | CAD$ | 3.3086 | 266667 |  |
| May 5, 2025 | May 5, 2030 | CAD$ | 3.9779 | 485000 |  |
| May 5, 2025 | May 5, 2028 | CAD$ | 3.632 | 90750 |  |
| June 12, 2025 | June 12, 2030 | CAD$ | 5.0768 | 3763500 |  |
| July 21, 2025 | July 21, 2030 | CAD$ | 7.3579 | 4572895 |  |
| July 21, 2025 | July 21, 2028 | CAD$ | 9.1973 | 233644 | - |
|  |  |  |  | **10593660** | **2037502** |

---

The weighted average remaining contractual life of warrants outstanding as of September 30, 2025, was 4.59 years (December 31, 2024 – 4.6 years).

---

| | | |
|:---|:---|:---|
|  | **Number of Warrants** | **Weighted Average<br> Exercise Price** |
| Outstanding, December 31, 2023 | 342992 | $15.75 |
| Issued | 5376370 | 3.35 |
| Exercised | (1991668) | 0.96 |
| Expired | (10192) | 125.00 |
| Outstanding, December 31, 2024 | 3717502 | $5.16 |
| **Issued** | **12587289** | **5.81** |
| **Exercised** | **(5711131)** | **(4.24)** |
| **Outstanding September 30, 2025** | **10593660** | $**6.01** |

---

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

**Critical Accounting Policies and Estimates**

***Newly adopted policy***

The Company has adopted a residual value method with respect to the measurement of shares and warrants issued as private placement units for equity treatment warrants, whereby the carrying amount of the warrants is determined based on any difference between gross proceeds and the estimated fair market value of the common shares. If the proceeds from the offering are less than or equal to the estimated fair market value of common shares issued, no value is assigned to the warrants. Warrants that are issued as payment to a finder or other transaction costs are accounted for as share-based payments.

 ****

***Significant estimates and assumptions***

The preparation of consolidated financial statements in accordance with IFRS requires the Company to make estimates and assumptions about reported amounts at the date of the consolidated financial statements and in the future. The Company's management reviews these estimates and underlying assumptions on an ongoing basis, based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Revisions to estimates are adjusted for prospectively in the period in which the estimates are revised.

*Share-based payments*

The cost of share-based payment transactions with directors, officers and employees are measured by reference to the fair value of the equity instruments. Estimating fair value for share-based payment transactions requires determining the most appropriate valuation model, which is dependent on the terms and conditions of the grant. This estimate also requires determining and making assumptions about the most appropriate inputs to the valuation model including the expected life, volatility, risk-free interest rate, expected forfeiture rate and dividend yield.

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

*Income taxes*

Provisions for income taxes are made using the best estimate of the amount expected to be paid based on a qualitative assessment of all relevant factors. The Company reviews the adequacy of these income tax provisions at the end of each reporting period. However, it is possible that at some future date an additional liability could result from audits by tax authorities. Where the final outcome of these tax-related matters is different from the amounts that were initially recorded, such differences will affect the tax provisions in the period in which such determination is made. Deferred tax assets are recognized when it is determined that the Company is likely to recognize their recovery from the generation of taxable income.

 

*Inventory*

Inventory is valued at the lower of cost and net realizable value. Net realizable value is determined with reference to the estimated selling price less costs to sell. The Company estimates selling price based upon assumptions about future demand and current and anticipated retail market conditions. The future realization of these inventories may be affected by future technology or other market- driven changes that may reduce future selling prices.

 

*Investments in Private companies*

Where the fair value of investments in private companies recorded on the consolidated statement of financial position cannot be derived from active markets, they are determined using a variety of valuation techniques. The inputs to these models are derived from observable market data where possible, but where observable market data is not available, judgment is required to establish fair value and this value may not be indicative of the eventual recoverable value.

 

*Expected credit losses on trade receivables and notes receivable*

The Company recognizes a loss allowance for the expected credit losses related to trade receivables. Expected credit losses are measures to reflect the probability weighted amount and reasonable supportable information regarding past events, current conditions and forecasts of future economic conditions.

The Company applies the simplified approach for trade receivables. Using the simplified approach, the Company records a loss allowance equal to the expected credit losses resulting from all possible default events.

Receivables are written off when the Company has no reasonable expectations of recovering all or any portion thereof.

 

*Useful lives of equipment and intangible assets*

Estimates of the useful lives of equipment and intangible assets are based on the period over which the assets are expected to be available for use. The estimated useful lives are reviewed annually and are updated if expectations differ from previous estimates due to physical wear and tear, technical or commercial obsolescence, and legal or other limits on the use of the relevant assets. In addition, the estimation of the useful lives of the relevant assets may be based on internal technical evaluation and experience with similar assets. It is possible, however, that future results of operations could be materially affected by changes in the estimates brought about by changes in the factors mentioned above. The amounts and timing of recorded expenses for any period would be affected by changes in these factors and circumstances. A reduction in the estimated useful lives of the equipment would increase the recorded expenses and decrease the non-current assets.

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

**Other Significant judgements**

The preparation of consolidated financial statements in accordance with IFRS requires the Company to make judgments, apart from those involving estimates, in applying accounting policies. The most significant judgments applied to the Company's consolidated financial statements include:

● The assessment of the Company's ability to continue as a going concern and whether there are events or conditions that may give rise to significant uncertainty;

● the classification of financial instruments;

● the assessment of revenue recognition using the five-step approach under IFRS 15 and the collectability of amounts receivable;

● the determination of whether a set of assets acquired and liabilities assumed constitute a business; and

● the determination of the functional currency of each entity in the group.

 ****

***Foreign currency translation***

Transactions in foreign currencies are translated into the functional currency at rates of exchange at the time of such transactions. Monetary assets and liabilities are translated at the reporting period rate of exchange. Non-monetary assets and liabilities are translated at historical exchange rates. Gains and losses resulting from foreign exchange adjustments are included in profit or loss.

 ****

The functional currencies of the parent company and each subsidiary are as follows:

---

| | |
|:---|:---|
| Draganfly Inc. | Canadian Dollar |
| Draganfly Innovations Inc. | Canadian Dollar |
| Draganfly Innovations USA, Inc. | US Dollar |
| Dronelogics Systems Inc. | Canadian Dollar |

---

Financial statements of subsidiaries for which the functional currency is not the Canadian dollar are translated into Canadian dollars as follows: all asset and liability accounts are translated at the year-end exchange rate and all revenue and expense accounts and cash flow statement items are translated at average exchange rates for the year. The resulting translation gains and losses are recorded as exchange differences on translation of foreign operations in other comprehensive loss.

***Share-based payments***

The Company may grant stock options or restricted share units ("RSU's") to its directors, officers, employees and consultants. The Company records share-based compensation related to stock options using the Black-Scholes Option Pricing Model.

The RSU's granted entitle an employee, director or officer to either the issuance of common shares or cash payments payable upon vesting with terms determined by the Company's Board of Directors at the time of the grant. If on the grant date it is determined there is an obligation to settle in cash, the RSU's are accounted for as liabilities, with the fair value remeasured at the end of each reporting period and on the settlement date. Changes in fair value are recognized in profit and loss. Expense is recognized over the vesting period.

The Company has a present obligation to settle in cash if the choice of settlement in shares has no commercial substance, or the Company has a past practice or a stated policy of setting in cash, or generally settles in cash whenever the counterparty asks for cash settlement. If no such obligation exists, RSUs are accounted for as equity settled share-based payments and are valued using the share price on grant date. Upon settlement:

&nbsp;&nbsp;&nbsp;&nbsp;a) If
 the Company elects to settle in cash, the cash payment is accounted for as the repurchase
 of an equity interest (i.e. as a deduction from equity), except as noted in (c) below.

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

&nbsp;&nbsp;&nbsp;&nbsp;b) If
 the Company elects to settle by issuing shares, the value of RSUs initially recognized in
 reserves is reclassified to share capital, except as noted in (c) below.

c) If
 the Company elects the settlement alternative with the higher fair value, as at the date
 of settlement, the Company recognizes an additional expense for the excess value given (i.e.
 the difference between the cash paid and the fair value of shares that would otherwise have
 been issued, or the difference between the fair value of the shares and the amount of cash
 that would otherwise have been paid, whichever is applicable).

The aggregate sales price or amount of common shares issued during any consecutive 12-month period will not exceed the greatest of the following: (i) USD $1,000,000; (ii) 15% of the total assets of the Company, measured at the Company's most recent balance sheet date; or (iii) 15% of the outstanding amount of the common shares of the Company, measured at the Company's most recent balance sheet date. At the election of the Board of Directors, upon each vesting date, participants receive (a) the issuance of common shares from treasury equal to the number of RSUs vesting, or (b) a cash payment equal to the number of vested RSUs multiplied by the fair market value of a common share, calculated as the closing price of the common shares on the CSE for the trading day immediately preceding such payment date; or (c) a combination of (a) and (b).

In conjunction with private placements or brokered financings, the Company may issue compensatory warrants to agents as consideration for services provided. Awards of grants are accounted for in accordance with the fair value method of accounting and result in an increase in share issue costs and a credit to warrants within shareholders' equity when warrants are issued.

***Loss per share***

Basic loss per share is calculated by dividing the loss attributable to common shareholders by the weighted average number of common shares outstanding in the year.

Diluted income per share is calculated by dividing the profit attributable to common shareholders of the parent by the weighted average number of common shares outstanding during the year plus the weighted average number of common shares that would be issued on the conversion of all the dilutive potential common shares into common shares. The Company had 10,214,085 warrants, 27,458 options and 558,381 RSU's that would be potentially dilutive if the Company were not in a loss position and were to calculate diluted income per share.

 **

***Financial Instruments***

 **

Financial instruments are accounted for in accordance with IFRS 9 Financial Instruments: Classification and Measurement. A financial instrument is any contract that gives rise to a financial asset of one entity and a financial liability or equity instrument of another entity.

 ****

---

| | |
|:---|:---|
| **Financial assets/liabilities** | **Classification** |
| Cash and cash equivalents | Fair value through profit or loss |
| Receivables | Amortized cost |
| Notes receivable | Fair value through profit or loss |
| Investments | Fair value through other comprehensive income |
| Trade payables | Amortized cost |
| Customer deposits | Amortized cost |
| Loans payable | Amortized cost |
| Derivative liability | Fair value through profit or loss |

---

 ****

 ****

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

 ****

***a)***  ***Financial assets*** 

 ****

***<u>Classification and measurement</u>***

The Company classifies its financial assets in the following categories: at fair value through profit or loss ("FVTPL"), at fair value through other comprehensive income ("FVTOCI") or at amortized cost. The classification depends on the purpose for which the financial assets were acquired. Management determines the classification of its financial assets at initial recognition.

The classification of debt instruments is driven by the business model for managing the financial assets and their contractual cash flow characteristics. Debt instruments are measured at amortized cost if the business model is to hold the instrument for collection of contractual cash flows and those cash flows are solely principal and interest. If the cash flows are not solely principal and interest, it is classified as FVTPL. Financial assets with embedded derivatives are considered in their entirety when determining whether their cash flows are solely payments of principal and interest.

Equity instruments that are held for trading (including all equity derivative instruments) are classified as FVTPL, for other equity instruments, on the day of acquisition the Company can make an irrevocable election (on an instrument by-instrument

basis) to designate them as at FVTOCI.

*<u>Financial assets at FVTPL</u>*

Financial assets carried at FVTPL are initially recorded at fair value and transaction costs are recorded to profit or loss. Realized and unrealized gains and losses arising from changes in the fair value of financial assets held at FVTPL are included in the profit or loss in the period in which they arise. Derivatives are also categorized as FVTPL unless they are designated as hedges.

*<u>Financial assets at FVTOCI</u>*

Financial assets carried at FVTOCI are initially recognized at fair value plus transaction costs. Subsequently they are measured at fair value, with gains and losses arising from changes in fair value recognized in other comprehensive income. There is no subsequent reclassification of fair value gains and losses to profit or loss following the derecognition of the investment.

 

*<u>Financial assets at amortized cost</u>*

Financial assets at amortized cost are initially recognized at fair value and subsequently carried at amortized cost less any impairment. They are classified as current assets or non-current assets based on their maturity date.

***<u>Impairment of financial assets at amortized cost</u>***

The Company recognizes a loss allowance for expected credit losses on financial assets that are measured at amortized cost. At each reporting date, the loss allowance for the financial asset is measured at an amount equal to the lifetime expected credit losses if the credit risk on the financial asset has increased significantly since initial recognition. If at the reporting date, the financial asset has not increased significantly since initial recognition, the loss allowance is measured for the financial asset at an amount equal to twelve month expected credit losses. For trade receivables the Company applies the simplified approach to providing for expected credit losses, which allows the use of a lifetime expected loss provision.

Impairment losses on financial assets carried at amortized cost are reversed in subsequent periods if the amount of the loss decreases and the decrease can be objectively related to an event occurring after the impairment was recognized.

 ****

***<u>Derecognition of financial assets</u>***

Financial assets are derecognized when the risks and rewards of ownership have been transferred. Gains and losses on derecognition of financial assets classified as FVTPL or amortized cost are recorded to profit or loss. Gains or losses on financial assets classified as FVTOCI remain within accumulated other comprehensive loss.

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

***b)***  ***Financial liabilities*** 

 ****

The Company classifies its financial liabilities into one of two categories as follows:

FVTPL - This category comprises derivatives and financial liabilities incurred principally for the purpose of selling or repurchasing in the near term. They are carried at fair value with changes in fair value recognized in profit or loss.

Other financial liabilities - This category consists of liabilities carried at amortized cost using the effective interest method. Trade payables, customer deposits and loans payable are included in this category.

***<u>Derecognition of financial liabilities</u>***

Financial liabilities are derecognized when its contractual obligations are discharged, cancelled, or expire. The Company also derecognizes a financial liability when the terms of the liability are modified such that the terms and/or cash flows of the modified instrument are substantially different, in which case a new financial liability based on the modified terms is recognized at fair value. Gains and losses on derecognition are recognized in profit or loss.

 ****

***Impairment of non-financial assets***

The carrying amounts of the non-financial assets are reviewed at each reporting date to determine whether there is any indication of impairment. If indicators exist, then the asset's recoverable amount is estimated. The recoverable amounts of the following types of intangible assets are measured annually, whether or not there is any indication that it may be impaired:

● an intangible asset with an indefinite useful life; and

● an intangible asset not yet available for use;

The recoverable amount of an asset or cash-generating unit ("CGU") is the greater of its value in use and its fair value less

costs to sell. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset.

If there is an indication that a corporate asset may be impaired, then the recoverable amount is determined for the CGU to which the corporate asset belongs.

An impairment loss is recognized if the carrying amount of an asset or its CGU exceeds its estimated recoverable amount. Impairment losses are recognized in profit or loss. Impairment losses recognized in respect of CGUs are allocated first to reduce the carrying amount of any goodwill allocated to the CGU, and then to reduce the carrying amounts of the other assets in the CGU on a pro rata basis.

In respect of assets other than goodwill and intangible assets that have indefinite useful lives, impairment losses recognized in prior periods are assessed at each reporting date for any indications that the loss has decreased or no longer exists. An impairment loss is reversed in a subsequent period when there has been an increase in the recoverable amount of a previously impaired asset or CGU. An impairment loss is reversed only to the extent that the asset's carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized.

***Income taxes***

*<u>Current income tax</u>*

Current income tax assets and liabilities for the current period are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted or substantively enacted, at the reporting date, in the countries where the Company operates and generates taxable income.

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

Current income taxes relating to items recognized directly in other comprehensive income or equity is recognized in other comprehensive income or equity and not in profit or loss. Management periodically evaluates positions taken in the tax returns with respect to situations in which applicable tax regulations are subject to interpretation and establishes provisions where appropriate.

*<u>Deferred income tax</u>*

Deferred income tax is recognized, using the asset and liability method, on temporary differences at the reporting date arising between the tax bases of assets and liabilities and their carrying amounts for financial reporting. The carrying amount of deferred income tax assets is reviewed at the end of each reporting period and recognized only to the extent that it is probable that sufficient taxable profit will be available to allow all or part of the deferred income tax asset to be utilized. Deferred income tax assets and liabilities are measured at the tax rates that are expected to apply to the year when the asset is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred income tax assets and deferred income tax liabilities are offset, if a legally enforceable right exists to set off current tax assets against current income tax liabilities and the deferred income taxes relate to the same taxable entity and the same taxation authority.

***Inventory***

Inventory consists of raw materials and finished goods for manufacturing of multi-rotor helicopters, industrial areal video systems, civilian small unmanned aerial systems or vehicles, health monitoring equipment, and wireless video systems. Inventory is initially valued at cost and subsequently at the lower of cost and net realizable value. Cost is determined using the first-in-first-out method. The cost of inventories comprises all costs of purchase, costs of conversion and other costs incurred in bringing the inventories to their present location and condition. The costs of purchase include the purchase price, import duties and non-recoverable taxes and transport, handling and other costs directly attributable to the acquisition of finished goods, materials or services. The costs of conversion include direct materials and labour costs and a systematic allocation of fixed and variable overheads incurred in converting materials into finished goods. The Company reviews inventory for obsolete and slow-moving goods and any such inventory is written-down to net realizable value.

***Revenue recognition***

Revenue comprises the fair value of consideration received or receivable for the sale of goods and consulting services in the ordinary course of the Company's business. Revenue is shown net of return allowances and discounts.

*<u>Sales of goods</u>*

The Company manufactures and sells a range of multi-rotor helicopters, industrial aerial video systems, and civilian small unmanned aerial systems or vehicles. Sales are recognized at a point-in-time when control of the products has transferred. The control transfer occurs in proximity to shipping. Revenue is recognized when the transfer of control has occurred.

Revenue from these sales is recognized based on the price specified in the contract, net of the estimated discounts and returns. Accumulated experience is used to estimate and provide for the discounts and returns, using the expected value method, and revenue is only recognized to the extent that it is highly probable that a significant reversal will not occur. To date, returns have not been significant. No element of financing is deemed present as the sales are made with a credit term of 30 to 60 days, which is consistent with market practice.

Revenue from these sales is recognized based on the price specified in the contract, net of the estimated discounts and returns. Accumulated experience is used to estimate and provide for the discounts and returns, using the expected value method, and revenue is only recognized to the extent that it is highly probable that a significant reversal will not occur. To date, returns have not been significant. No element of financing is deemed present as the sales are made with a credit term of 30 days, which is consistent with market practice.

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

Some contracts include multiple performance obligations, such as the sale of hardware and support or maintenance. Where support or maintenance is performed by another party and does not include an integration service it is accounted for as a separate performance obligation. In this case, the transaction price will be allocated to each performance obligation based on stand-alone selling price. Where the stand-alone selling price is not directly observable, the price is estimated based on expect cost plus margin. Where the support or maintenance is provided by the Company, the contract is analyzed to identify the performance obligations and transaction price. The price is then allocated across the obligations identified in the contract. Revenue is recognized when the Company satisfies a performance obligation.

 

*<u>Services</u>*

The Company provides consulting, custom engineering, drones as a service, and investigating and solving on a project-by-project basis under fixed-price and variable price contracts. Revenue from providing services is recognized over time as the services are rendered.

The Company provides rental of equipment which is measured based on rates through contracts or other written agreements with customers. Revenue is recognized in the period when services are performed and only when there is reasonable assurance that the revenue will be collected.

 ****

***Deferred Income***

A payment received is included as deferred revenue when products have yet be shipped to the customers as of the period end or there are unfulfilled obligations related to the revenue received. The amount to be recognized within twelve months following the year-end date is classified as current.

***Cost of Goods Sold***

Cost of sales includes the expenses incurred to acquire and produce inventory for sale, including product costs, freight costs, as well as provisions for reserves related to product shrinkage, or lower of cost and net realizable value adjustments as required.

***Intangible Assets***

An intangible asset is an identifiable asset without physical substance. An asset is identifiable if it is separable, or arises from contractual or legal rights, regardless of whether those rights are transferrable or separable from the Company or from other rights and obligations. Intangible assets include intellectual property, which consists of patent and trademark applications, brands and software.

Intangible assets acquired externally are measured at cost less accumulated amortization and impairment losses. The cost of a group of intangible assets acquired is allocated to the individual intangible assets based on their relative fair values. The cost of intangible assets acquired externally comprises its purchase price and any directly attributable cost of preparing the asset for its intended use. Research and development costs incurred subsequent to the acquisition of externally acquired intangible assets and on internally generated intangible assets are accounted for as research and development costs.

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

Intangible assets with finite useful lives are amortized on a straight-line basis over the expected life of each intellectual property to write off the cost of the assets from the date they are available for use.

---

| | |
|:---|:---|
| **Class of intangible asset** | **Useful live** |
| Customer relationship | 5 years |
| Brand | 5 years |
| Software | 5 years |
| Patents | 5 years |

---

Goodwill represents the excess of the value of the consideration transferred over the fair value of the net identifiable assets and liabilities acquired in a business combination. Goodwill is allocated to the cash generating unit to which it relates.

***Equipment***

January 1, 2024, there was change in estimate related to the useful lives of computer equipment and furniture and equipment with the depreciation changing from 30% declining balance to 3 year straight line for computer equipment and from 20% declining balance to 5 year straight line for furniture and equipment. The impact of this change in estimate in 2024 resulted in an increase in depreciation of $54, 220. It is not practical to quantify the impact on future years, but the change in estimate will result in the assets currently on the books related to this change in estimate depreciating faster over a shorter time frame.

Equipment is stated at historical cost less accumulated depreciation and accumulated impairment losses.

Subsequent costs are included in the asset's carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. The carrying amount of the replaced part is derecognized. All other repairs and maintenance are charged to the consolidated statement of comprehensive loss during the financial period in which they are incurred.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognized in the consolidated statement of comprehensive loss.

Depreciation is generally calculated on a straight-line balance method with the exception of vehicles that are on a declining balance method to write off the cost of the assets to their residual values over their estimated useful lives. Depreciation for leasehold improvements is fully expensed over the expected term of the lease. The depreciation rates applicable to each category of equipment are as follows:

---

| | |
|:---|:---|
| **Class of equipment** | **Depreciation rate** |
| Computer equipment | 3 years – straight line |
| Furniture and equipment | 5 years – straight line |
| Leasehold improvements | Expected lease term |
| Vehicles | 30% - declining balance |

---

 ****

***Research and development expenditures***

Expenditures on research are expensed as incurred. Research activities include formulation, design, evaluation and final selection of possible alternatives, products, processes, systems or services. Development expenditures are expensed as incurred unless the Company can demonstrate all of the following:

&nbsp;&nbsp;&nbsp;&nbsp;(i) the
 technical feasibility of completing the intangible asset so that it will be available for
 use or sale;

&nbsp;&nbsp;&nbsp;&nbsp;(ii) its
 intention to complete the intangible asset and use or sell it;

&nbsp;&nbsp;&nbsp;&nbsp;(iii) its
 ability to use or sell the intangible asset;

&nbsp;&nbsp;&nbsp;&nbsp;(iv) how
 the intangible asset will generate probable future economic benefits. The Company can also
 demonstrate the existence of a market for the output of the intangible asset or the intangible
 asset itself or, if it is to be used internally, the usefulness of the intangible asset;

&nbsp;&nbsp;&nbsp;&nbsp;(v) the
 availability of adequate technical, financial and other resources to complete the development
 and to use or sell the intangible asset; and

&nbsp;&nbsp;&nbsp;&nbsp;(vi) its
 ability to measure reliably the expenditure attributable to the intangible asset during its
 development.

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

***Government assistance***

Government grants are recognized when there is reasonable assurance that the grant will be received and all attached conditions will be complied with. When the grant relates to an expense item, it is recognized as income on a systematic basis over the period that the related costs, for which it is intended to compensate, are expensed. When the grant relates to an asset, the cost of the asset is reduced by the amount of the grant and the grant is recognized as income in equal amounts over the expected useful life of the asset.

***Leases***

A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. At the commencement date, the lease liability is recognized at the present value of the future lease payments and discounted using the interest rate implicit in the lease or the Company's incremental borrowing rate. A corresponding right-of-use ("ROU") asset will be recognized at the amount of the lease liability, adjusted for any lease incentives received and initial direct costs incurred. Over the term of the lease, financing expense is recognized on the lease liability using the effective interest rate method and charged to net income, lease payments are applied against the lease liability and depreciation on the ROU asset is recorded by class of underlying asset.

The lease term is the non-cancellable period of a lease and includes periods covered by an optional lease extension option if reasonably certain the Company will exercise the option to extend. Conversely, periods covered by an option to terminate are included if the Company does not expect to end the lease during that time frame. Leases with a term of less than twelve months or leases for underlying low value assets are recognized as an expense in net income on a straight-line basis over the lease term.

A lease modification will be accounted for as a separate lease if it materially changes the scope of the lease. For a modification that is not a separate lease, on the effective date of the lease modification, the Company will remeasure the lease liability and corresponding ROU asset using the interest rate implicit in the lease or the Company's incremental borrowing rate. Any variance between the remeasured ROU asset and lease liability will be recognized as a gain or loss in net income to reflect the change in scope.

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

**BUSINESS RISKS**

The Company does engage in significant transactions and activities in currencies other than its functional currency. Depending on the timing of the transactions and the applicable currency exchange rates such conversions may positively or negatively impact the Company.

An investment in the Company's Common Shares is highly speculative and involves significant risks. **In addition to the other ‎information contained in this MD&A and the documents incorporated by ‎reference herein and therein, you should review and carefully consider the risks described herein.** The risks described herein are not the only risk factors facing us and should not be ‎considered exhaustive. Additional risks and uncertainties not currently known to us, or that we currently ‎consider immaterial, may also materially and adversely affect our business, operations and condition, financial ‎or otherwise.‎

**Risks Related to the Company, its Business and Industry**

***The Company has a history of losses.***

 ****

The Company has incurred net losses since its inception. The Company cannot assure that it can ‎become profitable or avoid net losses in the future or that there will be any earnings or revenues in any ‎future quarterly or other periods. The Company expects that its operating expenses will increase as it ‎grows its business, including expending substantial resources for research, development and marketing. ‎As a result, any decrease or delay in generating revenues could result in material operating losses.‎

***A shareholder's holding in the Company may be diluted if the Company issues additional Common ‎Shares or other securities in the future.‎***

***‎***The Company may issue additional Common Shares or other securities in the future, which may dilute a ‎‎shareholder's holding in the Company. ‎The Company's articles permit the issuance of an unlimited ‎‎number of Common Shares, and shareholders have no pre-emptive rights in connection with further ‎‎issuances of any securities. The directors of the Company have the discretion to ‎determine if an ‎‎issuance of Common Shares or other securities is warranted, the price at which any such securities are ‎‎issued and the other ‎terms of issue of Common Shares or securities. In addition, the Company may ‎‎issue additional Common Shares upon the exercise of incentive stock options to ‎acquire Common ‎‎Shares under its share compensation plan or upon the exercise or conversion of other outstanding ‎convertible securities of the Company, which will result in further dilution to shareholders. In addition, ‎the ‎issuance of Common Shares or other securities in any potential ‎future acquisitions, if any, may also ‎‎result in further dilution to shareholder interests.‎‎

***The Company expects to incur substantial research and development costs and devote significant resources to ‎identifying and commercializing new products and services, which could significantly reduce its profitability and ‎may never result in revenue to the Company.‎***

‎The Company's future growth depends on penetrating new markets, adapting existing products to new ‎applications, ‎and introducing new products and services that achieve market acceptance. The Company ‎plans to incur ‎substantial research and development costs as part of its efforts to design, develop and ‎commercialize new ‎products and services and enhance its existing products. The Company believes that ‎there are significant opportunities in a number of business areas. Because the Company accounts for ‎research and development costs as ‎operating expenses, these expenditures will adversely affect its ‎earnings in the future. Further, the Company's ‎research and development programs may not produce ‎successful results, and its new products and services may not ‎achieve market acceptance, create any ‎additional revenue or become profitable, which could materially harm the ‎Company's business, ‎prospects, financial results and liquidity.‎

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

***Shortfalls in available external research and development funding could adversely affect the Company.‎***

 ****

‎The Company depends on its research and development activities to develop the core technologies ‎used in its UAV ‎products and for the development of the Company's future products. A portion of the ‎Company's research and ‎development activities can depend on funding by commercial companies and ‎the Canadian government. Canadian ‎government and commercial spending levels can be impacted by a ‎number of variables, including general ‎economic conditions, specific companies' financial performance ‎and competition for Canadian government ‎funding with other Canadian government-sponsored programs ‎in the budget formulation and appropriation ‎processes. Moreover, the Canadian, federal and provincial ‎governments provide energy rebates and incentives to ‎commercial companies, which directly impact the ‎amount of research and development that companies ‎appropriate for energy systems. To the extent that ‎these energy rebates and incentives are reduced or eliminated, ‎company funding for research and ‎development could be reduced. Any reductions in available research and ‎development funding could ‎harm the Company's business, financial condition and operating results.‎

***The Company's adoption of new business models could fail to produce any financial returns.‎***

‎Forecasting the Company's revenues and profitability for new business models is inherently uncertain ‎and ‎volatile. The Company's actual revenues and profits for its business models may be significantly ‎less ‎than the Company's forecasts. Additionally, the new business models could fail for one or more of ‎the ‎Company's products and/or services, resulting in the loss of Company's investment in the ‎development and ‎infrastructure needed to support the new business models, and the opportunity cost of ‎diverting management and ‎financial resources away from more successful businesses.‎

***The Company will be affected by operational risks and may not be adequately insured for certain risks.‎***

‎ The Company will be affected by a number of operational risks and the Company may not be adequately ‎insured ‎for certain risks, including: labour disputes; catastrophic accidents; fires; blockades or other ‎acts of social activism; ‎changes in the regulatory environment; impact of non-compliance with laws and ‎regulations; natural phenomena, ‎such as inclement weather conditions, floods, earthquakes and ground ‎movements. There is no assurance that the ‎foregoing risks and hazards will not result in damage to, or ‎destruction of, the Company's technologies, personal ‎injury or death, environmental damage, adverse ‎impacts on the Company's operation, costs, monetary losses, ‎potential legal liability and adverse ‎governmental action, any of which could have an adverse impact on the ‎Company's future cash flows, ‎earnings and financial condition. Also, the Company may be subject to or affected ‎by liability or sustain ‎loss for certain risks and hazards against which the Company cannot insure or which the ‎Company may ‎elect not to insure because of the cost. This lack of insurance coverage could have an adverse ‎impact ‎on the Company's future cash flows, earnings, results of operations and financial condition.‎

 ****

***The Company operates in evolving markets, which makes it difficult to evaluate the Company's business and ‎future prospects.‎***

‎The Company's unmanned aerial vehicles ("**UAVs**") are sold in rapidly evolving markets. The commercial UAV market is in early stages of ‎customer adoption. Accordingly, the Company's business and future prospects may be difficult to evaluate. The ‎Company cannot accurately predict the extent to which demand for its products and services will increase, if at all. ‎The challenges, risks and uncertainties frequently encountered by companies in rapidly evolving markets could ‎impact the Company's ability to do the following:‎

● generate sufficient revenue to reach and maintain profitability;

● acquire and maintain market share;‎

● achieve or manage growth in operations;‎

● develop and renew contracts;‎

● attract and retain additional engineers and other highly-qualified personnel;‎

● successfully develop and commercially market new products;‎

● adapt to new or changing policies and spending priorities of governments and government agencies; and

● access additional capital when required and on reasonable terms.‎

If the Company fails to address these and other challenges, risks and uncertainties successfully, its business, results ‎of operations and financial condition would be materially harmed.‎

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

***The Company operates in a competitive market.***

The Company faces competition and new competitors will continue to emerge throughout the world. ‎Services offered by the Company's competitors may take a larger share of consumer spending than ‎anticipated, which could cause revenue generated from the Company's products and services to fall ‎below expectations. It is expected that competition in these markets will intensify.

‎If competitors of the Company develop and market more successful products or services, offer ‎competitive products or services at lower price points, or if the Company does not produce consistently ‎high-quality and well-received products and services, revenues, margins, and profitability of the ‎Company will decline.‎

‎The Company's ability to compete effectively will depend on, among other things, the Company's pricing ‎of services and equipment, quality of customer service, development of new and enhanced products ‎and services in response to customer demands and changing technology, reach and quality of sales and ‎distribution channels and capital resources. Competition could lead to a reduction in the rate at which the ‎Company adds new customers, a decrease in the size of the Company's market share and a decline in ‎its customers. Examples include but are not limited to competition from other companies in the UAV ‎industry.‎

In addition, the Company could face increased competition should there be an award of additional ‎licenses in jurisdictions in which the Company operates in.‎

***The markets in which the Company competes are characterized by rapid technological change, which requires ‎the Company to develop new products and product enhancements and could render the Company's existing ‎products obsolete. ‎***

 ****

‎Continuing technological changes in the market for the Company's products could make its products ‎less ‎competitive or obsolete, either generally or for particular applications. The Company's future ‎success will depend ‎upon its ability to develop and introduce a variety of new capabilities and ‎enhancements to its existing product and ‎service offerings, as well as introduce a variety of new product ‎offerings, to address the changing needs of the ‎markets in which it offers products. Delays in ‎introducing new products and enhancements, the failure to choose ‎correctly among technical alternatives ‎or the failure to offer innovative products or enhancements at competitive ‎prices may cause existing and ‎potential customers to purchase the Company's competitors' products.‎

If the Company is unable to devote adequate resources to develop new products or cannot otherwise ‎successfully ‎develop new products or enhancements that meet customer requirements on a timely basis, ‎its products could lose ‎market share, its revenue and profits could decline, and the Company could ‎experience operating losses.‎

***Failure to obtain necessary regulatory approvals from Transport Canada or other governmental agencies, or ‎limitations put on the use of small UAV in response to public privacy concerns, may prevent the Company from ‎expanding sales of its small UAV to non-military customers in Canada.‎***

‎Transport Canada is responsible for establishing, managing, and developing safety and security ‎standards and regulations for civil aviation in Canada, and includes unmanned civil aviation ‎‎(drones). Civil operations include law enforcement, scientific research, or use by private sector ‎companies for commercial purposes. The Canadian Aviation Regulations ("**CARs**") govern civil ‎aviation safety and security in Canada, and by extension govern operation of drones in Canada ‎to an acceptable level of safety.‎

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

While Transport Canada has been a leader in the development of regulations for the commercial ‎use of remotely piloted aircraft systems ("**RPAS**") and continues to move forward rapidly with its regulatory development, it has ‎acknowledged the challenge of regulations keeping pace with the rapid development in ‎technology and the growing demand for commercial RPAS use, particularly in the beyond visual ‎line-of-sight environment. In 2012, the Canadian Aviation Regulation Advisory Council UAS ‎working group released its Phase 2 report which outlined a proposed set of revision to the CARs ‎to permit beyond visual line of sight operations. This report was the basis for the recently released Notice of Proposed Amendment ("**NPA**") by Transport Canada on lower ‎risk beyond visual line-of-sight.‎

Failure to obtain necessary regulatory approvals from Transport Canada or other governmental ‎agencies, including the granting of certain Special Flight Operations Certificates ("**SFOCs**"), or limitations put on the use of RPAS in ‎response to public safety concerns, may prevent the Company from testing or operating its ‎aircraft and/or expanding its sales which could have an adverse impact on the Company's ‎business, prospects, results of operations and financial condition.‎

***There are risks associated with the regulatory regime and permitting requirements of the Company's business.‎***

‎A significant portion of the Company's business is based on the operation of RPAS. The operation of ‎‎RPAS poses a risk or hazard to airspace users as well as personnel on the ground. As ‎the RPAS ‎‎industry is rapidly developing, the regulatory environment for RPAS is constantly evolving to keep pace. ‎‎‎As such, whenever a policy change with respect to operating regulations occurs, there is a risk that the ‎‎Company ‎could find itself to be in non-compliance with these new regulations. While the Company ‎‎endeavours to take all ‎necessary action to reduce the risks associated with the operations of RPAS and ‎‎to remain well-informed and up-‎to-date on any addendums and changes to the applicable regulations, ‎‎there is no assurance that an incident ‎involving an RPAS or the Company's non-compliance would not ‎‎create a significant current or future liability for ‎the company.‎

The regulation of RPAS operations within the Canadian Domestic Airspace ("**CDA**") is still evolving and is expected ‎to continue to change ‎with the proliferation of RPAS, advancements in technology, and standardization within the ‎industry. ‎Changes to the regulatory regime may be disruptive and result in the Company needing to adopt ‎‎significant changes in its operations and policies, which may be costly and time-consuming, and may ‎materially ‎adversely affect the Company's ability to manufacture and make delivery of its products and ‎services in a timely ‎fashion.‎

The Company's business and research and development activities are subject to oversight by Transport ‎‎Canada, the federal ‎institution responsible for transportation policies and programs, including the rules in ‎‎the CARs. Currently, Transport Canada requires that any non-recreational operators of RPAS have a ‎‎‎SFOC. The Company's ability to develop, test, demonstrate, and sell products and ‎services depends on ‎‎its ability to acquire and maintain a valid SFOC.‎

‎In addition, there exists public concern regarding the privacy implications of Canadian commercial and ‎‎law ‎enforcement use of small UAV. This concern has included calls to develop explicit written policies ‎‎and procedures ‎establishing UAV usage limitations. There is no assurance that the response from ‎‎regulatory agencies, customers and ‎privacy advocates to these concerns will not delay or restrict the ‎‎adoption of small UAV by prospective non-military customers‎.‎

***The Company may be subject to the risks associated with future acquisitions.***

As part of the Company's overall business strategy, the Company may pursue select strategic ‎acquisitions that would provide additional product or service offerings, additional industry expertise, and ‎a stronger industry presence in both existing and new jurisdictions. Any such future acquisitions, if ‎completed, may expose the Company to additional potential risks, including risks associated with: (a) ‎the integration of new operations, services and personnel; (b) unforeseen or hidden liabilities; (c) the ‎diversion of resources from the Company's existing business and technology; (d) potential inability to ‎generate sufficient revenue to offset new costs; (e) the expenses of acquisitions; or (f) the potential loss ‎of or harm to relationships with both employees and existing users resulting from its integration of new ‎businesses. In addition, any proposed acquisitions may be subject to regulatory approval.‎

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

***The Company's inability to retain management and key employees could impair the future success of the Company.***

The Company's future success depends substantially on the continued services of its executive officers ‎and its key development personnel. If one or more of its executive officers or key development ‎personnel were unable or unwilling to continue in their present positions, the Company might not be able ‎to replace them easily or at all. In addition, if any of its executive officers or key employees joins a ‎competitor or forms a competing company, the Company may lose experience, know-how, key ‎professionals and staff members as well as business partners. These executive officers and key ‎employees could develop drone technologies that could compete with and take customers and market ‎share away from the Company.‎

***The Company faces uncertainty and adverse changes in the economy.‎***

‎

Adverse changes in the economy could negatively impact the Company's business. Future economic ‎distress may ‎result in a decrease in demand for the Company's products, which could have a material ‎adverse impact on the ‎Company's operating results and financial condition. Uncertainty and adverse ‎changes in the economy could also ‎increase costs associated with developing and publishing products, ‎increase the cost and decrease the availability of ‎sources of financing, and increase the Company's ‎exposure to material losses from bad debts, any of which could ‎have a material adverse impact on the ‎financial condition and operating results of the Company.‎

***The Company is subject to certain market-based financial risks associated with its operations.***

The Company could be subject to interest rate risks, which is the risk that the value of a financial ‎instrument might be adversely affected by a change in the interest rates. In seeking to minimize the risks ‎from interest rate fluctuations, the Company manages exposure through its normal operating and ‎financing activities, however market fluctuations could increase the costs at which the Company can ‎access capital and its ability to obtain financing and the Company's cash balances carry a floating rate ‎of interest. In addition, the Company engages in transactions in currencies other than its functional ‎currency. Depending on the timing of these transactions and the applicable currency exchange rates, ‎conversions to the Company's functional currency may positively or negatively impact the Company.‎

‎***Negative macroeconomics and geopolitical trends could affect market and economic conditions.***

 ****

The global credit and financial markets have experienced extreme volatility and disruptions in the past several years, including severely diminished liquidity and credit availability, rising inflation and monetary supply shifts, rising interest rates, supply chain constraints, labor shortages, declines in consumer confidence, declines in economic growth, increases in unemployment rates, recession risks and uncertainty about economic stability. For instance, ongoing instability and current conflicts in global markets, including in Eastern Europe, the Middle East and Asia, and the potential for other conflicts and future terrorist activities, as well as other recent geopolitical events throughout the world, including new or increased tariffs and potential trade wars, have created and may continue to create economic and political uncertainties and impacts that could have a material adverse effect on our business, operations, and profitability. Sanctions imposed by the United States and other countries in response to military conflicts, including the one in Ukraine, may also adversely impact the financial markets and the global economy, and any economic countermeasures by the affected countries or others could exacerbate market and economic instability. If credit in financial markets outside of the United States tightened, it could adversely affect the ability of our international customers and suppliers to obtain financing and could result in a decrease in or cancellation of orders for our products, systems and services or impact the ability of our customers to make payments. In addition, the COVID-19 pandemic resulted in widespread unemployment, economic slowdown and extreme volatility in the capital markets. However, notwithstanding our current and anticipated position, these types of matters can cause uncertainty in financial markets and may significantly increase the political, economic and social instability in geographic areas in which we operate now or may operate in the future. The extent of the impact of these conditions on our operational and financial performance, including our ability to execute our business strategies and initiatives in the expected timeframe, as well as that of third parties upon whom we rely, will depend on future developments which are uncertain and cannot be predicted. There can be no assurance that further deterioration in credit and financial markets and confidence in economic conditions will not occur. Events involving limited liquidity, defaults, non-performance or other adverse developments that affect financial institutions, or concerns or rumors about any events of these kinds or other similar risks, have in the past and may in the future lead to market-wide liquidity problems. Our general business strategy may be adversely affected by any such economic downturn, volatile business environment or continued unpredictable and unstable market conditions. If the current equity and credit markets deteriorate, it may make any necessary debt or equity financing more difficult, more costly and more dilutive. Failure to secure any necessary financing in a timely manner and on favorable terms could have a material adverse effect on our growth strategy, financial performance and stock price and could require us to delay or abandon clinical development plans. In addition, there is a risk that one or more of our current suppliers or other partners may not survive an economic downturn, which could directly affect our ability to attain our operating goals on schedule and on budget.

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

***The Company may be subject to the risks associated with foreign operations in other countries.***

 ****

The Company's primary revenues are expected to be achieved in Canada and the US. However, the ‎Company may expand to markets outside of North America and become subject to risks normally ‎associated with conducting business in other countries. As a result of such expansion, the Company ‎may be subject to the legal, political, social and regulatory requirements and economic conditions of ‎foreign jurisdictions. The Company cannot predict government positions on such matters as foreign ‎investment, intellectual property rights or taxation. A change in government positions on these issues ‎could adversely affect the Company's business.‎

If the Company expands its business to foreign markets, it will need to respond to rapid changes in ‎market conditions, including differing legal, regulatory, economic, social and political conditions in these ‎countries. If the Company is not able to develop and implement policies and strategies that are effective ‎in each location in which it does business, then the Company's business, prospects, results of ‎operations and financial condition could be materially and adversely affected.‎

***There are tax risks the Company may be subject to in carrying on business in Canada.***

The Company is a resident of Canada for purposes of the *Income ‎Tax Act* (Canada) (the "**Tax Act**"). Since the ‎Company ‎is operating in a new and developing industry there is a risk that ‎foreign governments may look to ‎‎increase their tax revenues or levy additional taxes to level the playing ‎field for perceived disadvantages ‎to ‎traditional brick and mortar businesses. There is no guarantee that ‎governments will not impose such ‎additional ‎adverse taxes in the future‎.‎

***If critical components or raw materials used to manufacture the Company's products become scarce or ‎unavailable, then the Company may incur delays in manufacturing and delivery of its products, which could ‎damage its business.‎***

‎The Company obtains hardware components, various subsystems and systems from a limited group of ‎suppliers. ‎The Company does not have long-term agreements with any of these suppliers that obligate it ‎to continue to sell ‎components, subsystems, systems or products to the Company. The Company's ‎reliance on these suppliers ‎involves significant risks and uncertainties, including whether its suppliers will ‎provide an adequate supply of ‎required components, subsystems, or systems of sufficient quality, will ‎increase prices for the components, ‎subsystems or systems and will perform their obligations on a ‎timely basis.‎

If the ‎Company ‎is unable to obtain components from third-party ‎suppliers in the quantities and of the quality that it ‎requires, on a ‎timely basis and at acceptable prices, ‎then it may not be able to deliver its products on a timely or ‎cost-effective ‎basis to its customers, or at ‎all, which could cause customers to terminate their contracts with the Company, ‎‎increase the Company's ‎costs and seriously harm its business, results of operations and financial condition. ‎‎Moreover, if any of ‎the Company's suppliers become financially unstable, then it may have to find new suppliers. ‎‎It may take ‎several months to locate alternative suppliers, if required, or to redesign the Company's products to ‎‎‎accommodate components from different suppliers. The Company may experience significant delays in ‎‎‎manufacturing and shipping its products to customers and incur additional development, manufacturing ‎and other ‎‎costs to establish alternative sources of supply if the Company loses any of these sources or ‎is required to redesign ‎‎its products. The Company cannot predict if it will be able to obtain replacement ‎components within the time ‎‎frames that it requires at an affordable cost, if at all.‎

***Changes in U.S. trade policies or regulations***

Recent policy decisions by the U.S. presidential administration have introduced greater uncertainty with respect to trade policies, tariffs and government regulations affecting trade between the U.S. and other countries. Major developments in trade relations, such as the potential renegotiation or termination of the Canada-United States-Mexico Agreement, or the imposition of unilateral tariffs or other trade barriers on products imported into the U.S. as well as retaliatory tariffs or other trade barriers imposed by the U.S.'s trading partners, could impact the availability and cost of materials, resources and services, and the availability and cost of our products to U.S. customers, which in turn may affect our competitiveness and results of operations. The implementation of previously-announced, postponed, or new tariffs, or the escalation of trade disputes which interfere with our supply chain and our sales in affected markets, could have an adverse effect on our operations and profitability. In addition, rising protectionism and anti-globalization sentiment in the United States and other countries may adversely impact long-term economic growth in the countries in which we operate, which in turn may affect our business, results of operations and financial condition.

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

***Natural outdoor elements such as wind and precipitation may have a material adverse effect on the ‎use and effectiveness of the Company's products.***

The Company's business will involve the operation and flying of UAVs, a technology-based product ‎‎used outside. As such, the business is subject to various risks inherent in a technology-based ‎‎businesses operated in outdoor conditions, including faulty parts, breakdowns and crashes. Although ‎‎the Company anticipates the use of its UAVs in good climactic conditions and that adequate flying ‎‎conditions will be monitored by trained personnel, there can be no assurance that unpredictable natural ‎‎outdoor elements, which could be exacerbated due to risks associated with climate change, will not have a material adverse effect on the use and effectiveness of its products.‎

***The Company's products may be subject to recall or return.***

Manufacturers and distributors of products are sometimes subject to the recall or return of their products ‎‎‎for a variety of reasons, including product defects, safety concerns, packaging issues and inadequate ‎‎or inaccurate ‎labeling disclosure. If any of the Company's equipment were to be recalled due to an ‎‎alleged product ‎defect, safety concern or for any other reason, the Company could be required to incur ‎‎unexpected expenses of the recall ‎and any legal proceedings that might arise in connection with the ‎‎recall. The Company may lose a significant ‎amount of sales and may not be able to replace those sales ‎‎at an acceptable margin or at all. In ‎addition, a product recall may require significant management time ‎‎and attention. Additionally, product recalls may lead to ‎increased scrutiny of the Company's operations ‎‎by Transport Canada or other regulatory agencies, requiring ‎further management time and attention and ‎‎potential legal fees, costs and other expenses.‎‎

***‎‎If the Company releases defective products or services, its operating results could suffer.‎***

‎Products and services designed and released by the Company involve extremely complex software ‎‎programs and ‎are difficult to develop and distribute. While the Company has quality controls in place to ‎‎detect and prevent defects in its ‎products and services before they are released, these quality controls ‎‎are subject to human error, ‎overriding, and reasonable resource constraints. Therefore, these quality ‎‎controls and preventative measures may ‎not be effective in detecting and preventing defects in the ‎‎Company's products and services before they have been released into ‎the marketplace. In such an ‎‎event, the Company could be required, or decide voluntarily, to suspend the availability of the product or ‎‎services, which could significantly harm its business and operating results‎.‎

***‎The Company's products and services are complex and could have unknown defects or errors, which may give ‎rise to legal claims against the Company, diminish its brand or divert its resources from other purposes.‎***

The Company's UAVs rely on complex avionics, sensors, user-friendly interfaces and tightly integrated, ‎‎electromechanical designs to accomplish their missions. Despite testing, the Company's products have ‎contained ‎defects and errors and may in the future contain defects, errors or performance problems ‎when first introduced, ‎when new versions or enhancements are released, or even after these products ‎have been used by the Company's ‎customers for a period of time. These problems could result in ‎expensive and time-consuming design modifications ‎or warranty charges, delays in the introduction of ‎new products or enhancements, significant increases in the ‎Company's service and maintenance costs, ‎exposure to liability for damages, damaged customer relationships and ‎harm to the Company's ‎reputation, any of which could materially harm the Company's results of operations and ‎ability to achieve ‎market acceptance. In addition, increased development and warranty costs could be substantial ‎and ‎could significantly reduce the Company's operating margins.‎

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

The existence of any defects, errors, or failures in the Company's products or the misuse of the ‎Company's ‎products could also lead to product returns, recalls, or liability claims or lawsuits against it. A defect, error or ‎failure in one of the ‎Company's UAV could result in injury, death or property damage and significantly ‎damage the Company's ‎reputation and support for its UAV in general. The Company anticipates this risk ‎will grow as its UAV begins to be ‎used in Canadian domestic airspace and urban areas. The Company's ‎UAV test systems also have the potential to ‎cause injury, death or property damage in the event that ‎they are misused, malfunction or fail to operate properly ‎due to unknown defects or errors.‎ Although the ‎Company maintains insurance policies, it cannot provide any assurance that this insurance will be ‎‎adequate to protect the Company from all material judgments and expenses related to potential future ‎claims or ‎that these levels of insurance will be available in the future at economical prices or at all. A ‎successful product ‎liability claim could result in substantial cost to us. Even if the Company is fully ‎insured as it relates to a particular claim, the ‎claim could nevertheless diminish the Company's brand and ‎divert management's attention and resources, which ‎could have a negative impact on the Company's ‎business, financial condition and results of operations.‎

***The Company could be prohibited from shipping its products to certain countries if it is unable to obtain ‎Canadian government authorization regarding the export of its products, or if current or future export laws limit ‎or otherwise restrict the Company's business.‎***

The Company must comply with Canadian federal and provincial laws regulating the export of its ‎products. In ‎some cases, explicit authorization from the Canadian government is needed to export its ‎products. The export ‎regulations and the governing policies applicable to the Company's business are ‎subject to change. The Company ‎cannot provide assurance that such export authorizations will be ‎available for its products in the future. ‎Compliance with these laws has not significantly limited the ‎Company's operations or sales in the recent past, but ‎could significantly limit them in the future. Non-‎compliance with applicable export regulations could potentially ‎expose the Company to fines, penalties ‎and sanctions. If the Company cannot obtain required government ‎approvals under applicable ‎regulations, the Company may not be able to sell its products in certain international ‎jurisdictions, which ‎could adversely affect the Company's financial condition and results of operations.‎

***Negative consumer perception regarding the Company's products‎ could have a material adverse effect on the demand for the Company's ‎products and the business, results of operations, financial condition and cash flows of the Company.***

The Company believes the UAV industry is highly dependent upon consumer perception regarding the ‎‎safety, efficacy, and quality of the UAV used. Consumer perception of these products can be ‎‎significantly influenced by scientific research or findings, regulatory investigations, litigation, media ‎attention, ‎and other publicity regarding the use of UAV. There can be no assurance that future scientific ‎research, ‎findings, regulatory proceedings, litigation, media attention, or other research findings or ‎publicity will be ‎favourable to the UAV market. Future research reports, findings, regulatory proceedings, ‎litigation, media ‎attention or other publicity that are perceived as less favourable than, or that question, ‎earlier research ‎reports, findings or publicity could have a material adverse effect on the demand for the ‎Company's ‎products and the business, results of operations, financial condition and cash flows of the ‎Company. The ‎dependence upon consumer perceptions means that adverse scientific research reports, ‎findings, ‎regulatory proceedings, litigation, media attention or other publicity, whether or not accurate or ‎with merit, ‎could have a material adverse effect on the Company, the demand for the Company's ‎products, and the ‎business, results of operations, financial condition and cash flows of the Company. ‎Further, adverse ‎publicity reports or other media attention regarding the safety, the efficacy, and quality ‎of UAV based surveys in general, or the Company's products specifically, ‎could have a material adverse ‎effect.‎

***If the Company fails ‎‎to successfully promote its product brand, this could have a material adverse ‎effect on the Company's business, prospects, ‎‎financial condition and results of operations‎.***

The Company believes that brand recognition is an important factor to its success. If the Company fails ‎‎‎to promote its brands successfully, or if the expenses of doing so are disproportionate to any increased ‎‎‎net sales it achieves, it would have a material adverse effect on the Company's business, prospects, ‎‎‎financial condition and results of operations. This will depend largely on the Company's ability to ‎‎‎maintain trust, be a technology leader, and continue to provide high-quality and secure technologies, ‎‎‎products and services. Any negative publicity about the Company or its industry, the quality and ‎reliability of the Company's technologies, products and services, the Company's risk management ‎‎‎processes, changes to the Company's technologies, products and services, its ability to effectively ‎‎‎manage and resolve customer complaints, its privacy and security practices, litigation, regulatory ‎activity, and the experience of sellers and buyers with the Company's products or services, could ‎adversely affect the Company's reputation and the confidence in and use of the ‎‎Company's ‎technologies, products and services. Harm to the Company's brand can arise from ‎‎many sources, ‎including; failure by the Company or its partners to satisfy expectations of service and quality; ‎inadequate protection of sensitive information; compliance failures and claims; litigation and ‎‎other ‎claims; employee misconduct; and misconduct by the Company's partners, service ‎‎providers, or other ‎counterparties. If the Company does not successfully maintain a strong and trusted brand, its business ‎could be materially and adversely affected.‎ ‎

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

***The Company may be subject to electronic communication security risks.***

A significant potential vulnerability of electronic communications is the security of transmission of ‎confidential ‎information over public networks. Cyberattacks could result in unauthorized access to the ‎Company's computer ‎systems or its third-party IT service provider's systems and, if successful, ‎misappropriate personal or confidential ‎information. Anyone who is able to circumvent the Company's ‎security measures could misappropriate proprietary ‎information or cause interruptions in its operations. ‎The Company may be required to expend capital and other ‎resources to protect against such security ‎breaches or to alleviate problems caused by such breaches.‎

‎The last few years have seen an increase in the volume and sophistication ‎of targeted cyber-attacks. A failure of ‎the Company's IT ‎infrastructure could severely limit the Company's ability ‎to conduct ordinary operations or ‎expose the ‎Company to liability. To date, the Company's systems have functioned capably, and it has not ‎‎experienced a material impact to its ‎operations as a result of an IT infrastructure issue. Data security breaches ‎suffered by well-known companies and institutions have attracted a substantial amount of media attention, ‎prompting new foreign, federal, provincial and state laws and legislative proposals addressing data privacy and ‎security. As a result, the Company may become subject to more extensive requirements to protect the customer ‎information that it processes in connection with the purchase of its products, resulting in increased compliance ‎costs.‎

While the Company has taken measures to protect against cyberattacks, even the most well-protected IT networks, ‎systems and facilities remain potentially vulnerable because ‎the techniques used in attempted security breaches are ‎continually evolving and generally are not ‎recognized until launched against a target or, in some cases, are designed ‎not to be detected and, in ‎fact, may not be detected. Any such compromise of the Company's or its third party's IT ‎service ‎providers' data security and access, public disclosure, or loss of personal or confidential business ‎‎information, could result in legal claims and proceedings, liability under laws to protect privacy of ‎personal ‎information, and regulatory penalties, and could disrupt the Company's operations, require significant ‎‎management attention and resources to remedy any damages that result, and damage its reputation and ‎customers ‎willingness to transact business with us, any of which could adversely affect our business.‎ ‎

***The Company's business could be adversely affected if its consumer protection and data privacy practices are not ‎perceived as adequate or there are breaches of its security measures or unintended disclosures of its consumer data.‎***

‎The rate of privacy law-making is accelerating globally and interpretation and application of consumer ‎protection ‎and data privacy laws in Canada, the United States, Europe and elsewhere are often uncertain, ‎contradictory and in ‎flux. As business practices are being challenged by regulators, private litigants, and ‎consumer protection agencies ‎around the world, it is possible that these laws may be interpreted and ‎applied in a manner that is inconsistent with ‎the Company's data and/or consumer protection practices. If ‎so, this could result in increased litigation government ‎or court-imposed fines, judgments or orders ‎requiring that the Company change its practices, which could have an ‎adverse effect on its business and ‎reputation. Complying with these various laws could cause the Company to incur ‎substantial costs or ‎require it to change its business practices in a manner adverse to its business.‎

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

***The Company relies on its business partners, and they may be given access to sensitive and proprietary ‎information in order to provide services and support to the Company's teams.‎***

‎The Company relies on various business partners, including third-party service providers, vendors, ‎licensing partners, ‎development partners, and licensees, among others, in some areas of the Company's ‎business. In some cases, these ‎third parties are given access to sensitive and proprietary information in ‎order to provide services and support to the ‎Company's teams. These third parties may misappropriate ‎the Company's information and engage in ‎unauthorized use of it. The failure of these third parties to ‎provide adequate services and technologies, or the failure ‎of the third parties to adequately maintain or ‎update their services and technologies, could result in a disruption to ‎the Company's business ‎operations. Further, disruptions in the financial markets and economic downturns may ‎adversely affect ‎the Company's business partners and they may not be able to continue honoring their obligations ‎to the ‎Company. Alternative arrangements and services may not be available to the Company on commercially ‎‎reasonable terms or the Company may experience business interruptions upon a transition to an ‎alternative partner ‎or vendor. If the Company loses one or more significant business partners, the ‎Company's business could be ‎harmed.‎

***If the Company fails to protect, or incurs significant costs in defending, its intellectual property and other ‎proprietary rights, the Company's business, financial condition, and results of operations could be materially ‎harmed.‎***

‎The Company's success depends, in large part, on its ability to protect its intellectual property and other ‎proprietary ‎rights. The Company relies primarily on patents, trademarks, copyrights, trade secrets and ‎unfair competition laws, ‎as well as license agreements and other contractual provisions, to protect the ‎Company's intellectual property and ‎other proprietary rights. However, a portion of the Company's ‎technology is not patented, and the Company may ‎be unable or may not seek to obtain patent ‎protection for this technology. Moreover, existing Canadian legal ‎standards relating to the validity, ‎enforceability and scope of protection of intellectual property rights offer only ‎limited protection, may ‎not provide the Company with any competitive advantages, and may be challenged by ‎third parties. The ‎laws of countries other than Canada may be even less protective of intellectual property rights. ‎‎Accordingly, despite its efforts, the Company may be unable to prevent third parties from infringing ‎upon or ‎misappropriating its intellectual property or otherwise gaining access to the Company's ‎technology. Unauthorized ‎third parties may try to copy or reverse engineer the Company's products or ‎portions of its products or otherwise ‎obtain and use the Company's intellectual property. Moreover, ‎many of the Company's employees have access to ‎the Company's trade secrets and other intellectual ‎property. If one or more of these employees leave to work for ‎one of the Company's competitors, then ‎they may disseminate this proprietary information, which may as a result ‎damage the Company's ‎competitive position. If the Company fails to protect its intellectual property and other ‎proprietary rights, ‎then the Company's business, results of operations or financial condition could be materially ‎harmed. ‎From time to time, the Company may have to initiate lawsuits to protect its intellectual property and other ‎‎proprietary rights. Pursuing these claims is time consuming and expensive and could adversely impact ‎the ‎Company's results of operations.‎

‎In addition, affirmatively defending the Company's intellectual property rights and investigating whether ‎the ‎Company is pursuing a product or service development that may violate the rights of others may ‎entail significant ‎expense. Any of the Company's intellectual property rights may be challenged by others ‎or invalidated through ‎administrative processes or litigation. If the Company resorts to legal proceedings ‎to enforce its intellectual property ‎rights or to determine the validity and scope of the intellectual property ‎or other proprietary rights of others, then the ‎proceedings could result in significant expense to the ‎Company and divert the attention and efforts of the ‎Company's management and technical employees, ‎even if the Company prevails.‎

***Obtaining and maintaining the Company's patent protection depends on compliance with various procedural, document ‎submission, fee payment, and other requirements imposed by governmental patent agencies, and its patent ‎protection could be reduced or eliminated for non-compliance with these requirements.‎***

‎The Canadian Intellectual ‎Property Office ("**CIPO**"), the United States Patent and ‎Trademark Office ("**USPTO**") and various foreign national or international patent agencies ‎require compliance with a number of procedural, documentary, fee payment, and other similar provisions during ‎the patent application process. Periodic maintenance fees on any issued patent are due to be paid to the CIPO, the USPTO and ‎various foreign national or international patent agencies in several stages over the lifetime of the patent. While an ‎inadvertent lapse can in many cases be cured by payment of a late fee or by other means in accordance with the ‎applicable rules, there are situations in which non-compliance can result in abandonment or lapse of the patent or ‎patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. Non-compliance ‎events that could result in abandonment or lapse of patent rights include, but are not limited to, failure to timely file ‎national and regional stage patent applications based on the Company's international patent application, failure to respond to ‎official actions within prescribed time limits, non-payment of fees, and failure to properly legalize and submit ‎formal documents. If the Company fails to maintain the patents and patent applications covering its product candidates, its ‎competitors might be able to enter the market, which would have a material adverse effect on the Company's business. ‎

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

While a patent may be granted by a national patent office, there is no guarantee that the granted patent ‎is valid. ‎Options exist to challenge the validity of a patent which, depending upon the jurisdiction, may ‎include re-‎examination, opposition proceedings before the patent office, and/or invalidation proceedings ‎before the relevant ‎court. Patent validity may also be the subject of a counterclaim to an allegation of ‎patent infringement.‎

Pending patent applications may be challenged by third parties in protest or similar proceedings. Third ‎parties can ‎typically submit prior art material to patentability for review by the patent examiner. Regarding ‎Patent Cooperation ‎Treaty applications, a positive opinion regarding patentability issued by the ‎International Searching Authority does ‎not guarantee allowance of a national application derived from the ‎Patent Cooperation Treaty application. The ‎coverage claimed in a patent application can be significantly ‎reduced before the patent is issued, and the patent's ‎scope can be modified after issuance. It is also ‎possible that the scope of claims granted may vary from jurisdiction ‎to jurisdiction.‎

The grant of a patent does not have any bearing on whether the invention described in the patent ‎application would ‎infringe the rights of earlier filed patents. It is possible to both obtain patent protection ‎for an invention and yet still ‎infringe the rights of an earlier granted patent.‎

***The Company may be sued by third parties for alleged infringement of their proprietary rights, which could be ‎costly, time-consuming and limit the Company's ability to use certain technologies in the future.‎***

‎The Company may become subject to claims that its technologies infringe upon the intellectual property ‎or other ‎proprietary rights of third parties. Any claims, with or without merit, could be time-consuming ‎and expensive, and ‎could divert the Company's management's attention away from the execution of its ‎business plan. Moreover, any ‎settlement or adverse judgment resulting from these claims could require ‎the Company to pay substantial amounts ‎or obtain a license to continue to use the disputed technology, ‎or otherwise restrict or prohibit the Company's use of ‎the technology. The Company cannot assure that it ‎would be able to obtain a license from the third party asserting ‎the claim on commercially reasonable ‎terms, if at all, that the Company would be able to develop alternative ‎technology on a timely basis, if at ‎all, or that the Company would be able to obtain a license to use a suitable ‎alternative technology to ‎permit the Company to continue offering, and the Company's customers to continue ‎using, the ‎Company's affected product. An adverse determination also could prevent the Company from offering ‎‎its products to others. Infringement claims asserted against the Company may have a material adverse ‎effect on its ‎business, results of operations or financial condition.‎

 ****

***‎The Company may not be able to protect its intellectual property rights throughout the world.‎***

‎Filing, prosecuting, and defending patents on all of the Company's product candidates throughout the world would be ‎prohibitively expensive. Therefore, the Company has filed applications and/or obtained patents only in key markets ‎including the United States and Canada. Competitors may use the Company's technologies in jurisdictions where it has not ‎obtained patent protection to develop their own products and their products may compete with products of the Company.

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

***If the Company is required to write down goodwill and other intangible assets, the Company's financial ‎condition and results could be negatively affected. ‎***

 ****

Goodwill impairment arises when there is deterioration in the capabilities of acquired assets to generate ‎cash flows, ‎and the fair value of the goodwill dips below its book value. The Company is required to ‎review its goodwill for ‎impairment at least annually. Events that may trigger goodwill impairment include ‎deterioration in economic ‎conditions, increased competition, loss of key personnel, and regulatory ‎action. Should any of these occur, an impairment of ‎goodwill relating to the acquisition of Dronelogics ‎Systems Inc. could have a negative effect on the assets of the ‎Company.‎

 ****

***From time to time, the Company may become involved in legal proceedings, which could adversely affect the ‎Company.‎***

‎The Company may, from time to time in the future, become subject to legal proceedings, claims, ‎litigation and ‎government investigations or inquiries, which could be expensive, lengthy, and disruptive ‎to normal business ‎operations. In addition, the outcome of any legal proceedings, claims, litigation, ‎investigations or inquiries may be ‎difficult to predict and could have a material adverse effect on the ‎Company's business, operating results, or ‎financial condition.‎

***The Company's directors and officers may have conflicts of interest in conducting their duties.***

Because directors and officers of the Company are or may become directors or officers of other ‎‎reporting companies or have significant shareholdings in other technology companies, the directors and ‎‎officers of the Company may have conflicts of interest in conducting their duties. The Company and its ‎‎directors and officers will attempt to minimize such conflicts. In the event that such a conflict of interest ‎‎arises at a meeting of the directors of the Company, a director who has such a conflict will abstain from ‎‎voting for or against a particular matter in which the director has the conflict. In appropriate cases, the ‎‎Company will establish a special committee of independent directors to review a particular matter in ‎‎which several directors, or officers, may have a conflict. In determining whether or not the Company will ‎‎participate in a particular program and the interest therein to be acquired by it, the directors will primarily ‎‎consider the potential benefits to the Company, the degree of risk to which the Company may be ‎‎exposed and its financial position at that time. Other than as indicated, the Company has no other ‎‎procedures or mechanisms to deal with conflicts of interest.‎

‎The Company's Articles ‎provide that the Company must indemnify a director or former director against all judgments, ‎penalties ‎or fines to which such person is or may be liable by reason of such person being or having ‎been a director of the ‎Company and the executive officers and directors may also have rights to ‎indemnification from the Company, ‎including ‎pursuant to directors' and officers' liability insurance ‎policies, that will survive termination of their ‎‎agreements‎.‎

***Changes in accounting standards and subjective assumptions, estimates and judgments by ‎management ‎related to ‎complex accounting matters could significantly affect the Company's ‎reported financial results ‎or financial condition.‎***

 ****

Changes in accounting standards and subjective assumptions, estimates and judgments by ‎management ‎related to ‎complex accounting matters could significantly affect the Company's ‎reported financial results ‎or financial condition.

‎Generally accepted accounting principles and related accounting pronouncements, implementation ‎‎guidelines and ‎interpretations with regard to a wide range of matters that are relevant to the Company's ‎‎business, including but not limited to ‎revenue recognition, impairment of goodwill and intangible assets, ‎‎inventory, income taxes and litigation, are highly ‎complex and involve many subjective assumptions, ‎‎estimates and judgments. Changes in these rules or their ‎interpretation or changes in underlying ‎‎assumptions, estimates or judgments could significantly change the Company's reported ‎financial ‎‎performance or financial condition in accordance with generally accepted accounting principles.‎

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

**Risks Related to Our Common Shares**

**<u>The market price of the Common Shares may be highly volatile.</u>**

The market price of the Common Shares is highly volatile and has been subject to wide fluctuations ‎in response to a number of factors that are beyond the Company's control, including but not limited ‎to‎

● revenue or results of operations in any quarter failing to meet the expectations, published or otherwise, of ‎the investment community;‎

● actual or anticipated changes or fluctuations in its results of operations;‎

● announcements by us or the Company's competitors of new products or new or terminated significant contracts, ‎commercial relationships or capital commitments;‎

● rumors and market speculation involving it or other companies in its industry;‎

● changes in its executive management team or the composition of the board of directors of the Company (the "**Board** ");‎

● fluctuations in the share prices of other companies in the technology and emerging growth sectors;‎

● general market conditions and macroeconomic trends driven by factors outside the Company's control, such as pandemics, geopolitical conflicts, supply chain disruptions, market volatility, inflation, rising interest rate, political instability, and labor challenges, among other factors;

● actual or anticipated developments in its business or its competitors' businesses or the competitive ‎landscape generally;‎

● litigation involving us, the Company's industry or both, or investigations by regulators into its operations or those of ‎competitors;‎

● announced or completed acquisitions of businesses or technologies by the Company or its competitors;‎

● new laws or regulations or new interpretations of existing laws or regulations applicable to its ‎business;‎

● shareholder activism and related publicity;‎

● foreign exchange rates; and

● other risk factors as set out in the Company's most recent Annual Report (Form 20-F) and in the documents incorporated by ‎reference into the Annual Report.‎

If the market price of the Company's Common Shares drops significantly, shareholders could institute securities class action ‎lawsuits against it, regardless of the merits of such claims. Such a lawsuit could cause it to incur substantial ‎costs and could divert the time and attention of management and other resources from the Company's business, which ‎could harm its business, results of operations and financial condition.‎

***There is no guarantee that an active trading market for the Company's Common Shares will be maintained on ‎the CSE and/or Nasdaq. Investors may not be able to sell their Common Shares quickly or at the ‎latest market price if the trading in our Common Shares is not active.‎***

The Company's Common Shares are currently listed on the Canadian Stock Exchange ("**CSE**"), the Nasdaq Stock Market, LLC ("**Nasdaq**"), and the Frankfurt Stock Exchange, ‎however, it shareholders may be unable to sell significant quantities of Common Shares into the public ‎‎trading markets without a significant reduction in the price of their Common Shares, or at all and there ‎can be no guarantee that an active trading market for the Common Shares ‎may be maintained. There can ‎be no assurance that ‎there will be sufficient liquidity of its Common Shares on the trading market, and ‎that we will continue to meet ‎the listing requirements of the CSE, Nasdaq or any other public listing ‎exchange.‎

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

***Failure to meet Nasdaq's continued listing requirements could result in the delisting of the Company's Common Shares, negatively impact the price of the Company's Common Shares and negatively impact its ability to raise additional capital.***

 ****

If the Company fails to satisfy the continued listing requirements of the Nasdaq, such as corporate governance requirements or the minimum closing bid price requirement, the exchange may take steps to delist the Company's Common Shares. Such a delisting would likely have a negative effect on the price of the Company's Common Shares and would impair shareholders' ability to sell or purchase its Common Shares when they wish to do so.

As previously disclosed, on September 22, 2023, the Company received a letter from the Listing Qualifications ‎Department of Nasdaq notifying the Company of its noncompliance with Nasdaq Listing Rule 5550(a)(2) (the "Bid ‎Price Rule") by failing to maintain a minimum bid price for the Company's common shares of at least $1.00 per ‎share for 30 consecutive business days. The Company was allowed an initial 180-day grace period, or until March ‎‎20, 2024, (the "Bid Price Compliance Period"), to regain compliance with the Bid Price Rule. To regain compliance ‎with the Bid Price Rule the closing bid price of the Company's common shares needed to be at least $1.00 per share ‎for a minimum of ten consecutive business days during the Bid Price Compliance Period.

On March 21, 2024, the Company received notification that it had failed to regain compliance with the Bid Price ‎Rule and is not eligible for a second 180 day compliance period because of its failure to comply with the $5 million ‎minimum stockholders' equity initial listing requirement for the period ended September 30, 2023. Unless the ‎Company timely requests a hearing before an independent Nasdaq Hearings Panel (the "Nasdaq Panel"), the ‎Company's securities will be subject to delisting. Accordingly, the Company will request a hearing before the ‎Nasdaq Panel. The hearing request will automatically stay any suspension or delisting action pending the hearing ‎and the expiration of any additional extension period granted by the Nasdaq Panel following the hearing. In that ‎regard, pursuant to the Nasdaq Listing Bid Price Rules, the Nasdaq Panel has the discretion to grant an additional ‎extension period that can expire as late as September 17, 2024. At the hearing, the Company will be asked to ‎provide a plan to regain compliance to the Nasdaq Panel. The Company intends to present a plan to regain ‎compliance with the Bid Price Rule and request the continued listing of its common shares on Nasdaq pending such ‎compliance. However, there can be no assurance that the Nasdaq Panel will grant the Company's request or that ‎the Company will ultimately regain compliance with all applicable requirements for continued listing on Nasdaq.‎

***Future issuances of equity securities by us or sales by the Company's existing shareholders may cause the price ‎of its Common Shares to fall.‎***

The market price of the Company's Common Shares could decline as a result of issuances of securities or sales by its ‎existing shareholders in the market, including by its directors, executive officers and significant ‎shareholders, or ‎the perception that these sales could occur. Sales of the Company's Common Shares by ‎shareholders might also make it ‎more difficult for it to sell Common Shares at a time and price that it ‎deems appropriate. The Company also expects to ‎issue Common Shares in the future. Future issuances of Common ‎Shares, or the perception that such issuances ‎are likely to occur, could affect the prevailing trading ‎prices of the Common Shares.‎

***We may never pay dividends over the foreseeable future.‎***

Investors should not rely on an investment in the Company's Common Shares to provide dividend ‎income. The ‎Company does not anticipate that it will pay any cash dividends to holders of its Common ‎Shares in the ‎foreseeable future. Instead, the Company plans to retain any earnings to maintain and expand ‎its ‎operations. In addition, any future debt financing arrangement may contain terms prohibiting or limiting ‎‎the amount of dividends that may be declared or paid on its Common Shares. Accordingly, investors ‎must ‎rely on sales of their Common Shares after price appreciation, which may never occur, as the only ‎way to ‎realize any return on their investment. As a result, investors seeking cash dividends should not ‎purchase the ‎Company's Common Shares.‎

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

***United States investors may not be able to obtain enforcement of civil liabilities against us.***

 ****

The Company is incorporated under the laws of British Columbia, Canada, and its principal executive offices are located in Canada. Most of the Company's directors and officers and most of the experts named in this Annual Report reside outside of the United States and all or a substantial portion of the Company's assets and the assets of these persons are located outside the United States. Consequently, it may not be possible for an investor to effect service of process within the United States on the Company or those persons. Furthermore, it may not be possible for an investor to enforce judgments obtained in United States courts based upon the civil liability provisions of United States federal securities laws or other laws of the United States against those persons or the Company. There is doubt as to the enforceability, in original actions in Canadian courts, of liabilities based upon United States federal securities laws and as to the enforceability in Canadian courts of judgments of United States courts obtained in actions based upon the civil liability provisions of the United States federal securities laws. Therefore, it may not be possible to enforce those actions against the Company, certain of the Company's directors and officers or the experts named in this Annual Report.

***We are an emerging growth company and intend to take advantage of reduced disclosure requirements ‎applicable to emerging growth companies, which could make the Company's Common Shares less attractive to ‎investors.***

 ****

We are an "emerging growth company" as defined in the JOBS Act. We will remain an emerging growth ‎company until the earliest to occur of (i) the last day of the fiscal year in which we have total annual gross ‎revenue of $1.07 billion or more; (ii) December 31, 2026 (the last day of the fiscal year ending after the fifth ‎anniversary of the date of the completion of the first sales of its common equity pursuant to an effective ‎registration statement under the Securities Act); (iii) ‎the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-‎year period; or (iv) the date we qualify as a "large accelerated filer" under the rules of the SEC, which means the ‎market value of the Company's Common Shares held by non-affiliates exceeds $700 million as of the last business day of ‎its most recently completed second fiscal quarter after we have been a reporting company in the United States ‎for at least 12 months. For so long as we remain an emerging growth company, we are permitted to and intend to ‎rely upon exemptions from certain disclosure requirements that are applicable to other public companies that ‎are not emerging growth companies. These exemptions include not being required to comply with the auditor ‎attestation requirements of Section 404 ("**Section 404**") of the Sarbanes-Oxley Act (2002), as amended (the "**Sarbanes-Oxley Act**").‎

We may take advantage of some, but not all, of the available exemptions available to emerging growth ‎companies. ‎We cannot predict whether investors will find the Company's Common Shares less attractive if it relies on these ‎‎exemptions. If some investors find the Company's Common Shares less attractive as a result, there may be a less ‎active ‎trading market for its Common Shares and the price of its Common Shares may be more volatile. ‎

***We will incur increased costs as a result of operating as a public company in the United States ‎and the ‎Company's management will be required to devote substantial time to new compliance initiatives.‎***

 ****

As a U.S. public company, particularly if or when we are no longer an "emerging growth company" as ‎defined ‎‎under the JOBS Act, we incur significant legal, accounting and other expenses, in addition to ‎those we ‎incur as a ‎Canadian public company, that we did not incur prior to being listed on Nasdaq. In ‎‎addition, the Sarbanes-Oxley ‎Act, and rules implemented by the SEC and Nasdaq impose various other ‎‎requirements on public companies, and ‎the Company spends time and resources to ensure compliance with its ‎‎reporting obligations in both Canada and the ‎United States.‎

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

For example, pursuant to Section 404, we are required to furnish a report by our management on our ‎internal ‎control over financial reporting ("ICFR"), which, if or when we are no longer an emerging growth ‎company, must ‎be accompanied by an attestation report on ICFR issued by our independent registered ‎public accounting firm. ‎To achieve compliance with Section 404, we must document and evaluate our ‎ICFR, ‎which is both costly and challenging. In this regard, we must dedicate internal resources, ‎potentially engage outside consultants and adopt a detailed work plan to assess and document the ‎‎adequacy of our ICFR, continue steps to improve control processes as appropriate, validate through ‎testing that ‎controls are functioning as documented and implement a continuous reporting and ‎improvement process for ‎ICFR. Despite our efforts, there is a risk that neither we nor our independent ‎registered public accounting firm will ‎be able to conclude that our ICFR is effective as required by ‎Section 404. This ‎could result in a determination that there are one or more material weaknesses in our ‎ICFR, which could cause an ‎adverse reaction in the financial markets due to a loss of confidence in the ‎reliability of our consolidated ‎financial statements.‎

In addition, becoming a public company in the United States has increased legal and financial ‎compliance as well ‎as regulatory costs, such as additional Nasdaq fees, and has made some of our ‎public company obligations ‎more time consuming. We invest resources to comply with evolving laws, ‎regulations and standards in ‎both Canada and the United States, and this investment results in increased ‎general and administrative ‎expenses and increased diversion of management's time and attention from ‎revenue-generating activities to ‎compliance activities. If our efforts to comply with public company laws, ‎regulations and standards in the ‎United States are insufficient, regulatory authorities may initiate legal ‎proceedings against us and our business ‎may be harmed.‎

Being a public company in the United States and complying with applicable rules and ‎regulations also ‎makes it more expensive for us to obtain sufficient levels of director and officer liability insurance ‎‎coverage. This factor may also make it more difficult for us to attract and retain qualified executive ‎officers and ‎members of our Board of Directors.‎

***As a foreign private issuer, we are subject to different U.S. securities laws and rules than a domestic U.S. ‎issuer, which may limit the information publicly available to the Company's U.S. shareholders.‎***

We currently qualify as a "foreign private issuer" under applicable U.S. federal securities laws and, therefore, are ‎not required to comply with all of the periodic disclosure and current reporting requirements of the Exchange Act and related rules and regulations. As a result, we do ‎not file the same reports that a U.S. domestic issuer ‎would file with the SEC, although we are required to file ‎with or furnish to the SEC the continuous ‎disclosure documents that we are required to file in Canada under ‎Canadian securities laws. In addition, ‎the Company's officers, directors and principal shareholders are exempt from the ‎reporting and "short swing" profit ‎recovery provisions of Section 16 of the Exchange Act. Therefore, the Company's ‎shareholders may not know on as ‎timely a basis when its officers, directors and principal shareholders purchase ‎or sell our securities as ‎the reporting periods under the corresponding Canadian insider reporting requirements are ‎longer. In ‎addition, as a foreign private issuer, the Company is exempt from the proxy rules under the Exchange Act. The Company is ‎also exempt from Regulation FD, which prohibits issuers from making selective disclosures of material ‎non-‎public information. While the Company expects to comply with the corresponding requirements relating to proxy ‎statements ‎and disclosure of material non-public information under Canadian securities laws, these ‎requirements differ from ‎those under the Exchange Act and Regulation FD and shareholders should not ‎expect to receive in every case the ‎same information at the same time as such information is provided ‎by U.S. domestic issuers.

‎

In addition, as a foreign private issuer, we have the option to follow certain Canadian corporate ‎governance ‎practices, except to the extent that such laws would be contrary to U.S. federal securities ‎laws and Nasdaq ‎listing rules and provided that we disclose the requirements we are not following and ‎describe the Canadian ‎practices we follow instead. We rely on this exemption in part. As a result, the Company's ‎shareholders may not have ‎the same protections afforded to shareholders of U.S. domestic issuers that ‎are subject to all U.S. corporate ‎governance requirements.

At some point in the future, we may cease to be a foreign private issuer. If we cease to ‎qualify, we will ‎be subject to the same reporting requirements and corporate governance requirements as a U.S. ‎‎domestic issuer, which may increase the Company's costs of being a public company in the ‎United States.

**Draganfly Inc.**<br> **Management Discussion and Analysis**<br> **For the three and nine months ended September 30, 2025**<br>

**REGULATORY POLICIES**

***Disclosure Controls and Procedures***

Disclosure Controls and Procedures ("DC&P") are designed to provide reasonable assurance that all material information is gathered and reported on a timely basis to senior management so that appropriate decisions can be made regarding public disclosure and that information required to be disclosed by the issuer under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation. The Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"), along with other members of management, have designed, or caused to be designed under the CEO and CFO's supervision, DC&P and established processes to ensure that they are provided with sufficient knowledge to support the representations made in the interim certificates required to be filed under National Instrument 52-109.

***Internal Controls over Financial Reporting***

The CEO and CFO, along with participation from other members of management, are responsible for establishing and maintaining adequate ICFR to provide reasonable assurance regarding the reliability of financial statements prepared in accordance with IFRS. During the nine months ended September 30, 2025, there has been no change in the Company's ICFR that has materially affected, or is reasonably likely to materially affect, the Company's ICFR.

***Limitations of Controls and Procedures***

 

The Company's management, including its CEO and CFO, believe that any DC&P or ICFR, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, they cannot provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been prevented or detected. These inherent limitations include the realities that judgements in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Accordingly, because of the inherent limitations in a cost effective control system, misstatements due to error or fraud may occur and not be detected. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

**Other Information**

Additional information about the Company is available at www.draganfly.com

**Approval**

This MD&A is authorized for issue by the Board on November 12, 2025

## Exhibit 99.3

**Exhibit 99.3**

**Form 52-109F2**

***Certification of Interim Filings***

***Full Certificate***

 ****

I, Cameron Chell, the Chief Executive Officer of Draganfly Inc., certify the following:

1.  ***Review:*** I have reviewed the interim financial report and interim MD&A (together, the "interim
 filings") of Draganfly Inc. (the "issuer") for the interim period ended
 September 30, 2025.

2.  ***No misrepresentations:*** Based on my knowledge, having exercised reasonable diligence,
 the interim filings do not contain any untrue statement of a material fact or omit to state
 a material fact required to be stated or that is necessary to make a statement not misleading
 in light of the circumstances under which it was made, with respect to the period covered
 by the interim filings.

3.  ***Fair presentation:*** Based on my knowledge, having exercised reasonable diligence, the interim
 financial report together with the other financial information included in the interim filings
 fairly present in all material respects the financial condition, financial performance and
 cash flows of the issuer, as of the date of and for the periods presented in the interim
 filings.

4.  ***Responsibility:*** The issuer's other certifying officer(s) and I are responsible for establishing and
 maintaining disclosure controls and procedures (DC&P) and internal control over financial
 reporting (ICFR), as those terms are defined in National Instrument 52-109 *Certification of Disclosure in Issuers' Annual and Interim Filings, for the issuer.* 

5.  ***Design:*** Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer's
 other certifying officer(s) and I have, as at the end of the period covered by the interim
 filings

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) designed
 DC&P, or caused it to be designed under our supervision, to provide reasonable assurance
 that

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) material
 information relating to the issuer is made known to us by others, particularly during the
 period in which the interim filings are being prepared; and

(ii) information
 required to be disclosed by the issuer in its annual filings, interim filings or other reports
 filed or submitted by it under securities legislation is recorded, processed, summarized
 and reported within the time periods specified in securities legislation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) designed
 ICFR, or caused it to be designed under our supervision, to provide reasonable assurance
 regarding the reliability of financial reporting and the preparation of financial statements
 for external purposes in accordance with the issuer's GAAP.

5.1  ***Control framework:*** The control framework the issuer's other certifying officer(s) and
 I used to design the issuer's ICFR is the Internal Control – Integrated Framework
 (2013 COSO Framework) published by the Committee of Sponsoring Organizations of the Treadway
 Commission (COSO).

5.2 N/A.

5.3 N/A.

6.  ***Reporting changes in ICFR:*** The issuer has disclosed in its interim MD&A any change in the
 issuer's ICFR that occurred during the period beginning on July 1, 2025 and ended on
 September 30, 2025 that has materially affected, or is reasonably likely to materially affect,
 the issuer's ICFR.

Date: ___________, 2025

---

| |
|:---|
| ![](ex99-3_001.jpg) |
| Cameron Chell |
| Chief Executive Officer |

---

## Exhibit 99.4

**Exhibit 99.4**

**Form 52-109F2**

***Certification of Interim Filings***

***Full Certificate***

 ****

I, Paul Sun, the Chief Financial Officer of Draganfly Inc., certify the following:

1.  ***Review:*** I have reviewed the interim financial report and interim MD&A (together, the "interim
 filings") of Draganfly Inc. (the "issuer") for the interim period ended
 September 30, 2025.

2.  ***No misrepresentations:*** Based on my knowledge, having exercised reasonable diligence,
 the interim filings do not contain any untrue statement of a material fact or omit to state
 a material fact required to be stated or that is necessary to make a statement not misleading
 in light of the circumstances under which it was made, with respect to the period covered
 by the interim filings.

3.  ***Fair presentation:*** Based on my knowledge, having exercised reasonable diligence, the interim
 financial report together with the other financial information included in the interim filings
 fairly present in all material respects the financial condition, financial performance and
 cash flows of the issuer, as of the date of and for the periods presented in the interim
 filings.

4.  ***Responsibility:*** The issuer's other certifying officer(s) and I are responsible for establishing and
 maintaining disclosure controls and procedures (DC&P) and internal control over financial
 reporting (ICFR), as those terms are defined in National Instrument 52-109 *Certification of Disclosure in Issuers' Annual and Interim Filings, for the issuer.* 

5.  ***Design:*** Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer's
 other certifying officer(s) and I have, as at the end of the period covered by the interim
 filings

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) designed
 DC&P, or caused it to be designed under our supervision, to provide reasonable assurance
 that

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) material
 information relating to the issuer is made known to us by others, particularly during the
 period in which the interim filings are being prepared; and

(ii) information
 required to be disclosed by the issuer in its annual filings, interim filings or other reports
 filed or submitted by it under securities legislation is recorded, processed, summarized
 and reported within the time periods specified in securities legislation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) designed
 ICFR, or caused it to be designed under our supervision, to provide reasonable assurance
 regarding the reliability of financial reporting and the preparation of financial statements
 for external purposes in accordance with the issuer's GAAP.

5.1  ***Control framework:*** The control framework the issuer's other certifying officer(s) and
 I used to design the issuer's ICFR is the Internal Control – Integrated Framework
 (2013 COSO Framework) published by the Committee of Sponsoring Organizations of the Treadway
 Commission (COSO).

5.2 N/A.

5.3 N/A.

6.  ***Reporting changes in ICFR:*** The issuer has disclosed in its interim MD&A any change in the
 issuer's ICFR that occurred during the period beginning on July 1, 2025 and ended on
 September 30, 2025 that has materially affected, or is reasonably likely to materially affect,
 the issuer's ICFR.

Date: ___________________, 2025

---

| |
|:---|
| ![](ex99-4_001.jpg) |
| Paul Sun |
| Chief Financial Officer |

---